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Abstract 
 
Chapter 1 
 Bisphosphine monoxides have unique coordinating capabilities with transition 
metals. Several research groups have independently reported transition metal-catalyzed 
highly stereoselective reactions by using chiral bisphosphine monoxides as the ligands. A 
review of recent works in this field is provided in this chapter to showcase the features of 
this class of ligand. 
 
Chapter 2 
 We have developed a copper-catalyzed borylation method to synthesize α-
aminoboronic esters, which are biologically interesting molecules in enzyme inhibitions. 
Employment of hemiaminal ethers as substrates to in situ generate the corresponding 
aldimines obviated purification of the unstable aldimines and potential imine-enamine 
tautomerization. By using a chiral bisphosphine monoxide ligand in our copper-catalyzed 
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 borylation conditions, we successfully synthesized a variety of enantioenriched alkyl-
substituted α-aminoboronic esters in good yields and with good enantioselectivity. 
 
Chapter 3 
 A ruthenium-catalyzed three-step tandem sequence was established to prepare 
nitrogen-protected 2,3-dihydroxypyrrolidines and 2,3-dihydroxypiperidines. This tandem 
sequence includes ring-closing metathesis, olefin isomerization and olefin 
dihydroxylation, and utilizes the second-generation Grubbs’ catalyst as the initial 
ruthenium precatalyst. Readily accessible nitrogen-tethered dienes were used as the 
substrates to prepare the heterocyclic compounds in an efficient fashion. Through 
optimization, we discovered the optimal conditions for ruthenium-catalyzed 
dihydroxylation of ene-carbamates and ene-sulfonamides, which were the challenging 
substrates in the previous methods. 
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 1 
Chapter 1 
Literature Review: Recent Examples of Using Chiral 
Bisphosphine Monoxide Ligands in Transition Metal-
Catalyzed Asymmetric Reactions	  
1.1 General introduction 
Since the concept of “hemilabile ligand” was proposed in the 1970s,1 it has 
become an attractive direction in new ligand design. This class of ligand is consisted of a 
Lewis soft group, a Lewis hard group and the linker between these two fragments that 
possess distinctive coordinating capabilities. The soft moiety has strong affinity with a 
low-valent transition metal, but the hard moiety binds to the same metal in a relatively 
weak and reversible fashion. Compared to a conventional bidentate ligand, a hemilabile 
ligand can readily provide a vacant coordinating site on the chelated metal; compared to a 
monodentate ligand, a hemilabile ligand can contribute more stabilization to the chelated 
metal. This unique chelation mode sometimes leads to unexpected reactivity and/or 
selectivity in a transition metal-catalyzed reaction.  
 
Figure 1.1 The representative chelation mode of hemilabile ligands with transition metals 
                                                
1 For reviews, see: (a) Bader, A.; Lindner, E. Coord. Chem. Rev. 1991, 108, 27-110. (b) Braunstein, P.; 
Naud, F. Angew. Chem. Int. Ed. 2001, 40, 680-699. (c) Bassetti, M. Eur. J. Inorg. Chem. 2006, 4473-4482.  
P
P O
R2R1
M
R4R3
P
P O
R2R1
M
R4R3
vacant coordination site
 2 
Bisphosphine monoxides (BPMOs) constitute a broad and important branch in the 
field of hemilabile ligand.2 Their phosphine fragments can bind to various transition 
metals, whereas the phosphine oxide fragments serve as the labile coordinating sites. 
Recently, several groups separately reported highly enantioselective reactions employing 
chiral BPMO ligands. This chapter will provide a review of their studies. 
1.2 DuPhos-based chiral BPMOs 
 
 
Figure 1.2 Methyl-DuPhos and Methyl-DuPhos monoxide 
 
In the study of copper-catalyzed nucleophilic addition of dialkylzinc reagents to 
N-phosphinoylaldimines,3 Charette initially found that 5 mol% Cu(OTf)2 and 5.5 mol% 
1.1 served as the most effective catalyst system in the model reaction.3a During 
optimization they found that the stereoselectivity could be further improved by using 
additives. Addition of 5 mol% Zn(OTf)2 (entry 3, Table 1.1) or simply employing 10 
mol% Cu(OTf)2 (entry 4, Table 1.1) improved the enantioselectivity to 96% ee, but a 
comparable yield was only obtained in the latter case (entry 1 and 4, Table 1.1). With the 
optimal conditions Charette and coworkers tested a variety of aryl-substituted N-
                                                
2 For a review, see: Grushin, V. Chem. Rev. 2004, 104, 1629-1662.  
3 (a) Boezio, A. A.; Charette, A. B. J. Am. Chem. Soc. 2003, 125, 1692-1693. (b) Boezio, A. A.; 
Pytkowicz, J.; Côté, A.; Charette, A. B. J. Am. Chem. Soc. 2003, 125, 14260-14261. 
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 3 
phosphinoylimines in the reaction. High yields and enantioselectivities were obtained 
from almost all the surveyed substrates. 
 
Entry Cu(OTf)2  
(mol%) 
1.1  
(mol%) 
Additive  
(mol%) 
Conversion  
(%)a 
ee  
(%)b 
1 5.0  5.5 — 96 93 
2 8.0 8.5 — 96 96 
3 5.0  5.5 Zn(OTf)2 (5.0) 86 96 
4 10.0 5.0 — 95 95 
                                         aDetermined by 1H-NMR. bDetermined by chiral HPLC. 
 
Table 1.1 Optimization of catalyst and ligand loadings and additives 
 
 
Equation 1.1 Cu(OTf)2/Methyl-DuPhos Catalyzed nucleophilic addition of imines 
 
Meanwhile, Charette’s group conducted a mechanistic study of the reaction of 
Table 1.1.4 They observed that the addition sequence of required reagents is critical to the 
reaction outcome. If Cu(OTf)2 (6 mol%) and ligand 1.1 (3 mol%) were mixed for 1 h 
before Et2Zn (2.0 equiv) was added, 92% conversion and 89% ee were obtained (entry 1, 
Table 1.2). If Cu(OTf)2 and Et2Zn were mixed before the ligand was added, 38% 
                                                
4 Côté, A.; Boezio, A. A.; Charette, A. B. Angew. Chem. Int. Ed. 2004, 43, 6525-6528.    
Ph
N P
O
Ph
Ph
H
Cu(OTf)2 (x mol%)
1.1 (y mol%)
Et2Zn (2.0 equiv)
PhMe, 0 °C, 24 h
Ph
HN P
O
Ph
Ph
Et
Additive
1.3 1.4
R
N P
O
Ph
Ph
H
Cu(OTf)2 (10 mol%)
1.1 (5 mol%)
R12Zn (2.0 equiv)
PhMe, 0 °C, 24 h
R
HN P
O
Ph
Ph
R1
(R = aryl)
(R1 = Et, Me, nBu)
51-98% yield
89-96% ee
R = cyclopropyl, R1 = Et, 82% yield, 85% ee
 4 
conversion and a racemic product were obtained (entry 2, Table 1.2). According to these 
observations, Charette proposed that premixing Cu(OTf)2 and 1.1 caused the electron-
rich phosphines to be oxidized by Cu(II), and that the in situ generated phosphine oxide 
species was the actual ligand responsible for high reactivity and enantiocontrol. 
To test the hypothesis, Methyl-Duphos monoxide and bisoxide were synthesized 
and evaluated in the reaction respectively. The results of control experiments 
unambiguously indicated that 1.2 is a better ligand in the copper-catalyzed nucleophilic 
addition (entry 3 and 4, Table 1.2). With Methyl-DuPhos bisoxide the reaction still 
reached over 80% conversion, but produced no stereoselectivity. In addition, Charrete 
investigated oxidation of Methyl-DuPhos by different Cu(I) and Cu(II) salts. The results 
suggested that Methyl-DuPhos monoxide 1.2 is generated by mixing Methyl-DuPhos and 
Cu(OTf)2. 
 
Entry Ligand Conversion (%)a ee (%)b 
1c 1.1 92 89 
2d 1.1 38 0 
3d 1.2 100 97 
4d 1.2 100 97 
                                   aDetermined by 1H-NMR. bDetermined by chiral 
                                      HPLC. cCu(OTf)2 mixed with ligand, then Et2Zn. 
                                   dCu(OTf)2 mixed with Et2Zn, then ligand. 
Table 1.2 Control experiments for ligand identification 
 
Ph
N P
O
Ph
Ph
H
Cu(OTf)2 (6 mol%)
ligand (3 mol%)
Et2Zn (2.0 equiv)
PhMe, 0 °C
Ph
HN P
O
Ph
Ph
Et
1.3 1.4
 5 
As the actual ligand was identified Charette’s group developed a three-step gram-
scale synthesis to prepare 1.2,3b and then demonstrated its outstanding catalytic activity in 
the same type of reaction. 
 
Equation 1.2 The new reaction conditions based on Methyl-DuPhos monoxide ligand 
 
Encouraged by the success in aryl substrates, Charette and coworkers planed to 
extend the substrate scope to alkyl aldimines.5 A practical problem they had was lacking 
an efficient method to access alkyl-substituted N-phosphinoylaldimines, because these 
compounds usually are susceptible to hydrolysis and tend to undergo isomerization to the 
corresponding enamines. To overcome this issue, they introduced N-phosphinoyl α-
amino sulfones to in situ generate corresponding aldimines in presence of excess 
dialkylzinc reagents.5 Under the intial conditions shown in Scheme 1.1 the 3-
phenylpropanal derived model substrate gave 97% yield and 94% ee. To improve the 
enantioselectivity while retaining a high yield, they optimized the ratio of copper to 
ligand and discovered that approximate 1:1 ratio gave the most satisfying result (98% 
yield, 96% ee). Under the optimal conditions, other α-amino sulfone substrates also gave 
excellent yields and enantioselectivities. They proposed that EtZnOTf, generated from 
                                                
5 Côté, A.; Boezio, A. A.; Charette, A. B. Proc. Natl. Acad. Sci. 2004, 101, 5405-5410. 
R
N P
O
Ph
Ph
H
Cu(OTf)2 (6 mol%)
1.2 (3 mol%)
R12Zn (2.0 equiv)
PhMe, 0 °C, 16-24 h
R
HN P
O
Ph
Ph
R1
(R = aryl)
(R1 = Et, Me, iPr, nBu)
80-98% yield
89-98% ee
When R = cyclopropyl, R1 = Et, 95% yield, 94% ee
 6 
Et2Zn and Cu(OTf)2, could function as a Lewis acid to enhance the electrophilicity of in 
situ formed aldimines through coordinating with the amino protecting group.  
 
Scheme 1.1 in situ Generated alkyl imines in copper-catalyzed nucleophilic addition 
 
 
Equation 1.3 Alkyl-substituted α-amino sulfones in nucleophilic addition 
 
Based on the strategy developed by Snapper and Hoveyda of in situ generating o-
anisidyl aldimines from different aldehydes and o-anisidine in presence of excess 
dialkylzinc reagents,6 Charette also discovered a one-pot reaction condition to perform 
their copper-catalyzed nucleophilic additions to N-phosphinoylaldimines.7 A preformed 
copper(I) complex (1.2)2•CuOTf, prepared from CuOTf and Methyl-DuPhos(O), was 
used in the reaction conditions to simplify the experimental procedures. According to 
Charette’s investigation,7 this copper(I) complex has high oxygen stability, although 
                                                
6 (a) Porter, J. R.; Traverse, J. F.; Hoveyda, A. H.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 10409-
10410. (b) Akullian, L. C.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4244-4247. 
(c) Akullian, L. C.; Porter, J. R.; Traverse, J. F.; Snapper, M. L.; Hoveyda, A. H. Adv. Synth. Catal. 2005, 
347, 417-425. 
7 Côté, A.; Charette, A. B. J. Org. Chem. 2005, 70, 10864-10867. 
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Cu(OTf)2: 10 mol%, 1.2: 5 mol% 97% yield, 94% ee
Cu(OTf)2: 4.5 mol%, 1.2: 5 mol% 98% yield, 96% ee
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Cu(OTf)2 (4.5 mol%)
1.2 (5 mol%)
Et2Zn (2.5 equiv)
PhMe, -20 °C to rt, 16 h
R
HN P
O
Ph
Ph
R1
(R = alkyl) 86-98% yield90-97% ee
 7 
copper(I) species and electron-rich phosphines are usually oxygen-sensitive. With the 
established conditions, diphenylphosphinoylamide and a variety of aldehydes can be used 
directly as the starting materials to produce various enantioenriched secondary amines. 
 
Equation 1.4 The one-pot conditions for preparation of enantioenriched secondary amines 
 
In addition to using aldimines as the substrates, Charette and coworkers tried to 
apply their methodologies to trifluoromethyl-substituted ketimines to access 
corresponding enantioenriched tertiary amines.8 To circumvent the low reactivity of aryl 
trifluoromethyl ketones in condensation with N-diphenylphosphinoyl amide and the 
stability issue with the resulted ketimines, Charette employed the trifluoromethyl-
substituted hemiaminal ethyl ethers, which were prepared through a Ti(OEt)4-mediated 
three-component reation (Equation 1.5),8 as the precursors of the corresponding 
ketimines in presence of excess dialkylzinc reagents. The synthesized hemiaminal ethers 
can be deprotonated by the dialkylzinc reagents to release the parent ketimines in situ,8 
similar to the  “decomposation” pathway of N-phosphinoyl α-amino sulfones in their 
previous studies.5 Under the optimal conditions established for the aldimine substrates, 
the trifluoromethyl-substituted hemiaminal ethyl ethers produced the desired tertiary 
amines in good yields and high enantioselectivities (Equation 1.6).       
                                                
8 Lauzon, C.; Charette, A. B. Org. Lett. 2006, 8(13), 2743-2745. 
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1
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(3.0 equiv) (1.0 equiv)
(R1= alkyl, aryl)
(R2= Me, Et)
32-90% yield
90-97% ee
(1.2)2•CuOTf
P
O
P
Cu
P
O
P
OTf
 8 
 
Equation 1.5 Preparation of trifluoromethyl-substituted hemiaminal ethyl ethers 
 
 
 
Equation 1.6 Copper-catalyzed nucleophilic addition of hemiaminal ethyl ethers 
 
Back to the general principles of ligand design, Charette was interested in which 
phosphine-containing moiety in Methyl-DuPhos monoxide dominates stereocontrol in the 
abovementioned copper-catalyzed reactions. 9  Unfortunately, the disproportionating 
nature of Cu(I) caused rapid equilibration between the paramagnetic Cu(0) and Cu(II) 
complexes, which complicated 31P-NMR of Methyl-DuPhos(O) under the reaction 
conditions. Alternatively, Charette’s group conducted a series of control experiments 
with some analogues of ligand 1.2 that were synthesized separately.  
The fact that ligand 1.7, 1.8, or a mixture of 1.7 and 1.8 gave the racemic product 
indicated the necessity of a bidentate ligand for enantioinduction. The results obtained 
from ligand 1.9, 1.10 and 1.11 provided a clear clue to the “puzzle” they had. Ligand 1.10 
exhibited slight enantioselectivity, but 1.11 gave the same level of enantioselectivity as 
1.2. This comparison demonstrated that the chiral structure of phosphinyl fragment in 
Methyl-DuPhos(O) is important for the stereochemical outcome.  
                                                
9 Bonnaventure, I.; Charette, A. B. J. Org. Chem. 2008, 73, 6330-6340.  
R CF3
O
+ H2N
P
O
PhPh
(1.0 equiv)(2.7 equiv)
Ti(OEt)4
(1.8 equiv)
CH2Cl2, rt, 96 h
(R= aryl)
R CF3
NHPOPh2
OEt
46-63% yield
Cu(OTf)2 (10 mol%)
1.2 (5 mol%)
Et2Zn (3.0 equiv)
PhMe, 0 °C, 16 h
R CF3
NHPOPh2
OEt
(R= aryl)
R CF3
NHPOPh2
Et
71-83% yield
91-97% ee
 9 
                
Entry Ligand (mol%) Conversion (%)a ee (%)b 
1 1.2 (5) 85 96 
2 1.7 (10)  85 0 
3 1.8 (10) 81 0 
4 1.7 + 1.8 (5 + 5)  92 0 
5 1.9 (5) 65 60 
6 1.10 (5)  99 13 
7 1.11 (5)  95 96 
                aDetermined by 1H-NMR. bDetermined by chiral HPLC or SFC. 
 
 
 
Table 1.3 Ligand effect on the reactivity and stereoselectivity 
 
On the other hand, the significant difference in enantioselectivity produced by 
ligand 1.2 and 1.9 implied that the skeleton of phosphinoyl fragment also plays a role. In 
ligand 1.12, 1.13, 1.14, 1.15, and 1.16 the phosphinoyl group was replaced with another 
type of Lewis hard group, but they all gave low enantioselectivity (up to 29% ee) and 
mostly low conversions (up to 68%). This observation confirmed the importance of a 
suitable hemilabile group for good reactivity and selectivity. Focused on mixed 
phosphine-phosphine oxide ligands, Charette further studied the effect of different 
Ph
N P
O
Ph
Ph
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Et2Zn (2.0 equiv)
PhMe, 0 °C, 16 h
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O
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Me
Me
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P
Me
Me
O
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P
P
Me
Me
Me
Me
Me
O
P
P
Me
O Me
P
P
Me
Me
O
1.9 1.10 1.11
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phosphinoyl fragments on the reaction. To their delight, ligand 1.21 produced comparable 
conversion and enantioselectivity as the Methyl-DuPhos(O). 
 
Entry Ligand Conversion (%)a ee (%)b 
1 1.2 85 96 
2 1.17 75 90 
3 1.18 10 0 
4 1.19 36 60 
5 1.20 91 86 
6 1.21 84 94 
7 1.22 49 38 
                       aDetermined by 1H-NMR. bDetermined by chiral  
                         HPLC or SFC. 
 
           
 
 
Table 1.4 Effect of different Lewis hard groups on the reactivity and stereoselectivity 
 
As a conclusion, they proposed that the chiral skeleton of phosphine moiety in 
Methyl-DuPhos monoxide is an essential factor in stereocontrol, and that the Lewis 
Ph
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basicity of phosphine oxide moiety, manifested in bond length and polarizability, 
cooperatively poses impact on the shape of the chiral pocket and catalyst activity.5 
Charette also studied the same type of reaction with β-nitroalkenes as the 
substrates.10 When excess ligand 1.2 was used, making the ratio of copper to ligand as 1:4, 
high yields and enantioselectivities were obtained from most of the substrates. High 
ligand loading suppressed polymerization of the substrates and disrupted the dimerization 
of (1.2)•CuEt complex to a non-selective form.11 
        
Equation 1.7 Copper-catalyzed nucleophilic addition of diethylzinc to β-nitroalkenes 
 
  Another type of reaction that Charette explored with Cu(I)/Methyl-DuPhos(O) 
catalyst system is enantioselective hydrosilylation of β,β-disubstituted vinyl phenyl 
sulfones in presence of a proton source,12 which can serve as an alternative way of 
asymmetric hydrogenation of vinyl sulfones under mild conditions. Cu(I)/Methyl-
DuPhos(O) complex exhibited impressive enantiocontrol. Use of a NaOH aqueous 
solution as the additive suppressed consumption of phenylsilane by water13 and hence 
drove the reaction to completion. More importantly, this additive improved the 
                                                
10 Côté, A.; Lindsay, V. N. G.; Charette, A. B. Org. Lett. 2007, 9(1), 85-87.  
11 Charette, A. B.; Côté, A.; Desrosiers, J.-N.; Bonnaventure, I.; Lindsay, V. N. G.; Lauzon, C.; Tannous, 
J.; Boezio, A. A. Pure Appl. Chem. 2008, 80(5), 881-890.   
12 Desrosiers, J.-N.; Charette, A. B. Angew. Chem. Int. Ed. 2007, 46, 5955-5957.   
13 Schubert, U.; Lorenz, C. Inorg. Chem. 1997, 36, 1258-1259. 
R
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(1.2)2•CuOTf
1.2 (2.5 mol%)
Et2Zn (2.0 equiv)
Et2O, -70 °C, 16 h
(1.25 mol%)
R
NO2
Et
(R = alkyl, aryl) 70-99% yield
83-98% ee
P
O
P
Cu
P
O
P
OTf
(1.2)2•CuOTf
 12 
reproducibility of the reaction. Use of pure water or protic organic solvents as the 
additive led to low conversions. 
 
Equation 1.8 Enantioselective reduction of β ,β-disubstituted vinyl phenyl sulfones 
 
1.3 BINAP and SDP-based chiral BPMOs  
 
 
Figure 1.3 (R)-BINAP and (R)-BINAP monoxide, (R)-Xyl-SDP and (R)-Xyl-SDP monoxide 
 
In situ reduction of Pd(II) to Pd(0) by excess phosphine ligands14 is a frequently 
used strategy in Pd(0)/phosphine complex-catalyzed reactions. The sacrificed phosphines 
are converted to phosphine oxides, which are less coordinating to Pd(0) and usually 
treated as inert species. Since Oestreich’s group disclosed that chiral BINAP monoxides 
                                                
14 (a) Ozawa, F.; Kubo, A.; Hayashi, T. Chemistry Letters 1992, 2177-2180. (b) Amatore, C.; Carré, E.; 
Jutand, A.; M’Barki, M. A. Organometallics 1995, 14, 1818-1826. (c) Csákai, Z.; Skoda-Földes, R.; Kollár, 
L. Inorganica Chimica Acta 1999, 286, 93-97. 
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PhSiH3 (1.5 equiv)
PhH, rt, 12 h
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R1 = aryl or alkyl 33-98% yield
70-99% ee
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1.23
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1.24
PAr2
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Ar =
Me
Me
1.25
PAr2
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O
(R)-Xyl-SDP (R)-Xyl-SDP(O)
1.26
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can behave as effective ligands in enantioselective Heck reactions,15 the catalytic utility 
of this class of ligand started receiving more attention. 
In the early 1990s Hayashi reported an enantioselective intermolecular Heck 
reaction of 2,3-dihydrofuran and aryl triflates by using Pd(OAc)2 and (R)-BINAP (1:2 
ratio of Pd to ligand) as the catalyst system.16 The enantioselectivity initially came from a 
stereoselective olefin insertion step where a suitable orientation of 2,3-dihydrofuran 
could avoid close interaction to the ligand (Scheme 1.2). Use of aryltriflates as the 
coupling partners is important to this step, because the cationic aryl-Pd(II) intermediate 
can strongly bind with the olefin substrates and suppress partial dissociation of (R)-
BINAP from Pd(II) for olefin insertion. Otherwise, the insertion process will be much 
less stereoselective (aryl iodides resulted in racemic products).16a  
 
Equation 1.9 Hayashi’s catalyst system for arylation of 2,3-dihydrofuran 
 
                                                
15 (a) Wöste, T. H.; Oestreich, M. Chem. Eur. J. 2011, 17, 11914-11918. (b) Wöste, T. H.; Oestreich, M. 
ChemCatChem 2012, 4, 2096-2101.  
16 (a) Ozawa, F.; Kubo, A.; Hayashi, T.; Nishioka, E.; Yanagi, K.; Moriguchi, K.-I. J. Am. Chem. Soc. 
1991, 113, 1417-1419. (b) Ozawa, F.; Kubo, A.; Hayashi, T. Tetrahedron Letters 1992, 33(11), 1485-1488. 
(c) Ozawa, F.; Kobatake, Y.; Hayashi, T. Tetrahedron Letters 1993, 34(15), 2505-2508. 
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(5.0 equiv) 42-86% yield
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76-93% ee 46-67% ee
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Scheme 1.2 Proposed model for the stereoselectivity in Hayashi’s arylation 
 
Furthermore, the observed enantioselectivity was also a consequence of a kinetic 
resolution process, in which the more energetically favorable pathway will lead to a 
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subsequent hydrometallation/β-hydride elimination sequence (Scheme 1.2).17 As a net 
effect, this incorporated kinetic resolution enhanced enantiopurities of two final products 
through converting one enantiomer of the arylated compound to a different olefin isomer. 
The ratio of two olefin products is determined by the dissociation rate of the arylated 
olefin from a hydrido-Pd(II)-olefin complex (an associative mechanism is invovled).17 
In the same period, Hayashi also demonstrated that Pd(OAc)2 can 
stoichiometrically oxide BINAP to generate Pd(0) along with BINAP monoxide.14a 
Intrigued by these two related studies, Oestreich evaluated (R)-BINAP(O) as a chiral 
ligand in the same type of reaction.15a  
 
Entry Catalyst Ligand Solvent Yield (%) 
Ratioa 
(R)-1.28 : (R)-
1.29 
ee 
(%)b 
(R)-
1.28 
ee 
(%)b 
(R)-
1.29 
1 Pd(OAc)2 1.23 THF 68 100 : 0 66 — 
2 Pd(OAc)2 1.24 THF  80 2 : 98 — 92 
3 Pd(OAc)2 1.23 PhH 75 99 : 1 64 — 
4 Pd(OAc)2 1.24 PhH 70 12 : 88 76 88 
5 Pd(dba)2 1.23 PhH 56c 99 : 1 66 — 
6 Pd(dba)2 1.24 PhH 80 5 : 95 92 94 
           aDetermined by achiral GLC. bDetermined by chiral GLC. cIncomplete conversion.  
Table 1.5 Ligand effect on arylation of 2,3-dihydrofuran 
 
                                                
17  For a detailed mechanistic study, see: Ozawa, F.; Kubo, A.; Matsumoto, Y.; Hayashi, T. 
Organometallics, 1993, 12, 4188-4196. 
O
+
catalyst (3 mol%)
ligand (6 mol%)
iPr2NEt (3.0 equiv)
solvent, 80 °C
O Ph
(R)-1.28
+
O Ph
(R)-1.291.27
(5.0 equiv)
PhOTf
 16 
Unexpectedly, they observed contrasting selectivities from control experiments 
(note: the unisomerized product contains (R)- instead of (S)-configuration, which is a 
different observation than Hayashi disclosed). With (R)-BINAP the thermodynamically 
more stable compound (R)-1.28 was preferentially generated (entry 1, 3 and 5, Table 1.5). 
With (R)-BINAP(O) the unisomerized compound (R)-1.29 was the major product (entry 2, 
4 and 6, Table 1.5). This reversed product distribution indicated when chelated with (R)-
BINAP(O) the hydrido-Pd(II)-olefin triflate complex tends to undergo reductive 
elimination to release Pd(0) rather than hydrometallate the coordinated olefin. 
Presumably, the less electron-donating phosphinoyl group provides less stabilization to 
Pd(II) and hence kinetically favors reductive elimination. From another aspect, the higher 
enantioselectivities produced by (R)-BINAP(O) suggested that the initial olefin insertion 
step was more stereoselective. 
Oestreich also tested cyclopentene in the arylation conditions and found the same 
trend that with (R)-BINAP(O) olefin isomerization was minimized and products 
contained higher enantiopurities. 
 
Entry Catalyst Ligand Yield (%) Ratio
a  
(R)-1.31 : 1.32 
ee (%)b 
(R)-1.31 
1 Pd(OAc)2 1.23 41c 74 : 26 6 
2 Pd(OAc)2 1.24 75 90 : 10 80 
3 Pd(dba)2 1.23 24c 62 : 38 14 
4 Pd(dba)2 1.24 75 94 : 6 86 
aDetermined by achiral GLC. bDetermined by chiral GLC. cIncomplete conversion.  
Table 1.6 Ligand effect on arylation of cyclopentene 
+
catalyst (3 mol%)
ligand (6 mol%)
iPr2NEt (3.0 equiv)
PhH, 80 °C
Ph
(R)-1.31
+ Ph
1.30
(5.0 equiv)
PhOTf
1.32
 17 
Zhou and coworkers also independently investigated different chiral bisphosphine 
monoxide ligands in Hayashi’s olefin arylation reactions.18 They discovered that (R)-Xyl-
SDP(O) is a versatile ligand toward a variety of olefin substrates. Excellent 
enantioselectivity and good to high olefin selectivity were obtained from most of the 
cases they surveyed.  
 
Figure 1.4 (R)-Xyl-SDP(O) in enantioselective intermolecular Heck reaction 
 
 
Scheme 1.3 Synthetic application of Zhou’s arylation method 
                                                
18 Hu, J.; Lu, Y.; Li, Y.; Zhou, J. Chem. Commun. 2013, 49, 9425-9427. 
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To gain some insight of the origin of the observed high stereoselectivity, Zhou 
first synthesized a [(1.26)(4-CF3-phenyl)(I)Pd(II)] complex from (R)-Xyl-SDP(O), 
Pd2(dba)3 and 1-Iodo-4-(trifluoromethyl)benzene. The crystal structure of this complex 
shows that the aryl group is cis to the phosphinyl fragment of (R)-Xyl-SDP(O). A 
possible explanation for this orientation is that a trans configuration of two groups 
bearing strong trans effect would destabilize the palladium complex.18 Further, Zhou did 
DFT calculations of the transition state of the olefin insertion step. The results revealed 
that the bidentate coordinating mode of (R)-Xyl-SDP(O) with Pd(II) is energetically more 
favorable, and that the steric repulsion between the incoming olefin substrate and the 
phosphinoyl fragment of (R)-Xyl-SDP(O) plays an important role in stereocontrol. The 
energy difference between the favorable and unfavorable olefin orientations in the olefin 
insertion step is 2.6 kcal/mol. 
This study elucidated that the Lewis hard moiety in a BPMO ligand is also 
important for enantioinduction rather than simply behaving as a labile coordination site. 
A hemilabile ligand can become better chelating, as the transition metal becomes more 
Lewis acidic in an oxidative addition.  
 After identified the catalytic utility of BPMOs, Zhou designed a Heck reaction-
triggered intermolecular cyclization reaction with Pd(0)/(R)-BINAP(O) as the catalyst 
system.19 A vinyl group was installed at the ortho-position of aryl triflates, which can 
further react with the alkyl palladium intermediate before it undergoes β-hydride 
elimination. A 1,3-dienyl triflate 1.36 was tested to be an effective substrate as well. The 
scope of olefin substrates in this method includes simple cyclic alkenes, 2,3-dihydrofuran, 
                                                
19 Hu, J.; Hirao, H.; Li, Y.; Zhou, J. Angew. Chem. Int. Ed. 2013, 52, 8676-8680. 
 19 
N-Boc-2,3-dihydropyrrole and norbornenes. Cyclopentene, cycloheptene and cyclooctene 
gave decent yields (63-85%) and good to high enantioselectivities (88-99% ee), but no 
reaction occurred with cyclohexene. The proposed explanation is that the half-chair 
conformation of cyclohexene impeded its binding to Pd(II) center.19 The products from 
norbornene substrates contain good to excellent enantiopurity (up to 99% ee) and exo- 
configuration. To demonstrate the synthetic utility of this method, Zhou and coworkers 
also applied a cyclization product in a formal asymmetric synthesis of (-)-martinellic 
acid.19 
 
 
Figure 1. 5 Scope of triflates in the intermolecular cyclization reactions 
 
 
Equation 1.10 Norbornene in the intermolecular cyclization reactions 
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 More recently, Zhou discovered conditions for asymmetric intermolecular Heck 
reaction with aryl bromides or chlorides as the coupling partners. 20  To facilitate 
dissociation of halide anions from Pd(II) center for olefin insertion, Zhou tested different 
solvents and additives. Protic solvents were found to be crucial to achieve high reactivity, 
whereas with THF or 1,4-dioxane no reaction occurred. They proposed that the protic 
solvents, like MeOH, could accelerate departure of halide anions via hydrogen bond 
formation. Addition of silver salts as the halide scavengers could further improved the 
reactivity, but 4-nitrobenzoic acid turned to be a more effective additive that led to higher 
yields without loss of enantioselectivity. The in situ generated ammonium salt from 4-
nitrobenzoic acid and Hünig’s base may serve as the active species that benefits 
ionization of chlorine or bromine in the corresponding palladium-halogen bond.20 
Presumably, the tertiary ammonium cation can form an intimate ion pair with departed 
bromide or chloride anion. The principle behind this method is consistent with Hayashi’s 
conclusion16a that a cationic arylPd(II) complex is important for achieving high 
stereoselectivity, but it provides an opportunity of conducting asymmetric intermolecular 
Heck reaction without using expensive aryl triflates. 
 
                                                
20 Wu, C.; Zhou, J. J. Am. Chem. Soc. 2014, 136, 650-652. 
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 21 
 
 
Figure 1.6 Aryl halides in the enantioselective intermolecular Heck reactions 
 
 BPMOs also found applications in intramolecular Heck reaction. Oestreich 
proposed utilizing the hemilability of this type of ligand to “manipulate” the coordinating 
mode of Pd(II) in a desymmetrizing cyclization process.15b In 2007 Oestreich’s group 
reported Pd(0)/(R)-BINAP catalyzed intramolecular Heck reaction for desymmetrization 
of 1,6-dienes.21 They found that the existence of an oxygen-donor in the substrate caused 
dramatic increase in enantioselectivity (Table 1.7). The DFT calculations they conducted 
suggested that an oxygen-containing group can serve as a labile coordinating site to the 
14-electron Pd(II) cation after dissociation of the coordinated alkenyl group (Scheme 1.4). 
This coordinating mode prolonged the lifetime of the Pd(II) intermediate and allowed an 
coordination equilibrium between two alkenyl side chains to be established prior to the 
enantioselectivity-determining migratory insertion.21 Without this substrate assistance, 
coordination of each alkenyl side chain to Pd(II) was fast and irreversible, and low 
                                                
21 Machotta, A. B.; Straub, B. F.; Oestreich, M. J. Am. Chem. Soc. 2007, 129, 13455-13463. 
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stereoselectivity was observed due to the low energy difference between the different 
transition states.  
 
Entry X Temperature (°C) Yield (%) ee (%)a 
1 MeO 50 98 97 
2 H 80 86 8 
                          aDetermined by chiral GLC 
Table 1.7 Effect of the substrate structure on the reactivity and stereoselectivity 
 
 
Scheme 1.4 Proposed coordination equilibrium assisted by a functional group 
 
When a BPMO was used as the ligand, the hemilability of the phosphine oxide 
fragment could “force” both alkenyl side chains in the substrate to coordinate with Pd(II) 
to form intermediate 1.42. Through dissociation and reassociation of the phosphinoyl 
group in the ligand, the coordination of each side chain to Pd(II) can become 
interconvertible (Scheme 1.5) and then shift the migratory insertion to be the 
enantioselectivity-determining step.15b Indeed, when (R)-BINAP(O) was employed the 
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obtained enantioselectivity was slightly higher than that (R)-BINAP produced (Figure 
1.7). From another substrate 1.45, Oestreich also observed the same trend that (R)-
BINAP(O) exhibited better enantiocontrol than the parent (R)-BINAP (Figure 1.8). 
 
Scheme 1.5 Proposed coordination equilibrium assisted by a hemilabile ligand 
 
 
Figure 1.7 Ligand effect on the stereoselectivity of desymmetrization of 1,6-diene 
 
 
Figure 1.8 Ligand effect on the stereoselectivity of desymmetrization of 1,6- and 1,4-dienes 
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1.4 QuinoxP*-based chiral BPMO 
 
 
Figure 1.9 Quinoxp* and Quinoxp* monoxide 
 
Elbasvir, a compound containing a chiral hemiaminal ether moiety, is a protease 
inhibitor used for treating hepatitis C virus infection.22 To synthesize this molecule a 
research group in Merck & Co. Inc. designed a Buchwald-Hartwig amination reaction to 
construct the indole fragment, while controlling the stereochemistry of the in situ formed 
hemiaminal ether with a Pd(0)/chiral phosphine complex.23 Their exploration started with 
benzoxazine 1.49, the stereogenic center of which is stereochemically labile due to a 
ring-opening and reclosing process.23 During the screening of different palladium 
precatalysts and chiral phosphine ligands, they observed an interesting phenomena that 
when (R,R)-QuinoxP* combined with Pd(OAc)2 was applied the reaction achieved full 
conversion along with 96% ee, but when the same ligand combined with Pd2(dba)3 the 
reaction reached less than 20% conversion and 80% ee. This considerable difference in 
their reactivities drove they to suspect that (R,R)-QuinoxP* may undergo in situ oxidation 
by Pd(OAc)2 to generate the bisphosphine monoxide, which served as the actual ligand. 
                                                
22 Coburn, C. A.; Meinke, P. T.; Chang, W.; Fandozzi, C. M.; Graham, D. J.; Hu, B.; Huang, Q.; Kargman, 
S.; Kozlowski, J.; Liu, R.; McCauley, J. A.; Momeir, A. A.; Soll, R. M.; Vacca, J. P.; Wang, D.; Wu, H.; 
Zhong, B.; Olsen, D. B.; Ludmerer, S. W. ChemCatChem 2013, 8, 1930-1940. 
23 Li, H.; Belyk, K. M.; Yin, J.; Chen, Q.; Hyde, A.; Ji, Y.; Oliver, S.; Tudge, M. T.; Campeau, L.-C.; 
Campos, K. R. J. Am. Chem. Soc. 2015, 137, 13728-13731. 
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Figure 1.10 Structure of Elbasvir 
 
 
 
 
Equation 1.11 Designed Buchwald-Hartwig amination reaction 
 
 
 
 
Scheme 1.6 Proposed catalytic cycle of the designed amination reaction 
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To verify this possibility, two methods were employed. First, they synthesized 
(R,R)-QuinoxP*(O) separately and tested it with Pd2(dba)3 in the standard condition. The 
reaction gave almost full conversion and 89% ee. Next, they monitored 31P-NMR of the 
reaction carried with Pd(OAc)2/(R,R)-QuinoxP*. The observed signals matched with that 
of the reaction conducted with Pd2(dba)3/(R,R)-QuinoxP*(O). Hence, the actual ligand 
that gave high reactivity and stereoselectivity in the model reaction was identified to be 
(R,R)-QuinoxP*(O). Under the standard condition a variety of substrates containing 
different aryl substituents or backbones gave high yields (86-96%) and high 
enantioselectivities (87-97% ee). As for making alkyl-substituted hemiaminal ethers, 
(R,R)-QuinoxP*(O) produced about 70% ee, but the stereoselectivity could be improved 
by switching to a Josiphos ligand.23 
 
1.5 Conclusion 
 In transition metal-catalyzed asymmetric reactions, chiral bisphosphine monoxide 
ligands may exhibit higher catalytic activity and selectivity than the parent bisphosphines. 
This type of hemilabile ligand is actually well known in organometallic studies, but their 
catalytic utilities are still under discovery. As more chiral bisphosphine monoxides have 
become commercially available, this field will create more opportunities for synthetic 
chemists to develop new and powerful catalyst systems.      
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Chapter 2 
Borylation of Hemiaminal Ethers: An Approach of Making 
Enantioenriched Aliphatic α-Amino Boronates	  
2.1 General Introduction 
α-Aminoboronic acids have unique biological activities in enzyme inhibitions.1 
Since 1990s chemical biologists have discovered this class of molecule as potential 
inhibitors targeting proteasome, 2  thrombin 3  and β-lactamase. 4  Application of α-
aminoboronic acid-based organic compounds in clinic therapeutics leads to a new 
direction in drug discovery. A landmark in this field is that bortezomib (trade mark as 
Velcade®, by Millennium Pharmaceuticals, Inc. in 2003) was launched as the first 
proteasome inhibitor medicine on the market for treating myeloma and relapsed mantle 
cell lymphoma.5 
                                                
1 For reviews, see: (a) Yang, W.; Gao, X.; Wang, B. Medicinal Research Reviews 2003, 23(3), 346-368. (b) 
Dembitsky, V. M.; Serbnik, M. Tetrahedron 2003, 59, 579-593. (c) Matteson, D. S. Medicinal Research 
Reviews 2008, 28(2), 233-246. (d) Baker, S. J.; Ding, C. Z.; Akama, T.; Zhang Y. K.; Hernandez, V.; Xia, 
Y. Future Med. Chem. 2009, 1(7), 1275-1288. (e) Dick, L. R.; Fleming, P. E. Drug Discovery Today 2010, 
15, 243-249. (f) Touchet, S.; Carreaux, F.; Carboni, B.; Bouillon, A.; Boucher, J. L. Chem. Soc. Rev. 2011, 
40, 3895-3914. (g) Baker, S. J.; Tomsho, J. W.; Benkovic, S. J. Chem. Soc. Rev. 2011, 40, 4279-4285. (h) 
Smounm, R.; Rubinstein, A.; Dembitsky, V. M.; Serbnik, M. Chem. Rev. 2012, 112, 4156-4220.  
2 For representative examples, see: (a) Adams, J.; Behnke, M.; Chen, S.; Cruickshank, A. A.; Dick, L. R.; 
Grenier, L.; Klunder, J. M.; Ma, Y.-T.; Plamondon, L.; Stein, R. L. Bioorganic & Medicinal Chemistry 
Letters 1998, 8, 333-338. (b) Milo, L. J.; Lai, J. H. Jr.; Wu, W.; Liu, Y.; Maw, H.; Li, H.; Jin, Z.; Shu, Y.; 
Poplawski, S. E.; Wu, Y.; Sanford, D. G.; Sudmeier, J. L.; Bachovchin, W. W. J. Med. Chem. 2011, 54, 
4365-4377. (c) Gallerani, E.; Zucchetti, M.; Brunelli, D.; Marangon, E.; Noberasco, C.; Hess, D.; 
Delmonte, A.; Martinelli, G.; Böhm, S.; Driessen, C.; De Braud, F.; Marsoni, S.; Cereda, R.; Sala, F.; 
D’Incalci, M.; Sessa, C. Eur. J. Cancer, 2013, 49, 290.  
3 Fevig, J. M.; Abelman, M. M.; Brittelli, D. R.; Rettner, C. A.; Knabb, R. M.; Weber, P. C. Bioorg. Med. 
Chem. Lett. 1996, 6(3), 295-300. 
4 Chen, Y.; Shoichet, B.; Bonnet, R. J. Am. Chem. Soc. 2005, 127, 5423-5434. 
5 www. velcade.com 
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Figure 2.1 Selected examples of α-aminoboronic acid-based enzyme inhibitors 
 
The distinctive biological activities of α-aminoboronic acids is featured in 
forming reversible coordination between the boron atom and specific hydroxyl or 
nitrogen-containing groups in an enzyme.1a,c Once forming an anionic adduct with 
different Lewis bases, the boron atom will adopt a tetrahedral structure, which enables an 
α-aminoboronic acid to mimic an α-amino acid involved in different biological processes 
in the humane body.1a-c,g 
In synthetic chemistry, α-aminoboronic acids and related derivatives, like boronic 
esters or trifluoroborate salts, can be used as intermediates to synthesize amines. 
Suginome’s group conducted a systematic study of chiral aryl-substituted α-
amidoboronic esters in Pd-catalyzed Suzuki-Miyaura cross coupling reactions,6 which 
provides an alternative way to prepare enantioenriched benzhydryl amines. 7  They 
demonstrated that the stereochemical outcome could be controlled by carefully choosing 
                                                
6 (a) Ohmura, T.; Awano, T.; Suginome, M. Chemistry Letters, 2009, 38(7), 664-665. (b) Ohmura, T.; 
Awano, T.; Suginome, M. J. Am. Chem. Soc. 2010, 132, 13191-13193. (c) Awano, T.; Ohmura, T.; 
Suginome, M. J. Am. Chem. Soc. 2011, 133, 20738-20741. 
7 For arylstannanes mediated synthesis, see: (a) Hayashi, T.; Ishigedani, M. J. Am Chem. Soc. 2000, 122, 
976-977; for aryltitanium mediated synthesis, see: (b) Hayashi, T.; Kawai, M.; Tokunaga, N. Angew. Chem. 
Int. Ed. 2004, 43, 6125-6128; for arylboroxines and arylboronic acids mediated syntheses, see: (c) 
Kuriyama, M.; Soeta, T.; Hao, X.; Chen, Q.; Tomioka, K. J. Am Chem. Soc. 2004, 126, 8128-8129; (d) 
Tokunaga, N.; Otomaru, Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am Chem. Soc. 2004, 
126, 13584-13585; (e) Duan, H.-F.; Jia, Y.-X.; Wang, L.-X.; Zhou, Q.-L. Org. Lett. 2006, 8, 2567-2569.    
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different additives. When 2.5 equivalents phenol was used, products were generated in 
high stereospecificity with inverted stereochemistry.6c When substoichiometric amount of 
Zr(Oi-Pr)4•i-PrOH (0.5 equivalents) was used, the stereochemistry of the α-aminoboronic 
esters was retained in the products.6c   
 
 
Scheme 2.1 α-aminoboronic esters in enantiospecific Suzuki-Miyaura cross-coupling 
 
Ellman studied Rh-catalyzed nucleophilic addition of α-sulfinamido 
trifluoroborates to aryl or alkenyl trifluoromethyl ketones.8 1,2-Amino alcohols were 
generated with retentive stereochemistry from the diastereopure trifluoroborates. For α,β-
unsaturated ketones, only 1,2-addition products were observed. However, the substrate 
scope of α-sulfinamido trifluoroborates in the method was relatively narrow. Aliphatic 
                                                
8 Buesking, A. W.; Ellman, J. Chem. Sci. 2014, 5, 1983-1987. 
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trifluoroborates were not effective in the reaction, and aromatic trifluoroborates 
containing an electron-deficient aryl group were ineffective as well. 
 
 
Equation 2.1 Rh-Catalyzed addition of α-sulfinamido trifluoroborates to trifluoromethyl ketones 
 
In light of their emerging importance in biological and medicinal studies, several 
research groups have developed enantioselective catalytic reactions to prepare 
nonracemic α-aminoboronic esters (for an extensive introduction of the published works, 
please see Section 2.2 in this chapter). Unfortunately, according to the literature, 
synthesis of enantioenriched aliphatic α-aminoboronic esters is still a challenge to a 
catalyst-controlled reaction. Herein, we aim to develop a Cu(I)-catalyzed enantioselective 
borylation reaction to synthesize these biologically interesting compounds.    
	  
BF3NH4
NHSO +
O
R' CF3
[Rh(cod)(MeCN)2]BF4
(10 mol%)
DCE/EtOH (6:1)
50 °C, 22-24 h(2.0 equiv)
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R
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2.2 Precedents of enantioselective synthesis of α-aminoboronic esters9	  
2.2.1 Substrate-controlled processes 
In the 1980s Matteson utilized (+)-pinanediol boronic ester as a chiral auxiliary 
and developed the first enantioselective synthesis of α-amido boronic acid esters.10 The 
key step in his method is a diastereoselective homologation reaction.11 The obtained α-
chloromethyl boronic ester was in situ treated with LiHMDS to introduce 
bis(trimethylsilyl)amino group at the α-position. In presence of acetic acid, the silylamine 
reacted with acetic anhydride to generate the desired product. The industrial synthesis12 
of bortezomib employs an enhanced Matteson homologation reaction,13 in which ZnCl2 
(0.7 equiv) is added as a promoter. ZnCl2 has dual functions14 in the migration step: (1) 
facilitating departure of the chloride ion via coordination; (2) improving 
diastereoselectivity through chelating with an oxygen atom in boronic ester fragment and 
a chlorine atom in dichloromethyl fragment. 
                                                
9 For racemic syntheses, see: (a) Mann, G.; John, K. D.; Baker, R. T. Org. Lett. 2000, 2, 2105-2108. (b) 
Kawamorita, S.; Miyazaki, T.; Iwai, T.; Ohmiya, H.; Sawamura, M. J. Am. Chem. Soc. 2012, 134, 12924-
12927. (c) Li, Q.; Liskey, C. W.; Hartwig, J. F. J. Am. Chem. Soc. 2014, 136, 8755-8765. 
10 Matteson, D. S.; Sadhu, K. M. J. Am. Chem. Soc. 1981, 103, 5241-5242. 
11 For reviews of Matteson homologation reaction, see: (a) Matteson, D. S. J. Org. Chem. 2013, 78, 10009-
10023; (b) Matteson, D. S. Chem. Rev. 1989, 89, 1535-1551.  
12 Pickersgill, I. F.; Bishop, J.; Koellner, C.; Gomez, J.-M.; Geiser, A.; Hett, R.; Am-moscato, V.; Munk, 
S.; Lo, Y.; Chui, F.-T.; Kulkarni, V. R. WO Patent Appl. 097,809, 2005. 
13 (a) Matteson, D. S.; Sadhu, K. M.; Peterson, M. L. J. Am Chem. Soc. 1986, 108, 810-819. (b) Matteson, 
D. S.; Sadhu, K. M. J. Am Chem. Soc. 1983, 105, 2077-2078. 
14 Thomas, S. P.; French, R. M.; Jheengut, V.; Aggarwal, V. K. The Chemical Record 2009, 9, 24-39. 
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Scheme 2.2 The first example of enantioselective synthesis of α-amino boronic esters 
 
 
Scheme 2.3 Industrial synthesis of Bortezomib 
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 The amino-protecting group can also play a role in enantioinduction. Ellman 
employed Sadighi’s catalyst,15 a NHC-Copper complex, in cross additions of B2(pin)2 to 
(R)-N-tert-butanesulfinyl aldimines. 16  α-Sulfinamido boronates were produced in 
moderate to good yields and with high diastereoselectivity; aryl- and enolizable alkyl-
substituted aldimines were both effective substrates in the reaction. The nonracemic tert-
butylsulfinyl group acted as an amino protecting group and as the chiral auxiliary, which 
can be removed under acidic conditions. In 2014, Ellman reported greener and 
operationally simpler conditions17 for the same type of reaction, in which CuSO4 and 
PCy3 (added in form of HBF4 salt) were used as the catalyst and ligand, respectively. The 
reactions were conducted in aqueous toluene in open air with BnNH2 as the Lewis base. 
Ketimines were also tested to be suitable substrates in the new conditions to make tertiary 
α-amino boronates with good diastereoselectivity.  
     
 
Equation 2.2 NHC–Cu(I)-catalyzed borylation of N-tert-butanesulfinyl aldimines 
 
                                                
15 Laitar, D. S.; Tsui, E. Y.; Sadihi, J. P. J. Am. Chem. Soc. 2006, 128, 11036-11037. 
16 Beenen, M. A.; An, C.; Ellman, J. A. J. Am. Chem. Soc. 2008, 130, 6910-6911. 
17 Buesking, A. W.; Bacauanu, V.; Cai, I.; Ellman, J. A. J. Org. Chem. 2014, 79, 3671-3677. 
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Figure 2.2 Proposed models for observed diastereoselectivity 
 
 Sun and coworkers evaluated different types of NHC ligands in the above-
mentioned Ellman’s borylation strategy, and developed a one-pot procedure for making 
α-sulfinamido boronates.18 They found that a N,N’-dinaphthyl benzimidazole-derived 
NHC was a robust ligand for high reactivity, and that the NHC-Cu(I) catalyst could be 
preformed in the reaction vessel under argon without using a glovebox. Ketimine 
substrates were also investigated in the standard reaction conditions, but only modest 
diastereoselectivity was obtained.  
                                                
18 Wen, K.; Wang, H.; Chen, J.; Zhang, H.; Cui, X.; Wei, C.; Fan, E.; Sun, Z. J. Org. Chem. 2013, 78, 
3405-3409. 
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Equation 2.3 A benzimidazole-derived NHC ligand in borylation of aldimines and ketimines 
 
2.2.2 Catalyst-controlled processes 
 Transition metal-catalyzed borylation reactions provide an effective and tunable 
method to make boron-containing compounds. Enantioenriched α-amino boronates can 
be synthesized by using a chiral ligand in the reaction. 
 Lin and co-workers investigated chiral NHC-Cu(I)-catalyzed cross addition of 
B2(pin)2 to benzamide-derived aldimines.19 Through screening different imidazolium 
salts (the precursors of NHC ligands), they found that a (N-alkyl, N’-aryl)-hybrid NHC 
ligand gave good reactivity and high stereoselectivity. While aryl aldimines underwent 
borylation smoothly, two alkyl aldimines they tested produced low yields (up to 40%). It 
should be mentioned that these two alkyl substrates gave good stereoselectivity (80% and 
84% ee). They attributed the mass loss to the instability of alkyl aldimines under the 
reaction conditions. To avoid this issue, they employed α-benzamido sulfones as the 
                                                
19 Zhang, S.-S.; Zhao, Y.-S.; Tian, P.; Lin, G.-Q. Synlett 2013, 24, 437-442. 
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substrates to generate the corresponding aldimines in situ in presence of excess Cs2CO3, 
and successfully achieved reasonable yields without loss of stereoselectivity. 
 
Equation 2.4 Chiral NHC-Cu(I)- catalyzed borylation of aromatic aldimines 
 
 
 
 
Equation 2.5 α-Benzamido sulfones as substrates in enantioselective borylation reactions 
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Liao’s group applied a chiral sulfoxide-phosphine ligand in the borylation of N-
Boc-protected aryl aldimines.20 They found that either a cationic Cu(I) salt or CuCl was 
an effective precatalyst, and that using a less coordinating solvent, like tBuOMe, 
benefited the stereoselectivity. Unfortunately, the borylated products were not stable 
under the purification conditions they used. Although the NMR yields they obtained were 
above 80% in most of cases, the isolated yields were in the range of 40% to 65%. The 
alkyl substrate 2.29 gave low stereoselectivity under the standard conditions. 
 
Figure 2.3 Use of Cu(I)/chiral sulfoxide-phosphine complex in borylation of N-Boc-imines 
 
                                                
20 Wang, D.; Cao, P.; Wang, B.; Jia, T.; Lou, Y.; Wang, M.; Liao, J. Org. Lett. 2015, 17, 2420-2423. 
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More recently, Hirano and Miura developed a Cu(OAc)2-catalyzed 
enantioselective hydroamination reaction of alkenyl Bdan compounds (Bdan = 1,8-
diaminonaphthyl boronate).21 In presence of polymethylhydrosiloxane (as the hydride 
source) and sodium tert-butoxide, Cu(OAc)2 was in situ converted to Cu(I) hydride. The 
alkenyl substrates then underwent Cu–H insertion regioselectively, forming a Cu–C bond 
between the copper atom and the same carbon bearing the Bdan group. The driving force 
for this observed regioselectivity was attributed to the hyperconjugation between the Cu–
C bond and the empty p orbital on boron.22 The generated alkyl cuprates nucleophilically 
attacked a N,N-dialkyl hydroxylamine benzoate to install the amino group on the α 
carbon. With a SEGPHOS-based chiral bisphosphine ligand to control the stereochemical 
outcome of the initial hydrocupration process, various α-amino boronates could be 
synthesized with good to high enantioselectivity (up to 99:1 er). It should be noted that 
alkenyl Bpin substrates gave no desired products, as they completely decomposed under 
the standard reaction conditions.  
 
                                                
21 Nishikawa, D.; Hirano, K.; Miura, M. J. Am. Chem. Soc. 2015, 137, 15620-15623. 
22 For a related computational study, see: Dang, L.; Zhao, H.; Lin, Z. Organometallics 2007, 26, 2824-
2832. 
BdanR1
(1.2 equiv)
PMHS (3.0 equiv)
+ O
O
N R3
R2 (R)-DTBM-SEGPHOS
Cu(OAc)2 (10 mol%)
(10 mol%)
LiOtBu (4.0 equiv)
THF, rt, 4 h
BdanR1
N R2R3
46-81% yield
88:12 ! 99:1 er(R1 = alkyl, aryl) (R2 , R3 = alkyl)
2.31 2.32 2.33
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Equation 2.6 Cu(I)-Catalyzed enantioselective hydroamination of alkenyl Bdan compounds  
 
 Morken’s group applied a chiral Pt(0)/phosphoramidate complex in asymmetric 
diboration of aromatic N-(trimethylsilyl) aldimines. 23  Employment of this type of 
substrate brought two advantages: (1) they can be readily prepared by treating aryl 
aldehydes with LiHMDS; (2) the trimethylsilyl group in the borylated products can be 
swapped with an acyl group under mild conditions, which makes it convenient to 
introduce an α-amido boronate fragment into a peptide chain. Hence, they developed a 
tandem diboration/pivaloylation sequence, and prepared a variety of aryl-substituted α-
amidoboronic esters in above 75% overall yields and with high enantioselectivity (up to 
97:3 er). Unfortunately, the substrate scope in this strategy is limited to aromatic 
aldehydes. Aliphatic aldehydes failed to give the desired products with the same method. 
                                                
23 Hong, K., Morken, J. P. J. Am. Chem. Soc. 2013, 135, 9252-9254. 
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Scheme 2.4 Tandem diboration/pivaloylation of aromatic N-(trimethylsilyl) aldimines 
 
Tang and co-workers reported a Rh(I)-catalyzed enantioselective hydroboration 
reaction of N-acyl enamines to make tertiary α-amidoboronic esters.24 This catalyst-
controlled hydroboration proceeded in an anti-Markovnikov fashion, installing the Bpin 
fragment at the sterically less accessible position. The invented P-chiral monophosphine 
ligand was critical to the observed reactivity and stereoselectivity. Addition of DABCO 
further suppressed formation of the other regiomer and other byproducts. 
Benzylidenebenzamide, an aromatic aldimine, was tested in the same reaction conditions, 
but the hydroboration product was obtained in 20% yield and with 13% ee. This 
reactivity difference and the results of further deuterium-labeling experiments they 
conducted suggested that the active proton in the substrates was involved in the catalytic 
cycle, which explains generation of hydrogenation products, like compound 2.40, in 
absence of any external hydride sources. 
                                                
24 Hu, N.; Zhao, G.; Zhang, Y.; Liu, X,; Li, G.; Tang, W. J. Am. Chem. Soc. 2015, 137, 6746-6749. 
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Equation 2.7 Rh(I)-Catalyzed enantioselective hydroboration of α-aryl-N-Acylenamines 
 
 
 
Figure 2.4 The deuterium-labeling experiment in Tang’s hydroboration study   
 
2.2.3 Organocatalytic asymmetric syntheses of α-aminoboronic esters                     
 In absence of transition metals, Lewis bases such as methoxide anion25 or NHCs26 
can directly promote nucleophilic addition of pinacolboryl group to activated or 
unactivated olefins through forming adducts with B2(pin)2. 
                                                
25 For representative examples, see: (a) Bonet, A.; Gulyás, H.; Fernández, E. Angew. Chem. Int. Ed. 2010, 
49, 5130-5134. (b) Bonet, A.; Pubill-Ulldemolins, C.; Bo, C.; Gulyás, H.; Fernández, E. Angew. Chem. Int. 
Ed. 2011, 50, 7158-7161. (c) Pubill-Ulldemolins, C.; Bonet, A.; Bo, C.; Gulyás, H.; Fernández, E. Chem. 
Eur. J. 2012, 18, 1121-1126. 
26 For representative examples, see: (a) Lee, K.-s.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 
2009, 131, 7253-7255. (b) O’Brien, J. M.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 122, 7712-7715. (c) 
Wu, H.; Radomkit, S.; O’Brien, J. M.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 8277-8285.  
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Sun and Fan studied an achiral NHC-catalyzed hydroboration reaction of (R)-N-
tert-butanesulfinyl aldimines and imines with B2(pin)2 in methanol.27 A combination of a 
N,N’-dinaphthylimidazolium salt (as the NHC precursor) and DBU (as Lewis base) gave 
the most satisfying yields. In aprotic solvents no desired products were generated. 
Compared with other protic solvents they tested, methanol turned to be a better proton 
source. They used 11B-NMR and mass spectrum analysis to try to clarify whether a 
methoxide/B2(pin)2 or NHC/B2(pin)2 adduct was responsible for the nucleophilic addition, 
but the combined information indicated that a complex consisted of NHC, methanol and 
B2(pin)2 may serve as the active intermediate. Notably, α, β-unsaturated substrates 
(ketones, aldimines and imines) were also evaluated in the established conditions, and 
1,4-addition products were obtained as the exclusive products. 
 
Equation 2.8 NHC-Catalyzed hydroboration of (R)-N-tert-butanesulfinylaldimines and imines 
 
 Except strong electron donors, like NHCs, arylphosphines also can be used in 
organocatalytic borylation reactions. Based on their previous studies,24 Fernández’s 
group examined chiral phosphines in enantioselective hydroboration of N-
                                                
27 Wen, K.; Chen, J.; Gao, F.; Bhadury, P. S.; Fan, E.; Sun, Z. Org. Biomol. Chem. 2013, 11, 6350-6356. 
R1
N
R2
S O
DBU (10 mol%)
(10 mol%)
MeOH, rt, 24 h
R1
HN
Bpin
S O
R2
(R1 = alkyl, aryl) 65-90% yield
69:31 ! >99:1 dr
N N Cl
2.41 2.42
+ B2(pin)2
(1.1 equiv)
(R2 = H, Me, Ph)
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tosylaldimines.28 In presence of a Walphos-type chiral bisphosphine or chiral Quinap, 
aryl-substituted α-sulfonamido boronic acid pinacol esters (three examples) were 
obtained with moderate to good enantioselectivity, whereas the alkyl substrate gave poor 
stereoselectivity.  
 
Equation 2.9 Chiral bisphosphines for enantioselective hydroboration of N-tosylaldimines 
 
2.3 Proposed catalytic synthesis of α-amido boronates with hemiaminal ethers 
 Transition metal-catalyzed hydroboration reaction of aldimines or imines provides 
a straightforward method of synthesizing α-amino boronic esters, but previous catalyst-
controlled processes achieved limited success in accessing alkyl-substituted products 
with reasonable reactivity along with good enantioselectivity.  
Our working hypothesis originated from Lin’s strategy19 of in situ generation of 
alkyl-substituted aldimines from corresponding α-amido sulfones. We envisioned that 
hemiaminal ethers are also potential precursors for aldimines in presence of a strong 
                                                
28 Solé, C.; Gulyás, H.; Fernández, E. Chem. Commun. 2012, 48, 3769-3771. 
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Lewis base. Although, thermodynamically, it is unfavorable for deprotonated hemiaminal 
ethers to release the parent aldimines and alkoxides, forming adducts between B2(pin)2 
and the departed alkoxides may serve as the driving force for the dissociation process.   
Based on the following theories, we proposed a catalytic cycle of synthesizing α-
amino boronic acid pinacol esters from hemiaminal ethers: (1) catalytic amount of a 
strong Lewis base deprotonates the substrate, releasing the corresponding aldimine and 
alkoxide in an equilibrium, (2) the released alkoxide acts as a promoter for forming a Cu-
Bpin complex through activation of B2(pin)2 and the subsequent transmetallation, (3) the 
copper amide species produced from the borylation step deprotonates one molecule of the 
substrate to turn over the copper catalyst.   
 
Figure 2.5 Proposed catalytic cycle of borylation of hemiaminal ethers 
 
 
HN
OR2R1
PG
N
OR2R1
PG
N
R1
PG
B2(pin)2[Cu] OR2
Base
N
R1
PG
BPin
[Cu]
[Cu] Bpin
+
R2OBpin
HN
OR2R1
PG
HN
R1
PG
BPin
initial deprotonation
dissociation
nucleophilic
    attack
deprotonation
[Cu]
+
[Cu]
B2(pin)2
N
R1
Bz
BPin
pinB
+ [Cu] Bpin
competition
 45 
2.4 Development of copper-catalyzed borylation of hemiaminal ethers 
2.4.1 Borylation of the phenyl-substituted hemiaminal methyl ether  
Our preliminary exploration started with hemiaminal ether 2.47 as the substrate. 
The in situ generated N-benzoyl aldimine has reasonable stability, 29  and it is a 
nonenolizable aldimine. It should be noted that an electron-withdrawing protecting group 
on the nitrogen, for instance an acyl group, is crucial to the stability of borylated products, 
because unprotected α-amino boronic acid pinacol esters thermodynamically tend to 
undergo 1,2-boryl rearrangement.1h,5c   
 
Scheme 2.5 1,2-Boryl rearrangement of unprotected α-amino boronic acid pinacol esters 
 
Considering the added copper precatalyst might function as a Lewis acid and react 
with the substrate alone to generate an iminium intermediate instead of the desired 
aldimine, we first studied the influence of base loading on the reaction (Table 2.1). We 
chose Cu(OTf)2, which is a relatively strong Lewis acid,  as the precatalyst30 and NaOtBu 
as the Lewis base in the investigation. PPh3 and toluene were selected as the ligand and 
solvent, respectively. Since the borylated product 2.48 is a known compound, whose 
                                                
29 One method of making this aldimine is to heat N-(1-methoxy-1-phenylmethyl)benzamide at 120 ºC and 
remove produced methanol via vacuum. For reference, see: (a) Aggarwal, V. K.; Vasse, J.-L. Org. Lett. 
2003, 5(21), 3987-3990. (b) Uraguchi, D.; Sorimachi, K.; Terada, M. J. Am Chem. Soc. 2005, 127, 9360-
9361. 
30 Cu(OTf)2 can in situ generate CuOTf under a borylation condition. For representative examples, see: (a) 
Guzman-Martinez, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10634-10637. (b) Ibrahem, I.; 
Breistein, P.; Córdova, A. Angew. Chem. Int. Ed. 2011, 50, 12036-12041.  
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characterization data has been published,6b,6c,19 we used 1,3,5-trimethoxybenzene as the 
internal standard in the 1H-NMR analysis to accelerate our data collection.  
 
Entry NaOtBu  (mol%) 
Conversion  
(%)a 
Yield of 2.48 
 (%)a 
Yield of 2.49 
 (%)a 
1 10 41 17 5 
2 20 59 48 10 
3 50 78 54 21 
4 100 94 25 35 
                aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene as  
                   the internal standard. bReactions employed 0.1mmol of 2.47.     
 
Table 2.1 The influence of base loadingb 
 
With more NaOtBu being added, both conversion and yield increased (entry 1, 2 
and 3, Table 2.1). However, as 1 equivalent of NaOtBu was used, the yield dramatically 
decreased (entry 4). When the molecular ratio of Cu(OTf)2 to NaOtBu was 1 to 2, the 
reaction achieved the optimal conversion and yield (entry 2, Table 2.1).  
 Meanwhile, upon 1H-NMR analysis of the crude borylation products, the major 
byproduct in the reaction was identified to be the “protodeborylation” compound 2.49. 
Based on Ellman’s study,16 we proposed an explanation for generation of this byproduct 
(Scheme 2.6). In situ generated aldimine 2.50 can react with Cu-Bpin complex in two 
different patterns, in which either Bpin or ligated Cu(I) could be installed at the α-
position. Pathway A leads to the desired product, whereas pathway B results in the 
byproduct. In both cases, one molecule of substrate 2.47 serves as the proton source, and 
once it gets deprotonated the active copper amide intermediate in the catalytic cycle will 
HN
OMePh
Bz
+ B2(pin)2 PPh3 (10 mol%)
NaOtBu (x mol%)
PhMe (0.1 M)
rt, 20 h
HN
BpinPh
Bz
(1.1 equiv)
 Cu(OTf)2 (10 mol%)
2.47 2.48
+
HN
Ph
Bz
2.49
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be regenerated. Hence, pathway B does not terminate the catalytic cycle. An argument is 
that byproduct 2.49 may come from protodeborylation of the borylated product 2.48 
during the aqueous work-up. Nonetheless, the yields of this compound from screened 
conditions were not in a narrow range. For instance, following a consistent work-up 
procedure, byproduct 2.49 was detected to be 5% from the condition of entry 1 in Table 
2.1, but from the condition of entry 4 it was 35%. It is more likely that the byproduct 
mainly came from different reaction pathways. 
 
Scheme 2.6 Two possible pathways of the aldimine intermediate undergoing the nucleophilic addition 
 
 
Scheme 2.7 Proposed NaOMe-mediated borylation of aldimine 2.50 
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On the other hand, Fernández’s studies25,28 of methoxide anion-promoted 
borylation prompted us to consider another possibility involved in the borylation of 
substrate 2.47 (Scheme 2.7). NaOMe, generated from deprotonation of the substrate by 
NaOtBu, can directly form an adduct with B2(pin)2 prior to undergoing a salt metathesis 
with CuCl. Based on Fernández’s investigations, this adduct may function as a 
nucleophile and react with aldimine 2.50 to generate Intermediate 5. Stabilization by the 
phenyl group of the negative charge at the benzylic position may prolong the lifetime of 
Intermediate 5 in the reaction solution. Upon aqueous work-up or being quenched by the 
active proton of substrate 2.47, Intermediate 5 can produce byproduct 2.49. Hence, more 
NaOMe was generated in the reaction may lead to a higher yield of the byproduct.            
We next screened different copper precatalysts in the reaction (Table 2.2), and 
found that CuBr afforded the most satisfying conversion and yield.  
 
Entry Catalyst Conversion
  
(%)a 
Yield of 2.48  
(%)a 
Yield of 2.49  
(%)a 
1 [CuOTf]2•C6H6b 48 38 8 
2 Cu(OTf)2 59 48 10 
3 CuCl 49 42 6 
4 CuCl2 12 9 Trace 
5 Cu(OAc)2 77 64 12 
6 Cu(OPiv)2 31 17 2 
7 CuBr 89 79 16 
8 CuBr2 77 51 17 
9 CuI 90 69 13 
                      aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene 
                as the internal standard. b5 mol% was used. cReaction scale: 0.1mmol of 2.47.     
 
Table 2.2 Screening of different copper precatalystsc 
HN
OMePh
Bz
+
 Catalyst (10 mol%)
PPh3 (10 mol%)
NaOtBu (20 mol%)
PhMe (0.1 M)
rt, 20 h
HN
BpinPh
Bz
(1.1 equiv)
+ HN
Ph
Bz
2.48 2.492.47
B2(pin)2
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To further improve the reaction, we also studied the influence of different alkaline 
bases, ligand loadings and solvents on the yield. 
 
Entry Base PPh3 (mol%) Solvent 
Conversion  
(%)a 
Yield  
(%)a 
1 NaOtBu 10 PhMe 89 79 
2 LiOtBu 10 PhMe 34 22 
3 KOtBu 10 PhMe 33 26 
4 NaOtBu 20 PhMe 93 79 
5 NaOtBu 10 THF 83 43 
6 NaOtBu 10 1,4-dioxane 12 Trace 
7 NaOtBu 10 CH2Cl2 30 12 
8 NaOtBu 10 MTBEb 96 81 
9 NaOtBu 10 Et2O      >98       92 (82)c 
               aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene as the internal 
            standard. bMTBE: methyl tert-butyl ether. cThe isolated yield is shown in the parenthesis. 
           dReactions employed 0.1mmol of 2.47. 
 
Table 2.3 Further studies of other variables in the borylation reactionsd 
 
When NaOtBu was replaced with either LiOtBu or KOtBu, the reaction 
conversion and yield significantly decreased (entry 1, 2 and 3, Table 2.3). The different 
solubilities of these alkali metal tert-butoxides may be responsible for the observed 
reactivity difference (at room temperature, solubility of NaOtBu in toluene is 7% (w/w), 
but for LiOtBu and KOtBu it is 4% and 2%, respectively). Solvents with higher 
coordinating capabilities, like THF or 1,4-dioxane, impeded borylation (entry 4 and 5, 
Table 2.3). In MTBE and Et2O the reaction became completely heterogeneous, but better 
results were achieved (entry 7 and 8, Table 2.3). From the condition of entry 8 we 
HN
OMePh
Bz
+ B2(pin)2 PPh3 (x mol%)
Base (20 mol%)
Solvent (0.1 M)
rt, 20 h
HN
BpinPh
Bz
(1.1 equiv)
CuBr (10 mol%)
2.47 2.48
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obtained full conversion and 82% isolated yield. Higher ligand loading marginally 
enhanced the conversion (entry 4, Table 2.3).   
 
2.4.2 Copper-catalyzed borylation of alkyl-substituted hemiaminal ethers  
Alkyl-substituted α-amido boronic esters have broader and more important 
applications than the aryl-substituted compounds in biological studies. After successfully 
prepared the borylation product 2.48, we focused on aliphatic substrates in our method. 
Hemiaminal ether 2.53 was selected as the model substrate and tested in the above 
standard conditions of synthesis of 2.48, but, unfortunately, only trace amount of desired 
product was detected by 1H-NMR study. 
 
Scheme 2.8 Preparation of an alkyl-substituted hemiaminal ether 2.53 
 
 
Equation 2.10 The initial test of the alkyl hemiaminal ether in the borylation conditions 
 
To improve the reactivity, we screened different Cu(I) precatalysts, ligands, 
alkaline bases and solvents in the reaction conditions (Table 2.4). A combination of CuCl 
O
+
O
NH2 +
SO OH
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MeOH, rt, 14 hCH2Cl2, rt, 20 h
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2.52 2.53
HN
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Bz
+ B2(pin)2
   CuBr (10 mol%)
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NaOtBu (20 mol%)
PhMe (0.1 M)
rt, 20 h
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BPin
Bz
(1.1 equiv)
+
HN Bz
trace 4% yield5% Conversion
2.53 2.54 2.55
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and NaOtBu turned to be most effective for the borylation, and toluene was a better 
solvent than Et2O for the yield. The electron-rich phosphine ligand, PCy3, gave better 
results, but a higher loading of this reagent slightly benefited the conversion and yield 
(entry 14, Table 2.4). Two bidentate phosphine ligands were also evaluated in the 
reaction (entry 16 and 17), but lower yields were observed.  
 
Entry Catalyst Base Ligand Conversion (%)a 
Yield 
(%)a 
1 CuBr NaOtBu PPh3 5 trace 
2 CuBr NaOtBu PCy3 24 18 
3 CuBr NaOtBu P(OiPr)3 16 10 
4 CuBr KOtBu PCy3 24 16 
5 CuCl NaOtBu PCy3 45 40 
6 [CuOTf]2•C6H6b NaOtBu PCy3 7 trace 
7 Cu(OTf)2 NaOtBu PCy3 19 11 
8 Cu(OAc)2 NaOtBu PCy3 39 26 
9 CuI NaOtBu PCy3 22 4 
10 CuCl NaOtBu PPh3 23 11 
11 CuCl NaOtBu P(OiPr)3 32 21 
12 CuCl LiOtBu PCy3 21 12 
13 CuCl KOtBu PCy3 26 13 
14 CuCl NaOtBu PCy3c 54 44 
15 CuCl  NaOtBud PCy3 70 49 
16 CuCl NaOtBu rac-BINAP 32 16 
17 CuCl NaOtBu  43 18 
18d CuCl NaOtBu PCy3 49 35 
           aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene as the internal 
         standard. b5 mol% was used. c20 mol% was used. dEt2O was used as the solvent. eReactions 
         employed 0.1 mmol of 2.53. 
 
Table 2.4 Optimization of the reaction conditions of synthesis of 2.54e 
 
HN
OMe
Bz
+ B2(pin)2
Ligand (10 mol%)
Base (20 mol%)
PhMe (0.1 M)
rt, 20 h
HN
Bpin
Bz
(1.1 equiv)
Catalyst (10 mol%)
2.53 2.54
Cy2P
PCy2
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 The limited success achieved in the above optimization implied that the reaction 
is kinetically unfavorable. This information drove us to re-evaluate the factors that can 
facilitate the borylation. Electronically, aliphatic aldimines can be more electrophilic than 
the aromatic aldimines, because an aryl substituent can donate more electron density to 
the carbonyl carbon. Therefore, it seems that hemiaminal ether 2.53 would have reacted 
faster than 2.47. A rationale for the opposite observation is that the rate of releasing 
aldimine 2.57 from substrate 2.53 is determined by the dissociation equilibrium (Scheme 
2.9). The relatively higher electrophilicity of alkyl-substituted aldimines can make the 
dissociation direction less favorable, because NaOMe tends to re-attack aldimine 2.57, 
shifting the equilibrium to the left.  
 
 
Scheme 2.9 Proposed dissociation equilibrium of deprotonated substrate 2.53 
 
We came up with two separate solutions to accelerate the reaction: (1) increasing 
reaction temperature; (2) switching the methoxy group in hemiaminal ether 2.53 to an 
alkoxy group with higher leaving tendency (Table 2.5). As we expected, higher 
temperature indeed led to higher conversions and yields (entry 2 and 3, Table 2.5). At 50 
ºC we observed full conversion and 82% NMR yield. As for modification of the substrate, 
we reasoned that phenoxy group could be a good candidate, as electronically and 
sterically it is a better leaving group. The substrate 2.58 exhibited superior reactivity 
(entry 4), which gave product 2.54 in 88% isolated yield at room temperature.   
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 53 
 
Entry R Temperature (ºC) Conversion (%)a Yield (%)a 
1 Me– 22 45 40 
2 Me– 35 68 53 
3 Me– 50 >98 82 
4 Ph– 22 >98 92 (88)b 
                aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene as the  
             internal standard. bThe isolated yield is shown in the parenthesis. creaction scale: 0.1 mmol.   
 
Table 2.5 Influence of temperature and substrate structure on the reactivityc 
 
 
Scheme 2.10 Preparation of hemiaminal ether 2.58 
 
We also evaluated α-amido sulfone 2.52 in the borylation conditions, because α-
amido sulfones can be treated as precursors for N-acyl imines in presence of a Lewis 
base.31 We observed 33% conversion of the reaction, but no borylation product 2.54 was 
detected by 1H-NMR. In addition, 18% benzamide was found in the crude product. One 
possibility is that either sodium or copper(I) p-toluenesulfinate, generated in situ from the 
reaction, stayed as precipitate in the toluene solution and therefore failed to form an 
                                                
31 For reviews, see: (a) Petrini, M. Chem. Rev. 2005, 105(11), 3949-3977. (b) Yin, B.; Zhang, Y.; Xu, L.-
W. Synthesis 2010, 21, 3583-3595.  
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Bz
+ B2(pin)2
PCy3 (10 mol%)
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    81% yield
over two steps
2.52 2.58
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adduct with B2(pin)2. Hence, we deduced that the phenoxide released from deprotonation 
of substrate 2.58 played a role in activation of B2(pin)2.       
 
 
Equation 2.11 The α-amido sulfone as the substrate in the borylation conditions 
 
2.4.3 Development of enantioselective borylation of aliphatic hemiaminal ethers 
Synthesis of enantioenriched alkyl-substituted α-amido boronic esters is still a 
challenge in a catalyst-controlled asymmetric reaction. We envisioned that our borylation 
strategy could serve as an alternative way to prepare this type of molecule by using a 
chiral ligand. With the above reactivity issue solved, we screened different chiral ligands 
in the borylation conditions (Table 2.6). 
 
 
Ts
HN Bz + B2(pin)2
CuCl (10 mol%)
NaOtBu (20 mol%)
PCy3 (10 mol%)
PhMe (0.1 M)
Bpin
HN Bz
rt, 20 h
(1.1 equiv)
33% conversion
2.52 2.54
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O
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P
i-Pr
P
i-Pr
i-Pr
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O
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P
Et
P
Et
Et
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O
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O
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Entry Ligand (mol%) 
Conversiona 
(%) 
Yield of 2.54 
(%)b 
Yield of 2.55 
(%)a er
c 
1 ⎯ 51 36 2 ⎯ 
 2d PCy3 (10) 39 ⎯ ⎯ ⎯ 
3 L-1 (20) 93 79 8 53:47 
4 L-2 (20) 65 40 <2 67:33 
5 L-3 (12) >98 41 16 48:52 
6 L-4 (12) 82 62 <2 51:49 
7 L-5 (12) 74 51 3 49:51 
8 L-6 (12) >98 80 <2 87:13 
9 L-7 (12) 98 78 8 81:19 
10 L-6 (20) >98 80 <2 89:11 
         aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene as the  
           internal standard. bIsolated yield. cDetermined by chiral HPLC. dCuCl was not added. 
 
Table 2.6 Ligand screening in the enantioselective borylation reaction 
 
The first related information we collected is about the “background” reactions. In 
our method, the enantioselectivity can be affected by two possible “background” 
reactions: (1) CuCl can catalyze the borylation in absence of any external ligands, (2) 
NaOPh, generated in situ from the reaction, can mediate the borylation (according to 
Fernández’s organocatalytic reactions28). The control experiments (entry 1 and 2, Table 
2.6) indicated that a copper precatalyst is essential to obtain the borylated product, and 
that CuCl can appreciably catalyze the reaction without any external ligands. To 
kinetically suppress the “ligand-free” background reaction, we kept the molecular ratio of 
phosphine to copper as 2 to 1 in the following ligand screening.   
 
OPh
HN Bz + B2(pin)2
Catalyst (10 mol%)
NaOtBu (20 mol%)
Ligand (x mol%)
PhMe (0.1 M), rt, 20 h
Bpin
HN Bz
(1.1 equiv)
2.58 2.54
+
HN Bz
2.55
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Two monophosphine ligands, L-1 and L-2, were first evaluated (entry 3 and 4, 
Table 2.6). With ligand L-1 nearly no enantioselectivity was obtained, but we observed 
67:33 er from L-2. When (R,R)-Isopropyl-DuPhos, L-3, was employed, complex 
mixtures were generated and the isolated desired product turned to be almost racemic 
(entry 5). While (R)-MOP (L-2) is well known as a chiral monodentate ligand,32 some 
studies revealed that the methoxy group in this ligand can serve as a hemilabile 
coordinating site to a transition metal.33 In other words, ligand L-2 might function as a 
P,O-bidentate ligand in the tested conditions. Following this direction, we examined L-4 
and L-5, but, unfortunately, they both gave the racemic product (entry 6 and 7). 
Switching to the DuPhos-based bisphosphine monoxide ligands (L-6 and L-7), we were 
pleased to find that they were both effective in enantiocontrol and gave good yields. The 
reaction employing ligand L-6 was more enantioselective than that of ligand L-7 (entry 8 
and 9). To further suppress the “background” reaction, the loading of ligand L-6 was 
increased to 20 mol%, but the enantioselectivity was slightly improved (entry 10).   
We then investigated other variables of the reaction (Table 2.7). Lowering 
catalyst loading slightly improved the enantioselectivity (entry 3, Table 2.7), but the 
stereochemical outcome of the reaction was still under good control even at 2.5 mol% 
catalyst loading (entry 3). On the other hand, the yield of the reaction was improved by 
using less catalyst (entry 2 and 3). Increasing the reaction concentration accelerated the 
borylation, which was finished in 15 h, but the yield and enantioselectivity were both 
slightly diminished (entry 4). While preparing other aliphatic substrates, we found that 
                                                
32 For a review, see: Hayashi, T. Acc. Chem. Res. 2000, 33, 354-362.  
33 (a) RajanBabu, T. V.; Nomura, N.; Jin. J.; Radetich, B.; Park, H.; Nandi, M. Chem. Eur. J. 1999, 5(7), 
1963-1968. (b) Nandi, M.; Jin, J.; RajanBabu, T. V. J. Am. Chem. Soc. 1999, 121, 9899-9900. 
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several substrates exhibited relatively low solubility in commonly used organic solvents. 
To avoid low reaction conversions resulting from the solubility issue, we decided to use 
0.1 M as the reaction concentration in the following studies. Performing the borylation 
reaction at 4 ºC improved the enantioselectivity at the cost of reaction conversion (54% 
after 20 h at 4 ºC) (entry 5).       
 
Entry CuCl  (mol%) c (M) Temp. (ºC) 
Conversion  
(%)a 
Yield  
(%)b er
c 
1 10 0.1 22 >98 80 89:11 
2 5 0.1 22 >98 90 89:11 
 3d 2.5 0.1 22 >98 93 90:10 
 4e 2.5 0.2 22 >98 90 89:11 
5f 5 0.1 4 54 43 93:7 
                 aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene as  
                    the internal standard. bIsolated yields. cDetermined by chiral HPLC.  
                         dReaction time:19 h.eReaction time:15 h. fReaction time: 20 h.  
 
Table 2.7 Further optimization of the borylation conditions 
 
In addition, we were curious whether there was a kinetic resolution process 
involved in our method. Considering the facts that substrate 2.58 contains a stereogentic 
center and the borylation catalyst is a chiral Cu(I)/phosphine complex, the sterically 
matched enantiomer of substrate 2.58 will react faster than the mismatched enantiomer. If 
this were the case, the enantiopurity of product 2.54 would gradually decrease and, 
meanwhile, the enantiopurity of the unreacted substrate 2.58 would gradually increase, as 
the conversion increased. To test this hypothesis, we conducted a time study of the above 
reaction (Table 2.8). 
OPh
HN Bz + B2(pin)2
NaOtBu (2x mol%)
L-6 (2x mol%)
PhMe (c)
Bpin
HN Bz
Temperature, 12 h
(1.1 equiv)
CuCl (x mol%)
2.58 2.54
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Entry Temperature  (°C) 
Time 
 (h) 
Conversion  
(%)a er of 2.54
b er of 2.58b 
1c 22 2.5 42 89:11 49.5:50.5 
2c 22 8 87 90:10 48:52 
3d 22 12      >98 89:11 — 
4d 4 20 54     93:7 49:51 
                        aDetermined by 1H-NMR of unpurified products with 1,3,5-trimethoxybenzene as  
                   the internal standard. bDetermined by chiral HPLC. cThe unpurified products were  
                   used for the determination. dThe purified products were used for the determination. 
 
Table 2.8 A time study of the borylation reaction 
 
The er values of compound 2.54 collected from different reaction time scales 
indicated that the enantiopurity of the product nearly did not change as the reaction 
reaching higher conversions (entry 1, 2 and 3, Table 2.8). The unreacted substrate 2.58 
became slightly enantioenriched when the reaction proceeded to near completion (entry 
2). We also examined the recovered substrate 2.58 from the reaction conducted at 4 ºC, 
and found that it was almost racemic (entry 4). Based on these results, it seems that the 
racemic substrate 2.58 underwent kinetic resolution during the borylation, but, under the 
reaction conditions, this compound rapidly racemized or decomposed to the 
corresponding aldimine, which offset the effect of kinetic resolution.        
After made all the above effort, we turned our attention to the copper precatalyst 
used in the reaction. We noticed that a preformed complex of CuOTf and Methyl-DuPhos 
monoxide ((L-6)2•CuOTf) is commercially available, and tested this complex in our 
borylation conditions. To our delight, it produced higher enantioselectivity and a 
OPh
HN Bz + B2(pin)2
NaOtBu (10 mol%)
L-6 (10 mol%)
PhMe (0.1 M)
Bpin
HN Bz
Temperature, Time
(1.1 equiv)
CuCl (5 mol%)
2.58 2.54
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comparable yield (Equation 2.12). Compared with CuCl, the relatively more Lewis acidic 
CuOTf may have stronger binding with ligand L-6 and the in situ generated aldimine 
2.57, which can suppress ligand dissociation and make the aldimine adopt a more suitable 
orientation to avoid close interaction. Additionally, this oxygen-stable34 complex can 
potentially make the reaction results more reproducible and reliable. It should be noted 
that the enantiopurity of product 2.54 could be further enhanced to 99:1 through 
recrystallization from dichloromethane/hexane. The absolute stereochemistry of product 
2.54 was assigned to be (S)-configuration through the single crystal x-ray structure.  
   
 
Equation 2.12 The new reaction conditions for borylation of hemiaminal ethers 
 
 
 
Figure 2.6 The single crystal x-ray structure of enantioenriched compound 2.54 
 
                                                
34 Côté, A.; Charette, A. B. J. Org. Chem. 2005, 70, 10864-10867.  
OPh
HN Bz + B2(pin)2
NaOtBu (5.0 mol%)
PhMe (0.1M), rt, 19 h
Bpin
HN Bz
(1.1 equiv)
(L-6)2•CuOTf
(2.5 mol%)
> 98% conversion
        89% yield
          94:6 er
2.58 (S)-2.54
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We explored the substrate scope of our enantioselective borylation method with 
the above new reaction conditions (Figure 2.8).  
 
 
Figure 2.7 Substrate scope of the enantioselective borylation of hemiaminal ethers 
 
When the isopropyl group in substrate 2.58 was replaced with other alkyl groups 
the reaction proceeded smoothly as well. In most of cases, over 70% isolated yields were 
achieved. The mass loss mainly came from decomposition of the borylated products 
during the column purification process, because this type of molecule is sensitive to 
R OPh
HN Bz + B2(pin)2
NaOtBu (5.0 mol%)
PhMe (0.1M), rt, 19 h
R Bpin
HN Bz
(1.1 equiv)
(L-6)2•CuOTf
(2.5 mol%)
BPin
HN Bz
> 98% conversion, 
        74% yield, 
           97:3 er
BPin
HN Bz
 94% conversion 
       87% yield,
         93:7 er
BPin
HN Bz
> 98% conversion,
       74% yield,
          97:3 er
BPin
HN Bz
> 98% conversion,
       77% yield,
          95:5 er
BPin
HN Bz
> 98% conversion, 
       77% yield,
          96:4 er
BPin
HN Bz
Cl
> 98% conversion,
      78% yield,
         93:7 er
BPin
HN Bz
> 98% conversion,
       86% yield,
          92:8 er
BPin
HN Bz
TBSO
> 98% conversion,
      74% yield,
         94:6 er
BPin
HN Bz
BnO
> 98% conversion,
       32% yield,
         79:21 er
(S)-2.68 (S)-2.69
(S)-2.73
(S)-2.70
(S)-2.71 (S)-2.72
(S)-2.74 (S)-2.75 (S)-2.76
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commonly used stationary phases35 and tends to stay in the column. The slightly lower 
conversion observed from synthesis of product 2.69 was attributed to the poor solubility 
of the substrate in toluene. Substrates containing a longer and more linear side chain gave 
higher enantioselectivity (2.68, 2.70, 2.71 and 2.73, Figure 2.8). As for preparation of the 
methyl-substituted product 2.72, the small interaction between the substrate and the chiral 
copper complex may pose difficulty in enantiocontrol, and we indeed observed a lower 
enantiopurity of 2.72. In terms of functional group tolerance of our method, we were 
pleased to find that chlorine, alkenyl or silyl ether were left intact under the borylation 
conditions. For instance, based on 1H-NMR of the unpurified product 2.73, we did not 
detect olefin hydroboration products. As indicated by the result of product 2.76, there is a 
limitation in our substrate scope. We obtained a much lower yield and enantioselectivity 
from the reaction. Although the major byproduct was isolated, we could not identify its 
structure. A reasonable explanation for the observed low yield (32%) and low 
stereoselectivity (79:21 er) of making product 2.76 is that the substrate or the 
corresponding aldimine in situ generated from the reaction replaced the bisphosphine 
monoxide ligand and chelated with CuOTf, which complicated the borylation reaction 
and corroded the enantioselectivity. 
 
2.5 Conclusion 
We have successfully developed a copper-catalyzed borylation strategy to prepare 
aromatic and aliphatic α-amido boronic esters. With a chiral bisphosphine monoxide 
ligand, we also established a protocol of enantioselective synthesis of aliphatic α-amido 
                                                
35 In our case, Florisil® was used as the stationary phase.  
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boronic esters. Further evaluation of other substrates containing a readily removable 
amino protecting group and functionalization of the borylated products are the two future 
directions of this study.     
    
2.6 Experimental Procedures and Characterization 
General Information 
Unless otherwise noted, reactions were conducted in oven-dried glassware 
(160 °C) under dry N2 atmosphere. Work-up and purification processes were carried out 
with reagent grade chemicals in air.  
Dichloromethane (analytical grade, Aldrich) was purified with a solvent 
dispensing system (Pure Process Technology) by passing the solvent through two 
activated neutral alumina columns after being purged with nitrogen, and stored over 3Å 
molecular sieves in a N2-filled glovebox. Toluene (PhMe), tetrahydrofuran (THF), 
diethyl ether (Et2O), Methyl tert-butyl ether (MTBE) are analytical grade products from 
Fisher, purified by distillation from sodium benzophenone ketyl, and stored over 3Å 
molecular sieves in a N2-filled glovebox. Deuterated solvents for NMR studies were 
purchased from Cambridge Isotope Laboratories, Inc.  
Flash column chromatography was conducted on silica gel (SiliaFlash® F60, 230-
400 mesh) purchased from Silicycle. Florisil® (200 mesh) used for column 
chromatography was purchased from Aldrich. Thin-layer chromatography (TLC) was 
conducted on 250 µm glass-backed silica gel plates. TLC spots were visualized by using 
ultraviolet light (254 nm), phosphomolybdic acid (PMA), or cerium ammonium 
molybdate (CAM). 
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Fourier transform infrared (FTIR) spectra were measured with a Bruker alpha-P 
spectrophotometer, and transmission peaks are reported in wavenumber (cm-1). 1H-NMR 
spectra were measured with a Varian INOVA-600 (600 MHz) spectrometer. Chemical 
shifts are in ppm with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm, 
CDCl2: 5.32 ppm). Peak data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, p = pentet, br = broad, m = multiplet, app = 
approximate), coupling constants (J, Hz) and integration. 13C-NMR spectra were 
measured on a Varian INOVA-600 (151 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the 
internal standard (CDCl3: δ 77.16 ppm, CDCl2: 53.84 ppm). Peak data are reported as 
follows: chemical shift, multiplicity (singlet unless otherwise noted), and coupling 
constants (Hz). High-resolution mass spectrometry was performed on a JEOL AccuTOF-
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Melting 
points of solid compounds were determined with a MEL-TEMP II capillary melting point 
apparatus (Laboratory Devices Inc, USA).           
 
Benzaldehyde, acetaldehyde, pentanal, 2-methylpropanal, 3-methylbutanal, 
cyclohexanecarboxaldehyde, and 3-phenylpropionaldehyde were purchased from 
Aldrich and freshly distilled under N2 before use. 
4-pentenal was purchased from Oakwood Chemical and used as received. 
Benzyloxyacetaldehyde was purchased from Aldrich and used as received. 
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4-chloro-1-butanal was prepared according to a published procedure.36 
3-(tert-butyldimethylsilyloxy)propanal was prepared according to a published 
procedure and used without any purification.37  
Benzamide was purchased from Aldrich and used as received. 
4-Methylbenzenesulfinic acid was freshly prepared according to a published 
procedure38 and used immediately.      
1,2,3-Benzotriazole was purchased from Aldrich and used as received.  
Sodium methoxide (NaOMe) was prepared by adding freshly cut sodium metal in 
anhydrous methanol (HPLC grade, purchased from Fisher Scientific International, Inc.). 
Sodium phenoxide (NaOPh) was prepared according to a published procedure39 and 
stored in a N2-filled glovebox. 
Sodium tert-butoxide (NaOtBu) was purchased from Aldrich and stored in a N2-filled 
glovebox. 
Bis(pinacolato)diboron (B2(pin)2) was purchased from Combi-Blocks Inc. and 
recrystallized from pentane before use. 
Copper(I) chloride (99.99%-Cu) (CuCl) was purchased from Strem Chemicals Inc. and 
stored in a N2-filled glovebox. 
Copper(I) bromide (99.99%-Cu) (CuBr) was purchased from Aldrich and stored in a 
N2-filled glovebox. 
                                                
36 Smith, S. W.; Fu, G. C. Angew. Chem. Int. Ed. 2008, 47, 9334-9336. 
37 Valot, G.; Regans, C. S.; O’Malley, D. P.; Godineau, E.; Takikawa, H.; Fürstner, A. Angew. Chem. Int. 
Ed. 2013, 52, 9534-9538. 
38 Münster, N.; Harms, K.; Koert, U. Chem. Commun. 2012, 48, 1866-1867. 
39 Liang, L.-C.; Chien, P.-S.; Lee, P.-Y.; Lin, J.-M.; Huang, Y.-L. Dalton Trans. 2008, 3320-3327. 
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Tricyclohexylphosphine (PCy3) was purchased from Strem Chemicals Inc. and stored in 
a N2-filled glovebox. 
Triphenylphosphine (PPh3) was purchased from Aldrich, recrystallized from hot 
benzene, and stored in a N2-filled glovebox. 
L-1, (S)-(+)-Neomenthyldiphenylphosphine, was purchased from Strem Chemicals Inc. 
and stored in a N2-filled glovebox.  
L-2, (R)-(+)-2-(Diphenylphosphino)-2’-methoxy-1,1’-binaphthyl, was prepared 
according to a published procedure.40    
L-3, (+)-1,2-Bis[(2R,5R)-2,5-di-i-propylphospholano]benzene, was purchased from 
Strem Chemicals Inc. and stored in a N2-filled glovebox.  
L-4, 2-{2-[(2R,5R)-2,5-Diethyl-1-phospholano]phenyl}1,3-dioxolane, was purchased 
from Strem Chemicals Inc. and stored in a N2-filled glovebox.  
L-5, (R)-2-diphenylphosphino-2’-diphenylphosphinyl-1,1’-binaphthyl, was prepared 
according to a published procedure.41  
L-6, [1-(2R,5R)-2,5-Dimethylphospholanyl]-[2-(2R,5R)-2,5-dimethylphospholanyl-1-
oxide]benzene, was purchased from Strem Chemicals Inc. and stored in a N2-filled 
glovebox.  
L-7, [1-(2R,5R)-2,5-Diethylphospholanyl]-[2-(2R,5R)-2,5-diethylphospholanyl-1-
oxide]benzene, was purchased from Strem Chemicals Inc. and stored in a N2-filled 
glovebox. 
                                                
40 Uozumi, Y.; Kawatsura, M.; Hayashi, T. Organic Syntheses 2002, 78, 1-13.  
41 (a) Grushin, V. V. Organometallics 2001, 20, 3950-3961. (b) Hu, J.; Hirao, H.; Li, Y.; Zhou, J. Angew. 
Chem. Int. Ed. 2013, 52, 8676-8680.   
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(L-6)2•CuOTf, Bis{[1-(2R,5R)-2,5-dimethylphospholanyl]-[2-(2R,5R)-2,5-
dimethylphospholanyl-1-oxide]benzene}Copper(I) trifluoromethanesulfonate was 
purchase from Alfa Aesar and stored in a N2-filled glovebox. 
 
Preparation of hemiaminal methyl ethers    
N-(methoxyphenylmethyl)benzamide 2.47 
 
The title compound 2.47 was prepared according to a published procedure42 with 
modification. To a 100 mL round bottom flask containing a stir bar were added 
benzamide (1.454 g, 12.0 mmol), 1,2,3-benzotriazole (1.429 g, 12.0 mmol), 
benzaldehyde (1.22 mL, 12.0 mmol), and toluene (20 mL) in sequence. After a condenser 
and a Dean-Stark trap were installed onto the flask, the apparatus was placed in a 150 °C 
oil bath. The reaction mixture was stirred under reflux for 30 h, and then allowed to cool 
down to 22 °C naturally. Diethyl ether (20 mL) was added in the flask, and the resulting 
mixture was filtered with a Büchner funnel. The off-white solid collected from filtration 
was further washed with diethyl ether (5×5 mL), air-dried and recrystallized once from 
toluene (35 mL) to afford N-(1-benzotriazolyl-1-phenylmethyl)benzamide 2.77 as white 
needle-shaped crystals (2.01 g, 51%). This compound was used in the next step without 
further purification.  
                                                
42 (a) Katritzky, A. R.; Pernak, J.; Fan, W.-Q.; Saczewski, F. J. Org. Chem. 1991, 56, 4439-4443. (b) 
Katritzky, A. R.; Fan, W.-Q.; Black, M.; Pernak, J. J. Org. Chem. 1992, 57, 547-549. 
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N-(1-benzotriazolyl-1-phenylmethyl)benzamide 2.77 (2.003 g, 6.1 mmol) was 
added to a stirred solution of sodium methoxide (sodium: 0.281 g, 12.2 mmol, 2.0 equiv) 
in methanol (24 mL) in one portion. The reaction vessel, a 100 mL round bottom flask 
containing a stir bar, was fitted with a rubber septum and placed under N2. The reaction 
mixture was allowed to stir vigorously at 22 °C for 24 h. The resulted milky white 
suspension was concentrated in vacuo, and the residue was dissolved in a mixture of 
CH2Cl2 (20 mL) and saturated NH4Cl aqueous solution (30 mL). The obtained biphasic 
mixture was transferred to a separatory funnel, and the organic layer was isolated. The 
aqueous layer was extracted with CH2Cl2 (2×20 mL). The combined organic layers were 
washed with H2O (2×20 mL) and brine (20 mL), dried over Na2SO4, filtered and 
concentrated in vacuo. The obtained white solid residue was purified by silica gel column 
chromatography (dichloromethane: diethyl ether = 80:1) to afford the title compound as a 
white solid (1.208 g, 82% yield over two steps). 
1H-NMR (600 MHz, CDCl3) δ 7.82 – 7.80 (m, 2H), 7.54 – 7.50 (m, 3H), 7.46 – 7.44 (m, 
2H), 7.41 – 7.38 (m, 1H), 7.36-7.33 (m, 2H), 6.58 (d, J = 9.0 Hz, 1H), 6.38 (d, J = 9.6 Hz, 
1H), 3.55 (s, 3H). 
13C-NMR (151 MHz, CDCl3) δ 167.32, 139.33, 133.73, 131.99, 128.66, 128.65, 128.55, 
127.10, 125.90, 81.84, 56.21. 
FTIR (neat): 3293, 2941, 1649, 1513, 1486, 1446, 1342, 1273, 1088, 1047, 976, 750, 689, 
595 cm-1. 
HRMS (ESI+) calcd for C15H15NO2Na ([M+Na]+): 264.1000, found: 264.0988. 
Melting point: 99-100 °C 
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N-[2-methyl-1-[(4-methylphenyl)sulfonyl]propyl]benzamide 2.52 
 
To a 50 mL round bottom flask containing a stir bar were added benzamide 
(0.606 g, 5.0 mmol), 4-methylbenzenesulfinic acid (0.781 g, 5.0 mmol) and 3Å molecular 
sieves (0.9 g). The flask was fitted with a rubber septum and placed under N2, followed 
by successive addition of CH2Cl2 (10.0 mL) and 2-methylpropanal (456 µL, 5.0 mmol) 
via syringe. The reaction mixture was allowed to stir vigorously at 22 °C for 20 h. The 
resulted pale yellow cloudy solution was diluted with CH2Cl2 (10 mL) and filtered over a 
pad of celite, and the filter cake was washed with CH2Cl2 (2×10 mL). The collected 
filtrate was concentrated in vacuo to afford an off-white solid residue (1.503 g, 91% 
crude yield). This solid was dried under high vacuum for 3 h, and used in the next step 
without further purification. 
For characterization purpose and reactivity test, a small amount of this compound 
was purified by silica gel column chromatography (hexanes: dichloromethane: ethyl 
acetate = 10:10:1) to afford the title compound as a white microcrystalline solid. 
1H-NMR (600 MHz, CDCl3) δ 7.74 (d, J = 8.4 Hz, 2H), 7.63 – 7.62 (m, 2H), 7.55 – 7.52 
(m, 1H), 7.44 (t, J = 7.8 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 6.57 (d, J = 10.8 Hz, 1H), 5.32 
(dd, J = 10.8, 3.6 Hz, 1H), 2.92 – 2.85 (m, 1H), 2.37 (s, 3H), 1.22 (d, J = 7.2 Hz, 2H), 
1.12 (d, J = 7.2 Hz, 2H). 
HN
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13C-NMR (151 MHz, CDCl3) δ 166.66, 145.00, 134.83, 133.04, 132.22, 129.78, 128.75, 
128.65, 126.90, 72.63, 27.36, 21.66, 20.71, 17.21. 
FTIR (neat): 3272, 2975, 2962, 1650, 1592, 1526, 1331, 1298, 1265, 1130, 1077, 802, 
698, 618, 591, 565, 526, 422 cm-1. 
HRMS (DART+) calcd for C18H22NO3S ([M+H]+): 332.1320, found: 332.1327. 
Melting point: 113-115 °C 
 
N-(1-methoxy-2-methylpropyl)benzamide 2.53 
 
N-[2-methyl-1-[(4-methylphenyl)sulfonyl]propyl]benzamide 2.52 (1.503 g, 4.54 
mmol) was added to a stirred solution of sodium methoxide (sodium: 0.209 g, 9.08 mmol, 
2.0 equiv) in methanol (18 mL) in one portion. The reaction vessel, a 100 mL round 
bottom flask containing a stir bar, was fitted with a rubber septum and placed under N2. 
The reaction mixture was allowed to stir vigorously at 22 °C for 24 h. The resulted 
slightly yellow cloudy solution was concentrated in vacuo, and the pale yellow semisolid 
residue was dissolved in a mixture of CH2Cl2 (30 mL) and saturated NH4Cl aqueous 
solution (30 mL). The obtained biphasic mixture was transferred to a separatory funnel, 
and the organic layer was isolated. The aqueous layer was extracted with CH2Cl2 (2×15 
mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in 
vacuo. The obtained pale yellow solid residue was purified by silica gel column 
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chromatography (hexanes:  ethyl acetate = 10:1 to 8:1) to afford the title compound as a 
white microcrystalline solid (0.757 g, 73% yield over two steps). 
1H-NMR (600 MHz, CDCl3) δ 7.81–7.79 (m, 2H), 7.55–7.52 (m, 1H), 7.48–7.45 (m, 2H), 
6.23 (br d, J = 9.6 Hz, 1H), 5.11 (dd, J = 10.2, 6.0 Hz, 1H), 3.40 (s, 3H), 1.93 (octet, J = 
6.6 Hz, 1H), 1.02 (d, J = 6.6 Hz, 3H), 0.99 (d, J = 6.6 Hz, 3H). 
13C-NMR (151 MHz, CDCl3) δ 167.67, 134.14, 131.79, 128.66, 126.92, 85.83, 56.21, 
33.28, 17.80, 17.34. 
FTIR (neat): 3257, 2962, 2930, 1638, 1532, 1316, 1145, 1086, 1045, 982, 803, 698, 663, 
588 cm-1. 
HSMS (ESI+) calcd for C12H17NO2Na ([M+Na]+): 230.1157, found: 230.1157. 
Melting point: 94-96 °C 
 
Preparation of hemiaminal phenyl ethers 
 
Figure 2.8 Preparation of hemiaminal phenyl ethers 
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N-(2-methyl-1-phenoxypropyl)benzamide 2.58 
 
N-[2-methyl-1-[(4-methylphenyl)sulfonyl]propyl]benzamide 2.52 was prepared 
according to the abovementioned procedure with minor modifications (unreacted 
benzamide complicates the second step). To a 50 mL round bottom flask containing a stir 
bar were added benzamide (0.242 g, 2.0 mmol), 4-methylbenzenesulfinic acid (0.406 g, 
2.6 mmol, 1.3 equiv) and 3Å molecular sieves (0.36 g). The flask was fitted with a rubber 
septum and placed under N2, followed by sequential addition of CH2Cl2 (4.0 mL) and 2-
methylpropanal (237 µL, 2.6 mmol, 1.3 equiv) via syringe. The reaction mixture was 
allowed to stir vigorously at 22 °C for 20 h. The resulted pale yellow cloudy solution was 
diluted with a mixture of CH2Cl2 (10 mL) and MeOH (5 mL), filtered over a pad of 
celite. The filter cake was washed with CH2Cl2 (2×5 mL). The collected filtrate was 
concentrated in vacuo to afford a pale yellow semisolid that slowly solidifies to an off-
white solid (0.755 g, over 100% crude yield). This solid was dried under high vacuum for 
3 h and used in the next step without further purification. 
In a N2-filled glovebox NaOPh (0.302 g, 2.6 mmol, 1.3 equiv) was added to a 100 
mL round bottom flask charged with a stir bar and N-[2-methyl-1-[(4-
methylphenyl)sulfonyl]propyl]benzamide 2.52 (0.755 g, crude form). The vessel was 
fitted with a rubber septum before it was removed from the glovebox, and placed under 
N2. CH2Cl2 (8.0 mL) was added in the flask via syringe, and the reaction mixture was 
allowed to stir vigorously at at 22 °C for 14 h. The resulted pale yellow thick suspension 
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was diluted with CH2Cl2 (10 mL) and saturated NH4Cl aqueous solution (15 mL). The 
resulting biphasic mixture was transferred to a separatory funnel, and the organic layer 
was isolated. The aqueous layer was extracted with CH2Cl2 (2×15 mL). The combined 
organic layers was washed with saturated Na2CO3 aqueous solution (10 mL) and brine 
(10 mL), dried over Na2SO4, filtered and concentrated in vacuo. The obtained white solid 
residue was triturated with H2O (4×3 mL) to remove the majority of excess phenol, and 
then purified by silica gel column chromatrography (hexanes: dichloromethane: diethyl 
ether = 10:10:0.1) to afford the title compound as a white solid (0.441 g, 82% yield over 
steps).  
1H-NMR (600 MHz, CDCl3) δ 7.74 – 7.72 (m, 2H), 7.52 – 7.49 (m, 1H), 7.42 (t, J = 7.8 
Hz, 2H), 7.28 – 7.25 (overlapped with CDCl3, m, 2H), 7.06 (d, J = 7.8 Hz, 2H), 6.95 (t, J 
= 7.2 Hz, 1H), 6.41 (d, J = 9.6 Hz, 1H), 6.00 (dd, J = 10.2, 6.0 Hz, 1H), 2.17 (octet, J = 
6.6 Hz 1H), 1.13 (d, J = 6.6 Hz, 3H), 1.10 (d, J = 6.6 Hz, 3H). 
13C-NMR (151 MHz, CDCl3) δ 166.96, 156.66, 133.84, 131.89, 129.62, 128.65, 126.97, 
121.57, 115.74, 82.23, 33.84, 17.58, 17.16. 
FTIR (neat): 3271, 2960, 1633, 1580, 1536, 1485, 1321, 1225, 1046, 971, 754, 692, 664 
cm-1. 
HSMS (ESI+): calcd for C17H19NO2Na ([M+Na]+): 292.1313, found: 292.1317. 
Melting point: 118-121 °C 
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N-(3-methyl-1-phenoxybutyl)benzamide 2.59 
 
 
The title compound was synthesized analogous to compound 2.58 in two steps. 3-
Methylbutanal (279 µL, 2.6 mmol, 1.3 equiv), benzamide (0.242 g, 2.0 mmol), 4-
methylbenzenesulfinic acid (0.406 g, 2.6 mmol, 1.3 equiv) and 3Å molecular sieves (0.36 
g) were used to prepare α-amido sulfone 2.78 (0.809 g, crude product). NaOPh (0.302 g, 
2.6 mmol, 1.3 equiv) and 2.78 (0.809 g) were used to prepare hemiaminal ether 2.59. The 
crude product was purified by silica gel column chromatography (hexanes: 
dichloromethane: diethyl ether = 10:10:0.1) to afford the title compound as a white solid 
(0.378 g, 67% over two steps). 
1H-NMR (600 MHz, CDCl3) δ 7.75 – 7.70 (m, 2H), 7.51 – 7.48 (m, 1H), 7.41 (t, J = 7.8 
Hz, 2H), 7.28 – 7.26 (overlapped with CDCl3, m, 2H), 7.08 (d, J = 8.4 Hz, 2H), 6.96 (t, J 
= 7.2 Hz, 1H), 6.42 (br d, J = 9.6 Hz, 1H), 6.29 (dt, J = 9.6, 6.0 Hz, 1H), 1.92 (dt, J = 
13.2, 6.6 Hz, 2H), 1.87 (dt, J = 13.2, 6.6 Hz, 1 H), 1.73 (dt, J = 13.2, 6.6 Hz, 1H), 1.03 (d, 
J = 6.6 Hz, 3H), 0.99 (d, J = 6.6 Hz, 2H). 
13C-NMR (151 MHz, CDCl3) δ 166.60, 156.45, 133.72, 131.91, 129.64, 128.62, 127.02, 
121.65, 115.89, 45.08, 24.60, 22.78, 22.52. 
FTIR (neat): 3254, 3069, 2958, 1638, 1538, 1493, 1295, 1226, 1029, 978, 748, 704 cm-1. 
HSMS (ESI+) calcd for C18H21NO2Na ([M+Na]+): 306.1470, found: 306.1466. 
Melting point: 111-112 °C 
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N-(1-cyclohexyl-1-phenoxymethyl)benzamide 2.60 
 
The title compound was synthesized analogous to 2.58 in two steps. 
Cyclohexanecarboxaldehyde (315 µL, 2.6 mmol, 1.3 equiv), benzamide (0.242 g, 2.0 
mmol), 4-methylbenzenesulfinic acid (0.406 g, 2.6 mmol, 1.3 equiv) and 3Å molecular 
sieves (0.36 g) were used to prepare α-amido sulfone 2.79 (0.853 g, crude prodcut). 
NaOPh (0.302 g, 2.6 mmol, 1.3 equiv) and 2.79 (0.853 g) were used to prepare 
hemiaminal ether 2.60. The crude product was purified by silica gel column 
chromatography (hexanes: dichloromethane: diethyl ether = 10:10:0.1) to afford the title 
compound as a white solid (0.423 g, 68% over two steps). 
1H-NMR (600 MHz, CDCl3) δ 7.74 – 7.72 (m, 2H), 7.51 – 7.48 (m, 1H), 7.43 – 7.40 (m, 
2H), 7.28 – 7.24 (overlapped with CDCl3, m, 2H), 7.07 – 7.03 (m, 2H), 6.95 (t, J = 7.2 
Hz, 1H), 6.42 (br d, J = 10.2 Hz, 1H), 5.99 (dd, J = 9.6, 6.0 Hz, 1H), 2.02 (br d, J = 12.6 
Hz, 1H), 1.88 – 1.79 (m, 4H), 1.70 (d, J = 12.6 Hz, 1H), 1.33 – 1.17 (m, 5H). 
13C-NMR (151 MHz, CDCl3) δ 166.91, 156.76, 133.80, 131.88, 129.61, 128.63, 127.00, 
121.53, 115.72, 81.79, 43.36, 28.15, 27.67, 26.26, 25.74, 25.66. 
FTIR (neat): 3219, 3062, 2919, 2848, 1635, 1598, 1542, 1485, 1345, 1226, 1027, 1007, 
892, 801, 748, 706, 692 cm-1. 
HSMS (ESI+) calcd for C20H23NO2Na ([M+Na]+): 332.1626, found: 332.1621. 
Melting point: 143-144 °C 
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N-(1-phenoxypentyl)benzamide 2.61 
 
The title compound was synthesized analogous to compound 2.58 in two steps. 
Pentanal (276 µL, 2.6 mmol, 1.3 equiv), benzamide (0.242 g, 2.0 mmol), 4-
methylbenzenesulfinic acid (0.406 g, 2.6 mmol, 1.3 equiv) and 3Å molecular sieves (0.36 
g) were used to prepare α-amido sulfone 2.80 (0.918 g, crude prodcut). NaOPh (0.302 g, 
2.6 mmol, 1.3 equiv) and 2.80 (0.918 g) were used to prepare hemiaminal ether 2.61. The 
crude product was purified by silica gel column chromatography (hexanes: 
dichloromethane: diethyl ether = 10:10:0.1) to afford the title compound as a white solid 
(0.340 g, 60% yield over two steps), 
1H-NMR (600 MHz, CDCl3) δ 7.75 – 7.73 (m, 2H), 7.52 – 7.47 (m, 1H), 7.42 – 7.39 (m, 
2H), 7.29 – 7.25 (overlapped with CDCl3, m, 2H), 7.08 – 7.06 (m, 2H), 6.96 (tt, J = 7.2, 
1.2 Hz, 1H), 6.55 (br d, J = 9.6 Hz, 1H), 6.22 (dt, J = 9.6, 6.0 Hz, 1H), 2.04 – 1.98 (m, 
1H), 1.90 – 1.84 (m, 1H), 1.57 – 1.36 (m, 4H), 0.93 (t, J = 7.8 Hz, 3H). 
13C-NMR (151 MHz, CDCl3) δ 166.69, 156.50, 133.74, 131.90, 129.62, 128.61, 127.02, 
121.65, 115.91, 78.74, 35.88, 26.77, 22.39, 13.98. 
FTIR (neat): 3273, 2950, 2927, 2866, 1631, 1580, 1534, 1485, 1292, 1217, 1146, 1121, 
1078, 1028, 1013, 987, 866, 754, 696, 665 cm-1. 
HSMS (ESI+) calcd for C18H21NO2Na ([M+Na]+): 306.1470, found: 306.1467. 
Melting point: 117-119 °C 
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N-(1-phenoxy-3-phenylpropyl)benzamide 2.62 
 
The title compound was synthesized analogous to compound 2.58 in two steps. 3-
phenylpropionaldehyde (342 µL, 2.6 mmol, 1.3 equiv), benzamide (0.242 g, 2.0 mmol), 
4-methylbenzenesulfinic acid (0.406 g, 2.6 mmol, 1.3 equiv) and 3Å molecular sieves 
(0.36 g) were used to prepare α-amido sulfone 2.81 (0.980 g, crude prodcut). NaOPh 
(0.302 g, 2.6 mmol, 1.3 equiv) and 2.81 (0.980 g) were used to prepare hemiaminal ether 
2.62. The crude product was purified by silica gel column chromatography (hexanes: 
dichloromethane: diethyl ether = 11:10:0.1) or recrystallization (hexane: ethyl acetate = 
5:1) to afford the title compound as a white solid (0.442 g, 67% yield over two steps). 
1H-NMR (600 MHz, CDCl3) δ 7.63 (d, J = 7.2 Hz, 2H), 7.49 (t, J = 7.2 Hz, 1H), 7.39 (t, J 
= 7.8 Hz, 2H), 7.31 – 7.23 (overlapped with CDCl3, m, 5H), 7.21 (t, J = 7.2 Hz, 1H), 7.07 
(d, J = 7.8 Hz, 2H), 6.97 (t, J = 7.2 Hz, 1H), 6.44 (d, J = 9.6 Hz, 1H), 6.28 (dt, J = 9.6, 
6.0 Hz, 1H), 2.94 (ddd, J = 13.8, 9.6, 6.6 Hz, 1H), 2.84 (ddd, J = 13.8, 9.0, 6.0 Hz, 1H), 
2.32 (ddt, J = 13.8, 9.0, 6.6 Hz, 1H), 2.24 (ddt, J = 13.8, 9.0, 6.0 Hz, 1H). 
13C-NMR (151 MHz, CDCl3) δ 166.59, 156.34, 140.97, 133.57, 131.94, 129.66, 128.61, 
128.58, 128.46, 126.99, 126.16, 121.80, 115.98, 78.25, 37.50, 30.88. 
FTIR (neat): 3238, 3062, 3028, 2923, 2856, 1631, 1499, 1542, 1486, 1293, 1224, 1179, 
1028, 1010, 989, 751, 696, 502 cm-1. 
HSMS (ESI+) calcd for C22H21NO2Na ([M+Na]+): 354.1470, found: 354.1470. 
Melting point: 139-140 °C 
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N-[1-[(4-methylphenyl)sulfonyl]ethyl]benzamide 2.82 
 
To a 50 mL round bottom flask containing a stir bar were added benzamide 
(0.182 g, 1.5 mmol), 4-methylbenzenesulfinic acid (0.305 g, 1.95 mmol, 1.3 mmol) and 
3Å molecular sieves (0.27 g). The flask was fitted with a rubber septum and placed under 
N2. CH2Cl2 (3.0 mL) and acetaldehyde (420 µL, 7.5 mmol, 5.0 equiv) were sequentially 
added via syringe, and the reaction mixture was allowed to stir vigorously at 22 °C for 18 
h. The resulted yellow viscous cloudy solution was diluted with CH2Cl2 (10 mL) and 
filtered over a pad of celite. The filter cake was washed with CH2Cl2 (2×10 mL), and the 
collected filtrate was concentrated in vacuo. The obtained colorless viscous oil residue 
was purified by silica gel column chromatography (hexanes: dichloromethane: ethyl 
acetate = 10:10:1) to afford α-amido sulfone 2.82 as a white solid (0.283 g, 62% yield). 
1H-NMR (600 MHz, CDCl3) δ 7.77 (d, J = 8.4 Hz, 2H), 7.63 – 7.58 (m, 2H), 7.52 (t, J = 
7.2 Hz, 1H), 7.41 (t, J = 7.2 Hz, 2H), 7.27 (overlapped with CDCl3, m, 2H), 6.56 (br d, J 
= 9.6 Hz, 1H), 5.56 (dq, J = 10.8, 7.2 Hz, 1H), 2.39 (s, 3H), 1.72 (d, J = 7.2 Hz, 3H). 
13C-NMR (151 MHz, CDCl3) δ 166.14, 145.24, 133.37, 132.87, 132.18, 129.81, 129.08, 
128.65, 127.00, 65.31, 21.69, 13.26. 
FTIR (neat): 3260, 3062, 2926, 1645, 1522, 1488, 1310, 1291, 1244, 1139, 1124, 1082, 
1020, 812, 714, 694, 670, 641, 570, 534, 520 cm-1. 
HSMS (DART+) calcd for C16H18NO3S ([M+H]+): 304.1007, found: 304.0998. 
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Melting point: 122-125 °C 
 
N-(1-phenoxyethyl)benzamide 2.63 
 
In a N2-filled glovebox NaOPh (0.0882 g, 0.76 mmol, 0.95 equiv) was added in a 
25 mL round bottom flask containing a stir bar. The vessel was fitted with a rubber 
septum, removed from the glovebox and placed under N2. In a 2-dram vial α-amido 
sulfone 2.82 (0.243 g, 0.8 mmol) was dissolved in CH2Cl2 (2.0 mL, plus 2×0.6 mL for 
rinse), and the obtained solution was added in the reaction flask in one portion. The 
reaction mixture was allowed to stir vigorously at 22 °C for 14 h. The resulted milky 
white suspension was diluted with CH2Cl2 (5 mL) and H2O (5 mL), and transferred to a 
separatory funnel. The organic layer was isolated, and the aqueous layer was extracted 
with CH2Cl2 (2×5 mL). The combined organic layers were washed with brine (10 mL), 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The obtained white 
solid residue was purified by silica gel column chromatography (dichloromethane: 
hexanes: diethyl ether = 20:10:0.3, plus 0.5% Et3N) to afford the title compound as a 
white solid (0.143 g, 78% yield). 
1H-NMR (600 MHz, CDCl3) δ 7.76 – 7.71 (m, 2H), 7.52 – 7.48 (m, 1H), 7.43 – 7.39 (m, 
2H), 7.29 – 7.25 (overlapped with CDCl3, m, 2H), 7.08 – 7.03 (m, 2H), 6.97 (tt, J = 7.2, 
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1.2 Hz, 1H), 6.55 (br d, J = 9.0 Hz, 1H), 6.37 (dq, J = 9.0, 5.4 Hz, 1H), 1.65 (d, J = 5.4 
Hz, 3H). 
13C-NMR (151 MHz, CDCl3) δ 166.48, 156.20, 133.67, 131.94, 129.62, 128.62, 127.01, 
121.78, 116.07, 75.70, 22.16. 
FTIR (neat): 3259, 3067, 2994, 1639, 1592, 1530, 1491, 1291, 1226, 1151, 1105, 1063, 
942, 751, 692 cm-1. 
HSMS (DART+) calcd for C15H15NO2Na ([M+Na]+): 264.1000, found: 264.0996. 
Melting point: 134-136 °C 
 
N-(4-penten-1-yl-1-phenoxy)benzamide 2.64 
 
The title compound was synthesized analogous to compound 2.58 in two steps. 4-
pentenal (257 µL, 2.6 mmol, 1.3 equiv), benzamide (0.242 g, 2.0 mmol), 4-
methylbenzenesulfinic acid (0.406 g, 2.6 mmol, 1.3 equiv) and 3Å molecular sieves (0.36 
g) were used to prepare α-amido sulfone 2.83 (0.886 g, crude prodcut). NaOPh (0.302 g, 
2.6 mmol, 1.3 equiv) and 2.83 (0.886 g) were used to prepare hemiaminal ether 2.64. The 
crude product was purified by silica gel column chromatography (hexanes: 
dichloromethane: diethyl ether = 10:10:0.1) to afford the title compound as a white solid 
(0.254 g, 45% yield over two steps). 
1H-NMR (600 MHz, CDCl3) δ 7.74 – 7.72 (m, 2H), 7.52 – 7.49 (m, 1H), 7.43 – 7.40 (m, 
2H), 7.29 – 7.25 (overlapped with CDCl3, m, 2H), 7.07 – 7.05 (m, 2H), 6.96 (tt, J = 7.2, 
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1.2 Hz, 1H), 6.50 (br d, J = 9.0 Hz, 1H), 6.25 (dt, J = 9.0, 6.0 Hz, 1H), 5.88 (ddt, J = 16.8, 
10.2, 6.6 Hz, 1H), 5.09 (dq, J = 17.4, 1.8 Hz, 1H), 5.03 (dq, J = 10.2, 1.2 Hz, 1H), 2.38 – 
2.24 (m, 2H), 2.10 (ddt, J = 13.8, 9.0, 6.6 Hz, 1H), 1.99 (ddt, J = 13.8, 9.0, 6.0 Hz, 1H). 
13C-NMR (151 MHz, CDCl3) δ 166.65, 156.39, 137.20, 133.65, 131.95, 129.63, 128.63, 
127.03, 121.76, 115.95, 115.64, 78.32, 35.22, 28.86. 
FTIR (neat): 3252, 3067, 1631, 1599, 1532, 1486, 1292, 1222, 1146, 1013, 992, 912, 807, 
750, 690 cm-1. 
HSMS (DART+) calcd for C18H19NO2Na ([M+Na]+): 304.1313, found: 304.1312. 
Melting point: 87-89 °C 
 
N-[4-chloro-1-[(4-methylphenyl)sulfonyl]butyl]benzamide 2.84 
 
To a 50 mL round bottom flask containing a stir bar were added benzamide 
(0.303 g, 2.5 mmol, 1.0 equiv), 4-methylbenzenesulfinic acid (0.391 g, 2.5 mmol, 1.0 
equiv) and 3Å molecular sieves (0.45 g). The flask was fitted with a rubber septum and 
placed under N2. CH2Cl2 (5.0 mL) and 4-chloro-1-butanal (0.266 g, 2.5 mmol) were 
sequentially added via syringe. The reaction mixture was allowed to stir vigorously at 22 
°C for 24 h. The resulted yellow cloudy suspension was diluted with a mixture of CH2Cl2 
(10 mL) and MeOH (5 mL), and filtered over a pad of celite. The filter cake was washed 
with CH2Cl2 (2×5 mL). The collected filtrate was concentrated in vacuo. The obtained 
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colorless gum residue was purified by silica gel column chromatography (hexanes: 
dichloromethane: ethyl acetate = 10:12:1.2) to afford the α-amido sulfone 2.84 as a white 
solid (0.279 g, 31% yield). 
1H-NMR (600 MHz, CDCl3) δ 7.78 – 7.76 (m, 2H), 7.63 – 7.61 (m, 2H), 7.53 – 7.50 (m, 
1H), 7.43 – 7.39 (m, 2H), 7.28 – 7.25 (overlapped with CDCl3, m, 2H), 6.73 (d, J = 10.2 
Hz, 1H), 5.46 (td, J = 10.8, 3.6 Hz, 1H), 3.61 – 3.54 (m, 2H), 2.55 – 2.49 (m, 1H), 2.39 
(s, 3H), 2.14 – 2.07 (m, 1H), 1.93 (dq, J = 9.6, 6.0 Hz, 2H). 
13C-NMR (151 MHz, CDCl3) δ 166.59, 145.40, 133.42, 132.61, 132.35, 129.88, 129.01, 
128.72, 127.00, 68.51, 43.83, 28.44, 24.47, 21.70. 
FTIR (neat): 3214, 3063, 1646, 1524, 1487, 1435, 1329, 1302, 1243, 1142, 1082, 806, 
699, 657, 647, 579, 539 cm-1. 
HSMS (DART+) calcd for C18H21ClNO3S ([M+H]+): 366.0931, found: 366.0917. 
Melting point: 111-112 °C 
 
N-(4-chloro-1-phenoxybutyl)benzamide 2.65 
 
In a N2-filled glovebox sodium phenoxide (0.0838 g, 0.722 mmol, 0.95 equiv) 
was added in a 25 mL round bottom flask containing a stir bar. The vessel was fitted with 
a rubber septum, removed from the glovebox and placed under N2. In a 2-dram vial α-
amido sulfone 2.84 (0.279 g, 0.76 mmol) was dissolved in CH2Cl2 (2.0 mL, plus 2×0.5 
HN
S
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O
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Cl NaOPh
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mL for rinse), and the obtained solution was added in the reaction flask in one portion via 
a syringe. The reaction mixture was allowed to stir vigorously at 22 °C for 14 h. The 
resulted milky white suspension was diluted with CH2Cl2 (5 mL) and H2O (5 mL), and 
transferred to a separatory funnel. The organic layer was isolated, and the aqueous layer 
was extracted with CH2Cl2 (2×5 mL). The combined organic layers were washed with 
brine (10 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
obtained white solid residue was purified by silica gel column chromatography 
(dichloromethane: hexanes: diethyl ether = 10:5:0.1, plus 5% Et3N) to afford the title 
compound as a white solid (0.199 g, 91% yield). 
1H-NMR (600 MHz, CDCl3) δ 7.76 – 7.69 (m, 2H), 7.53 – 7.48 (m, 1H), 7.42 (t, J = 7.8 
Hz, 2H), 7.29 – 7.26 (overlapped with CDCl3, m, 2H), 7.05 (dd, J = 8.4, 0.6 Hz, 2H), 
6.97 (td, J = 7.2, 0.6 Hz, 1H), 6.48 (br d, J = 9.6 Hz, 1H), 6.25 (dt, J = 9.6, 6.0 Hz, 1H), 
3.63 (t, J = 6.0 Hz, 2H), 2.20 – 2.13 (m, 1H), 2.10 – 2.03 (m, 2H), 2.02 – 1.95 (m, 1H). 
13C-NMR (151 MHz, CDCl3) δ 166.75, 156.19, 133.45, 132.07, 129.70, 128.67, 127.03, 
121.91, 115.82, 78.16, 44.48, 33.50, 27.91. 
FTIR (neat): 3325, 2954, 1639, 1600, 1583, 1519, 1486, 1447, 1343, 1289, 1229, 1167, 
1050, 992, 754, 692, 663, 643 cm-1. 
HSMS (DART+) calcd for C17H18ClNO2Na ([M+Na]+): 326.0924, found: 326.0919. 
Melting point: 103-104 °C 
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N-[1-[(4-methylphenyl)sulfonyl]-3-(tert-butyldimethylsilyloxy)propyl]benzamide 
2.85 
 
To a 50 mL round bottom flask containing a stir bar were added benzamide 
(0.151 g, 1.25 mmol), 4-methylbenzenesulfinic acid (0.195 g, 1.25 mmol) and 3Å 
molecular seives (0.225 g). The flask was fitted with a rubber septum and placed under 
N2. CH2Cl2 (1.5 mL) was added in the flask via syringe. In a 1-dram vial 3-(tert-
butyldimethylsilyloxy)propanal (0.283 g, 1.5 mmol) was dissolved in CH2Cl2 (0.5 mL, 
plus 0.5 mL for rinse), and the obtained solution was added in the reaction flask via 
syringe. The reaction mixture was allowed to stir vigorously at 22 °C for 20 h. The 
resulted yellow viscous suspension was diluted with a mixture of CH2Cl2 (10 mL) and 
MeOH (5 mL), and filtered over a pad of celite. The filter cake was washed with CH2Cl2 
(2×5 mL). The collected filtrate was concentrated in vacuo. The obtained pale yellow 
gum residue was purified by silica gel column chromatography (hexanes: 
dichloromethane: ethyl aceate = 10:10:1) to afford the α-amido sulfone 2.85 as a white 
solid (0.239 g, 45% yield) 
1H-NMR (600 MHz, CDCl3) δ 7.77 (d, J = 8.4 Hz, 2H), 7.60 (dd, J = 8.4, 1.2 Hz, 2H), 
7.52 – 7.49 (m, 1H), 7.40 (t, J = 7.8 Hz, 2H), 7.25 (overlapped with CDCl3, d, J = 7.8 Hz, 
2H), 7.02 (d, J = 10.2 Hz, 1H), 5.62 (ddd, J = 9.6, 9.0, 3.6 Hz, 1H), 4.02 (app ddd, J = 
10.8, 9.0, 3.6 Hz, 1H), 3.84 (dt, J =10.8, 4.8 Hz, 1H), 2.52-2.46 (m,1H), 2.38 (s, 3H), 
2.27 – 2.21 (m, 1H), 0.83 (s, 9H), 0.027 (s, 3H), -0.008 (s, 3H). 
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13C-NMR (151 MHz, CDCl3) δ 166.24, 145.05, 134.03, 133.23, 132.05, 129.74, 129.07, 
128.61, 126.96, 67.61, 59.57, 29.80, 25.80, 21.69, 18.23, -5.51, -5.56. 
FTIR (neat): 3212, 2954, 2930, 2857, 1646, 1597, 1525, 1486, 1326, 1252, 1143, 1084, 
836, 775, 697, 655, 581 cm-1. 
HSMS (DART+) calcd for C23H34NO4SSi ([M+H]+): 448.1978, found: 448.1976. 
Melting point: 127-128 °C 
     
N-[1-phenoxy-3-(tert-butyldimethylsilyloxy)propyl]benzamide 2.66 
 
In a N2-filled glovebox NaOPh (0.0573 g, 0.494 mmol, 0.95 equiv) was added in 
a 25 mL round bottom flask containing a stir bar. The vessel was fitted with a rubber 
septum, removed from the glovebox and placed under N2. In a 2-dram vial α-amido 
sulfone 2.85 (0.233 g, 0.52 mmol) was dissolved in CH2Cl2 (1.1 mL, plus 2×0.5 mL for 
rinse), and the obtained solution was added in the reaction flask via syringe. The reaction 
mixture was allowed to stir vigorously at 22 °C for 14 h. The resulted milky white 
suspension was diluted with CH2Cl2 (5 mL) and H2O (5 mL), and transferred to a 
separatory funnel. The organic layer was isolated, and the aqueous layer was extracted 
with CH2Cl2 (2×5 mL). The combined organic layers were washed with brine (10 mL), 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The obtained colorless 
viscous oil residue was purified by silica gel column chromatography (hexanes: 
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dichloromethane: diethyl ether = 5:2.5:0.1) to afford the title compound as a white solid 
(0.119 g, 62% yield). 
1H-NMR (600 MHz, CDCl3) δ 7.76 – 7.72 (m, 2H), 7.66 (br d, J = 9.0 Hz, 1H), 7.49 (tt, J 
= 7.2, 1.2 Hz, 1H), 7.42 – 7.37 (m, 2H), 7.29 – 7.26 (overlapped with CDCl3, m, 2H), 
7.16 – 7.12 (m, 2H), 6.96 (tt, J = 7.2, 1.2 Hz, 1H), 6.40 (dt, J = 9.6, 4.2 Hz, 1H), 4.22 
(ddd, J = 10.2, 8.4, 4.2 Hz, 1H), 3.87 (dt, J = 10.2, 4.8 Hz, 1H), 2.16 – 2.08 (m, 2H), 0.89 
(s, 9H), 0.10 (s, 3H), 0.07 (s, 3H). 
13C-NMR (151 MHz, CDCl3) δ 166.70, 156.54, 134.02, 131.76, 129.54, 128.45, 127.15, 
121.70, 116.57, 59.14, 36.60, 25.96, 18.44, -5.36, -5.41. 
FTIR (neat): 3293, 2952, 2925, 2853, 1637, 1585, 1532, 1492, 1228, 1107, 1092, 1057, 
1027, 1016, 853, 834, 768, 747, 691 cm-1. 
HSMS (ESI+): calcd for C22H31NO3SiNa ([M+Na]+): 408.1971, found: 408.1964. 
Metling point: 71-73 °C 
    
N-[1-[(4-methylphenyl)sulfonyl]-2-(phenylmethoxy)ethyl]benzamide 2.86 
 
To a 50 mL round bottom flask containing a stir bar were added benzamide 
(0.182 g, 1.5 mmol), 4-methylbenzenesulfinic acid (0.305 g, 1.95 mmol, 1.3 equiv) and 
3Å molecular seives (0.27 g). The flask was fitted with a rubber septum and placed under 
N2. CH2Cl2 (1.5 mL) was added in the flask via syringe. In a 1-dram vial 
benzyloxyacetaldehyde (211 µL, 1.5 mmol) was dissolved in CH2Cl2 (1.0 mL, plus 0.5 
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mL for rinse), and the obtained solution was added in the reaction flask via syringe. The 
reaction mixture was allowed to stir vigorously at 22 °C for 20 h. The resulted pale 
yellow viscous suspension was diluted with a mixture of CH2Cl2 (10 mL) and MeOH (5 
mL), and filtered over a pad of celite. The filter cake was washed with CH2Cl2 (2×5 mL). 
The collected filtrate was concentrated in vacuo. The obtained slightly yellow solid 
residue was purified by silica gel column chromatography (hexanes: dichloromethane: 
ethyl acetate = 10:5:1 to 10:10:1) to afford the α-amido sulfone 2.86 as a white solid 
(0.353 g, 57%). 
1H-NMR (600 MHz, CDCl3) δ 7.79 – 7.75 (m, 2H), 7.65 – 7.64 (m, 2H), 7.53 – 7.50 (m, 
1H), 7.42 (t, J = 7.8 Hz, 2H), 7.34 – 7.28 (m, 5H), 7.26 (overlapped with CDCl3, d, J = 
7.8 Hz, 2H), 7.02 (br d, J = 9.6 Hz, 1H) 5.60 (dt, J = 9.6, 4.2 Hz, 1H), 4.64 (d, J = 12.0 
Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H) 4.31 (dd, J = 10.8, 4.2 Hz, 1H), 3.94 (dd, J = 10.8, 4.2 
Hz, 1H), 2.39 (s, 3H). 
13C-NMR (151 MHz, CDCl3) δ 166.33, 145.24, 136.98, 134.44, 132.89, 132.26, 129.81, 
129.00, 128.70, 128.50, 128.02, 127.88, 127.10, 73.66, 68.46, 65.67, 21.70. 
FTIR (neat): 3338, 3060, 2999, 1644, 1531, 1490, 1316, 1288, 1145, 1115, 1084, 821, 
697, 659, 607, 581, 536 cm-1. 
HSMS (DART+) calcd for C23H24NO4S ([M+H]+): 410.1426, found: 410.1411. 
Melting point: 128-129 °C 
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N-(1-phenoxy-2-(phenylmethoxy)ethyl]benzamide 2.67 
 
In a N2-filled glovebox sodium phenoxide (0.086 g, 0.741 mmol, 0.95 equiv) was 
added in a 25 mL round bottom flask containing a stir bar. The vessel was fitted with a 
rubber septum, removed from the glovebox and placed under N2. In a 2-dram vial α-
amido sulfone 2.86 (0.319 g, 0.78 mmol) was dissolved in CH2Cl2 (2.1 mL, plus 2×0.5 
mL for rinse), and the obtained solution was added in the reaction flask via syringe. The 
reaction mixture was allowed to stir vigorously at 22 °C for 14 h. The resulted milky 
white suspension was diluted with CH2Cl2 (5 mL) and H2O (5 mL), and transferred to a 
separatory funnel. The organic layer was isolated, and the aqueous layer was extracted 
with CH2Cl2 (2×5 mL). The combined organic layers were washed with brine (10 mL), 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The obtained colorless 
viscous oil residue was purified by silica gel column chromatography (hexanes: 
dichloromethane: diethyl ether = 5:5:0.1) to afford the title compound as a white solid 
(0.244 g, 95% yield). 
1H-NMR (600 MHz, CDCl3) δ 7.77 – 7.71 (m, 2H), 7.51 (app tt, J = 7.8, 1.2 Hz, 1H), 
7.42 (app t, J = 7.8 Hz, 2H), 7.39 – 7.32 (m, 3H), 7.32 – 7.25 (overlapped with CDCl3, m, 
4H), 7.12 (d, J = 7.8 Hz, 2H), 7.00 – 6.97 (m, 1H), 6.95 (d, J = 9.0 Hz, 1H), 6.36 (dt, J = 
9.6, 3.6 Hz, 1H), 4.73 (d, J = 12.0 Hz, 1H), 4.68 (d, J = 12.0 Hz, 1H), 3.90 (dd, J = 10.8, 
3.6 Hz, 1H), 3.80 (dd, J = 10.8, 3.6 Hz, 1H). 
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13C-NMR (151 MHz, CDCl3) δ 166.75, 156.21, 137.57, 133.53, 132.03, 129.62, 128.62, 
128.52, 127.95, 127.87, 127.14, 122.01, 116.30, 77.30, 73.79, 70.91. 
FTIR (neat): 3272, 3061, 3029, 2872, 1633, 1588, 1538, 1486, 1291, 1226, 1103, 1085, 
1042, 1025, 754, 695 cm-1. 
HSMS (ESI+) calcd for C22H21O3NNa ([M+Na]+): 370.1419, found: 370.1424.  
Melting point: 117-119 °C 
 
CuBr-catalyzed racemic synthesis of N-[phenyl(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)methyl]benzamide 2.48 (0.1 mmol scale) 
 
In a N2-filled glovbox N-(methoxyphenylmethyl)benzamide 2.47 (0.0241 g, 0.1 
mmol), B2(pin)2 (0.0279 g, 0.11 mmol, 1.1 equiv), PPh3 (0.0026 g, 0.01 mmol, 0.1 equiv) 
and NaOtBu (0.0019 g, 0.02 mmol, 0.2 equiv) were sequentially added in an oven-dried 
2-dram vial containing a stir bar. Diethyl ether (1.0 mL) was then added in the vial via 
syring. The resulted mixture was stirred vigorously at 22 °C for 5 min. During the stirring 
the vial was occasionally tilted to make the NaOtBu solid stuck on the inside wall of the 
vial dissolved in the solution. CuBr (0.0014 g, 0.01 mmol, 0.1 equiv) was added in the 
vial in one portion. The vial was sealed with a phenolic screw cap and electrical tape, and 
removed from the glovebox. The reaction mixture, a milky white suspension, was 
allowed to stir vigorously at 22 °C for 20 h before it was diluted with CH2Cl2 (10 mL). 
The obtained solution was transferred into a separatory funnel, and washed with saturated 
HN
OMePh
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PPh3 (10 mol%)
NaOtBu (20 mol%)
Et2O (0.1 M), rt, 20 h
HN
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NH4Cl aqueous solution (10 mL) and saturated NaHCO3 aqueous solution (10 mL) in 
sequence. The two aqueous layers were combined and extracted with CH2Cl2 (5 mL). 
The combined organic layers were washed with brine (10 mL), dried over anhydrous 
Na2SO4, filtered and concentrated to a white solid residue in vacuo. The crude product 
was purified by florisil column chromatography (dichloromethane: hexanes: ethyl acetate 
= 5:1:0.6 to 5:1:1) to afford the title compound as a white solid (0.0276 g, 82% yield). 
1H-NMR (600 MHz, CDCl3) δ 8.83 (br s, 1H), 7.90 (d, J = 7.8 Hz, 2H), 7.56 (t, J = 7.2 
Hz, 1H), 7.42 (t, J = 7.2 Hz, 2H), 7.29 – 7.22 (overlapped with CDCl3, m, 2H), 7.19 –
7.12 (m, 3H), 3.94 (s, 1H), 1.04 (s, 6H), 0.96 (s, 6H). 
13C-NMR (151 MHz, CDCl3) δ 174.73, 143.59, 136.26, 131.43, 131.14, 130.57, 129.69, 
128.87, 128.33, 83.34, 55.60, 27.20, 26.92. 
FTIR (neat): 3190, 3066, 2967, 2924, 1602, 1573, 1534, 1522, 1489, 1365, 1193, 1145, 
1090, 1000, 932, 753, 696, 642, 589 cm-1.  
HSMS (DART+) calcd for C20H25BNO3 ([M+1]+): 338.1928, found: 338.1921. 
 
Enantioselective borylation of alkyl-substituted hemiaminal ethers with a chiral 
copper(I)/bisphosphine monoxide complex 
N-[(1S)-2-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl]benzamide 
(S)-2.54 (0.25 mmol reaction scale)  
  
 
OPh
HN Bz + B2(pin)2
NaOtBu (5.0 mol%)
PhMe (0.1M), rt, 19 h
Bpin
HN Bz
(1.1 equiv)
(L-6)2•CuOTf
(2.5 mol%)
> 98% conversion
        89% yield
          94:6 er
2.58 (S)-2.54
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In a N2-filled glovbox N-(2-methyl-1-phenoxypropyl)benzamide 2.58 (0.0673 g, 
0.25 mmol) and B2(pin)2 (0.0698 g, 0.275 mmol, 1.1 equiv) were added in an oven-dried 
2-dram vial containing a stir bar. Toluene (2.0 mL) was added in the vial to completely 
dissolve the two solid materials. Then, NaOtBu (0.0012 g, 0.0125 mmol, 0.05 equiv) was 
added in the obtained solution, and the resulted mixture was stirred vigorously at 22 °C 
for 10 min. During the stirring the vial was occasionally tilted to make the NaOtBu solid 
stuck on the inside wall of the vial dissolved in the solution. (L-6)2•CuOTf (0.0054 g, 
0.00625 mmol, 0.025 equiv) was added in the vial in one portion followed by addition of 
toluene (0.5 mL) to rinse the inside wall of the vial. The vial was sealed with a phenolic 
screw cap and electrical tape, and removed from the glovebox. The reaction mixture, a 
cloudy brown solution, was allowed to stir vigorously at 22 °C for 19 h before it was 
diluted with CH2Cl2 (15 mL). The obtained clear solution was transferred into a 
separatory funnel, and washed with saturated NH4Cl aqueous solution (10 mL) and 
saturated NaHCO3 aqueous solution (10 mL) in sequence. The two aqueous layers were 
combined and extracted with CH2Cl2 (5 mL). The combined organic layers were washed 
with brine (10 mL), dried over anhydrous Na2SO4, filtered and concentrated to a white 
solid residue in vacuo. The crude product was purified by florisil column 
chromatography (dichloromethane: hexanes: ethyl acetate = 5:1:0.5 to 5:1:0.7) to afford 
the title compound as a white solid (0.0675 g, 89% yield, 94:6 er). 
1H-NMR (600 MHz, CD2Cl2) δ 7.80 – 7.76 (m, 2H), 7.55 – 7.46 (overlapped with a 
broad peak, m, 2H), 7.40 (t, J = 7.8 Hz, 2H), 2.94-2.92 (m, 1H), 2.06 – 1.99 (m, 1H), 
1.263 (s, 6H), 1.258 (s, 6H), 1.03 (d, J = 7.2 Hz, 3H), 1.01 (d, J = 7.2 Hz, 3H). 
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13C-NMR (151 MHz, CD2Cl2) δ 169.79, 132.68, 131.38, 128.96, 127.99, 82.49, 48.53, 
30.50, 25.55, 25.50, 20.76, 20.06. 
FTIR (neat): 3194, 3072, 2979, 2948, 2927, 1603, 1574, 1526, 1490, 1220, 1185, 1153, 
1123, 1107, 1091, 1004, 977, 733, 706, 644 cm-1. 
HSMS (DART+) calcd for C18H29BNO3 ([M+1]+): 318.2241, found: 318.2245. 
Melting point: 164-167 ºC. [α]D20 = +31.6 (c = 0.46, THF) for 94:6 er. 
HPLC (Chiralpak® AD-H column, hexanes: isopropanol = 96:4, 0.5 mL/min, 220 nm) tR 
(Major)= 11.26 min, tR (minor) = 14.02 min.  The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
 
Authentic racemic product 2.54 
 
Peak# Ret. Time (min) Area (%) 
1 11.41 49.95 
2 14.03 50.05 
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Enantioenriched product (S)-2.54 
 
Peak# Ret. Time (min) Area (%) 
1 11.26 94.12 
2 14.02 5.88 
 
Enantioenriched product (S)-2.54 after recrystallization from dichloromethane/hexane 
 
Peak# Ret. Time (min) Area (%) 
1 11.26 99.77 
2 13.94 0.23 
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N-[(1S)-3-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butyl]benzamide 
(S)-2.68 (0.4 mmol reaction scale) 
 
In a N2-filled glovbox N-(3-methyl-1-phenoxybutyl)benzamide 2.59 (0.113 g, 0.4 
mmol) and B2(pin)2 (0.112 g, 0.44 mmol, 1.1 equiv) were added in an oven-dried 2- dram 
vial containing a stir bar. Toluene (3.0 mL) was added in the vial to dissolve the two solid 
materials. Then, NaOtBu (0.0019 g, 0.02 mmol, 0.05 equiv) was added in the obtained 
solution followed by addition of toluene (0.5 mL) to rinse the inside wall of the vial. The 
resulted mixture was stirred vigorously at 22 °C for 10 min. During the stirring the vial 
was occasionally tilted to make the NaOtBu solid stuck on the inside wall of the vial 
dissolved in the solution. (L-6)2•CuOTf (0.0086 g, 0.01 mmol, 0.025 equiv) was added in 
the vial in one portion followed by addition of toluene (0.5 mL) to rinse the inside wall of 
the vial. The vial was sealed with a phenolic screw cap and electrical tape, and removed 
from the glovebox. The reaction mixture, a cloudy brown solution, was allowed to stir 
vigorously at 22 °C for 19 h before it was diluted with CH2Cl2 (25 mL). The obtained 
clear solution was transferred into a separatory funnel, and washed with saturated NH4Cl 
aqueous solution (15 mL) and saturated NaHCO3 aqueous solution (15 mL) in sequence. 
The two aqueous layers were combined and extracted with CH2Cl2 (10 mL). The 
combined organic layers were washed with brine (10 mL), dried over anhydrous Na2SO4, 
filtered and concentrated to a slightly yellow semi-solid residue in vacuo. The crude 
OPh
HN Bz + B2(pin)2
NaOtBu (5.0 mol%)
Toluene (0.1M)
Bpin
HN Bz
rt, 19 h
(1.1 equiv)
(L-6)2•CuOTf
(2.5 mol%)
2.59 (S)-2.68
> 98% conversion
        74% yield
          97:3 er
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product was purified by florisil column chromatography (dichloromethane: hexanes: 
ethyl acetate = 2:1:0.3 to 2:1:0.5) to afford the title compound as a white solid (0.0946 g, 
74% yield, 97:3 er). 
1H-NMR (600 MHz, CD2Cl2) δ 7.79 – 7.73 (m, 2H), 7.57 – 7.52 (m, 1H), 7.48 – 7.36 
(overlapped with a broad peak, m, 3H), 3.04 – 2.96 (m, 1H), 1.79 – 1.70 (m, 1H), 1.52 – 
1.44 (m, 2H), 1.25 (s, 6H), 1.24 (s, 6H), 0.97 (d, J = 2.4 Hz, 3H), 0.96 (d, J = 2.4 Hz, 
3H). 
13C-NMR (151 MHz, CD2Cl2) δ 169.82, 132.57, 129.00, 128.38, 127.75, 81.18, 41.35, 
40.64, 25.82, 24.94, 24.90, 23.02, 22.03. 
FTIR (neat): 3196, 2960, 2922, 1603, 1574, 1532, 1490, 1200, 1156, 1110, 1100, 1016, 
984, 707, 686, 614 cm-1. 
HSMS (DART+) calcd for C18H29BNO3 ([M+H]+): 318.2241, found: 318.2246. 
Melting point: 154-156 ºC. [α]D20 = +22.2 (c = 0.325, THF) for 97:3 er. 
HPLC (Chiralpak® AS-H column, hexanes: isopropanol = 98:2, 0.5 mL/min, 220 nm) tR 
(Major)= 12.92 min, tR (minor) = 15.04 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.68 
 
Peak# Ret. Time (min) Area (%) 
1 12.88 49.99 
2 14.87 50.01 
 
Enantioenriched product (S)-2.68 
 
Peak# Ret. Time (min) Area (%) 
1 12.92 97.29 
2 15.04 2.71 
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N-[(1S)-1-cyclohexyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl]benzamide (S)-2.69 (0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. N-(1-
cyclohexyl-1-phenoxymethyl)benzamide 2.60 (0.124 g, 0.4 mmol) was used in the 
reaction (Note: 2.60 has very poor solubility in toluene. After 19 h at 22 °C the 
conversion of 2.60 is 94%). The crude product was purified by florisil column 
chromatography (dichloromethane: hexanes: ethyl acetate = 2:1:0.3 to 2:1:0.5) to afford 
the title compound as a white solid (0.119 g, 87%, 93:7 er). 
1H-NMR (600 MHz, CD2Cl2) δ 7.81 – 7.77 (m, 2H), 7.57 – 7.52 (m, 1H), 7.47 – 7.42 (m, 
2H), 6.97 (s, 1H), 3.06 – 2.99 (m, 1H), 1.85 – 1.77 (m, 2H), 1.77 – 1.70 (m, 2H), 1.70 – 
1.63 (m, 2H), 1.32 – 1.21 (overlapped peaks, m, 14H), 1.19 – 1.08 (m, 3H). 
13C-NMR (151 MHz, CD2Cl2) δ 168.60, 132.09, 131.88, 128.48, 127.21, 82.44, 46.11, 
39.86, 30.98, 30.18, 26.46, 26.38, 26.36, 24.92, 24.89. 
FTIR (neat): 3195, 2970, 2921, 2851, 1604, 1573, 1530, 1487, 1446, 1191, 1155, 1109, 
1011, 984, 708, 626 cm-1. 
HSMS (DART+) calcd for C20H31BNO3 ([M+H]+): 344.2397, found: 344.2400. 
Melting point: 152-153 ºC. [α]D20 = +31.6 (c = 0.38, THF) for 93:7 er. 
HPLC (Chiralpak® AS-H column, hexanes: isopropanol = 98:2, 0.5 mL/min, 220 nm) tR 
(Major)= 20.20 min, tR (minor) = 15.29 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.69 
 
 
 
Peak# Ret. Time (min) Area (%) 
1 15.23 50.35 
2 20.33 49.65 
 
Enantioenriched product (S)-2.69 
 
Peak# Ret. Time (min) Area (%) 
1 15.29 7.36 
2 20.20 92.64 
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      N-[(1S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-  
      yl)pentyl]benzamide (S)-2.70 (0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. N-
(1-phenoxypentyl)benzamide 2.61 (0.113 g, 0.4 mmol) was used in the reaction. The 
crude product was purified by florisil column chromatography (dichloromethane: 
hexanes: ethyl acetate = 2:1:0.3 to 2:1:0.5) to afford the title compound as a white solid 
(0.0943 g, 74% yield, 97:3 er). 
1H-NMR (600 MHz, CDCl3) δ 8.30 (s, 1H), 7.84 – 7.79 (m, 2H), 7.49 – 7.42 (m, 1H), 
7.33 (t, J = 7.8 Hz, 2H), 2.81 – 2.75 (m, 1H), 1.75 – 1.67 (m, 1H), 1.62 – 1.53 (m, 1H), 
1.45 – 1.35 (m, 2H), 1.36 – 1.28 (m, 2H), 1.26 (s, 6H), 1.24 (s, 6H), 0.88 (t, J = 7.2 Hz, 
3H). 
13C-NMR (151 MHz, CDCl3) δ 170.67, 132.86, 128.39, 128.12, 128.03, 80.88, 44.90, 
30.87, 30.02, 25.42, 25.08, 22.84, 14.03. 
FTIR (neat): 3191, 3073, 2960, 2926, 1601, 1574, 1526, 1488, 1362, 1184, 1155, 1125, 
1102, 1016, 874, 707, 684, 569 cm-1. 
HSMS (DART+) calcd for C18H29BNO3 ([M+H]+): 318.2241, found: 318.2256. 
Melting point: 125-127 ºC. [α]D20 = +36.8 (c = 0.31, THF) for 97:3 er 
HPLC (Chiralpak® AD-H column, hexanes: isopropanol = 98:2, 0.5 mL/min, 220 nm) tR 
(Major)= 34.40 min, tR (minor) = 39.19 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.70 
 
Peak# Ret. Time (min) Area (%) 
1 34.72 50.53 
2 39.14 49.47 
 
Enantioenriched product (S)-2.70 
 
Peak# Ret. Time (min) Area (%) 
1 34.40 97.05 
2 39.19 2.95 
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 N-[(1S)-3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propyl]benzamide (S)-2.71 (0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. 
N-(1-phenoxy-3-phenylpropyl)benzamide 2.62 (0.133 g, 0.4 mmol) was used in the 
reaction (Note: substrate 2.62 has poor solubility in toluene, but after 19 h at 22 °C it can 
be completely consumed in the reaction). The crude product was purified by florisil 
column chromatography (dichloromethane: hexanes: ethyl acetate = 2:1:0.3 to 2:1:0.5) to 
afford the title compound as a white solid (0.113 g, 77% yield, 95:5 er). 
1H-NMR (600 MHz, CDCl3) δ 7.55 – 7.51 (m, 2H), 7.51 – 7.48 (m, 1H), 7.38 – 7.34 (m, 
2H), 7.34 – 7.30 (m, 2H), 7.28 – 7.25 (m, 2H), 7.25 – 7.22 (m, 1H), 6.92 (s, 1H), 2.93 
(ddd, J = 13.8, 7.8, 4.8 Hz, 1H), 2.88 (ddd, J = 8.4, 4.8, 2.4 Hz, 1H), 2.70 (dt, J = 13.8, 
8.4 Hz, 1H), 2.12 (ddt, J = 14.4, 7.8, 4.8 Hz, 1H), 1.89 (ddd, J = 17.4, 14.4, 8.4 Hz, 1H), 
1.28 (s, 6H), 1.26 (s, 6H). 
13C-NMR (151 MHz, CDCl3) δ 170.48, 142.84, 133.13, 128.73, 128.62, 128.58, 127.74, 
127.70, 126.03, 80.81, 45.30, 35.36, 32.77, 25.38, 25.16. 
FTIR (neat): 3195, 2967, 2922, 1602, 1572, 1532, 1491, 1383, 1360, 1198, 1152, 1106, 
1035, 971, 702, 631, 577 cm-1. 
HSMS (DART+) calcd for C22H29BNO3 ([M+H]+): 366.2241, found: 366.2235. 
Melting point: 135-137 ºC. [α]D20 = +39.5 (c = 0.41, THF) for 95:5 er. 
HPLC (Chiralpak® OD-H column, hexanes: isopropanol = 96:4, 0.5 mL/min, 220 nm) tR 
(Major)= 12.53 min, tR (minor) = 20.00 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
 
BPin
HN Bz
(S)-2.71
 101 
Authentic racemic product 2.71 
 
Peak# Ret. Time (min) Area (%) 
1 12.62 50.20 
2 19.88 49.80 
 
Enantioenriched product (S)-2.71 
 
Peak# Ret. Time (min) Area (%) 
1 12.53 94.72 
2 20.00 5.28 
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N-[(1S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl]benzamide 
(S)-2.72 (0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. N-(1-
phenoxyethyl)benzamide 2.63 (0.0965 g, 0.4 mmol) was used in the reaction. The crude 
product was purified by florisil column chromatography (dichloromethane: hexanes: 
ethyl acetate = 2:1:0.3 to 2:1:1.2) to afford the title compound as a colorless gum (0.0946, 
86%, 92:8 er). 
1H-NMR (600 MHz, CDCl3) δ 9.60 (br s, 1H), 7.80 (d, J = 7.2 Hz, 2H), 7.40 – 7.35 (m, 
1H), 7.28 – 7.22 (overlapped with CDCl3, m, 2H), 2.77 (q, J = 7.2 Hz, 1H), 1.25 
(overlapped peak, s, 6H), 1.24 (overlapped peak, d, J = 7.2 Hz, 3H), 1.22 (overlapped 
peak, s, 6H). 
13C-NMR (151 MHz, CDCl3) δ 170.95, 132.99, 128.35, 128.25, 126.85, 80.47, 41.04, 
25.23, 24.79, 16.17. 
FTIR (neat): 3195, 3066, 2969, 2926, 1610, 1577, 1528, 1489, 1363, 1240, 1186, 1159, 
1124, 967, 945, 709, 608 cm-1. 
HSMS (DART+) calcd for C15H23BNO3 ([M+H]+): 276.1771, found: 276.1774. 
[α]D20 = +28.2 (c = 0.425, THF) for 92:8 er. 
HPLC (Chiralpak® AS-H column, hexanes: isopropanol = 96:4, 0.5 mL/min, 220 nm) tR 
(Major)= 10.14 min, tR (minor) = 11.42 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.72 
 
Peak# Ret. Time (min) Area (%) 
1 10.06 49.77 
2 11.33 50.23 
 
Enantioenriched product (S)-2.72  
 
Peak# Ret. Time (min) Area (%) 
1 10.14 92.10 
2 11.42 7.90 
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N-[(1S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-penten-
1-yl]benzamide (S)-2.73 (0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. N-
(4-penten-1-yl-1-phenoxy)benzamide 2.64 (0.113, 0.4 mmol) was used in the reaction. 
The crude product was purified by florisil column chromatography (dichloromethane: 
hexanes: ethyl acetate = 2:1:0.3 to 2:1:0.5) to afford the title compound as a white solid 
(0.097 g, 77% yield, 96:4 er). 
1H-NMR (600 MHz, CDCl3) δ 7.93 (s, 1H), 7.81 – 7.75 (m, 2H), 7.53 – 7.49 (m, 1H), 
7.39 (t, J = 7.8 Hz, 2H), 5.87 (ddt, J = 17.4, 10.2, 6.6 Hz, 1H), 5.08 (dq, J = 17.4, 1.2 Hz, 
1H), 5.01 – 4.96 (m, 1H), 2.88 – 2.81 (m, 1H), 2.27 – 2.20 (m, 2H), 1.88 – 1.79 (m, 1H), 
1.72 – 1.64 (m, 1H), 1.27 (s, 6H), 1.25 (s, 6H). 
13C-NMR (151 MHz, CDCl3) δ 170.70, 139.34, 133.07, 128.60, 128.08, 127.90, 114.78, 
80.95, 44.56, 32.57, 30.28, 25.35, 25.08. 
FTIR (neat): 3192, 3073, 2968, 2923, 1601, 1574, 1526, 1488, 1362, 1199, 1150, 1106, 
1020, 708, 684, 627, 562 cm-1. 
HSMS (DART+) calcd for C18H27BNO3 ([M+H]+): 316.2084, found: 316.2094. 
Melting point: 141-142 ºC. [α]D20 = +35.2 (c = 0.335, THF) for 96:4 er. 
HPLC (Chiralpak® AS-H column, hexanes: isopropanol = 98:2, 0.5 mL/min, 220 nm) tR 
(Major)= 16.16 min, tR (minor)= 18.60 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.73 
 
Peak# Ret. Time (min) Area (%) 
1 16.36 49.91 
2 18.67 50.09 
 
Enantioenriched product (S)-2.73 
 
Peak# Ret. Time (min) Area (%) 
1 16.16 95.86 
2 18.60 4.14 
 
 
 
13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0 21.0 22.0 min
0
25
50
75
100
125
150
mV
Detector A Ch1:220nm 
16
.3
61
18
.6
68
13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0 21.0 22.0 min
0
50
100
150
200
250
300
350
400
mV
Detector A Ch1:220nm 
16
.1
63
18
.6
02
 106 
N-[(1S)-4-chloro-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butyl]benzamide (S)-2.74 (0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. 
N-(4-chloro-1-phenoxybutyl)benzamide 2.65 (0.122 g, 0.4 mmol) was used in the 
reaction. The crude product was purified by florisil column chromatography 
(dichloromethane: hexanes: ethyl acetate = 2:1:0.3 to 2:1:0.9) to afford the title 
compound as a white solid (0.105 g, 78%, 93:7 er). 
1H-NMR (600 MHz, CDCl3) δ 8.87 (s, 1H), 7.85 – 7.79 (m, 2H), 7.47 – 7.42 (m, 1H), 
7.32 (t, J = 7.8 Hz, 2H), 3.57 – 3.46 (m, 2H), 2.76 – 2.69 (m, 1H), 1.96 – 1.86 (m, 2H), 
1.86 – 1.69 (m, 2H), 1.26 (s, 6H), 1.24 (s, 6H). 
13C-NMR (151 MHz, CDCl3) δ 171.09, 133.22, 128.48, 128.22, 127.29, 80.97, 45.16, 
44.42, 30.55, 28.72, 25.49, 25.15. 
FTIR (neat): 3186, 3076, 2966, 2921, 1603, 1569, 1531, 1487, 1362, 1186, 1138, 1013, 
970, 948, 807, 733, 712, 686, 623, 612, 578 cm-1.  
HSMS (DART+) calcd for C17H26BClNO3 ([M+H]+): 338.1694, found: 338.1705. 
Melting point: 158-160 ºC. [α]D20 = +46.7 (c = 0.445, THF) for 93:7 er. 
HPLC (Chiralpak® AD-H column, hexanes: isopropanol = 96:4, 0.5 mL/min, 220 nm) tR 
(Major)= 18.78 min, tR (minor) = 21.24 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.74 
 
Peak# Ret. Time (min) Area (%) 
1 18.80 49.94 
2 21.19 50.06 
 
Enantioenriched product (S)-2.74 
 
Peak# Ret. Time (min) Area (%) 
1 18.78 93.20 
2 21.24 6.80 
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N-[(1S)-3-(tert-butyldimethylsilyloxy)-1-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)propyl]benzamide  
(S)-2.75 (0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. N-[1-phenoxy-
3-(tert-butyldimethylsilyloxy)propyl]benzamide 2.66 (0.154 g, 0.4 mmol) was used in the 
reaction. The crude product was purified by florisil column chromatography 
(dichloromethane: hexanes: ethyl acetate = 2:1:0.3 to 2:1:0.5) to afford the title 
compound as a white solid (0.124 g, 74%, 94:6 er). 
1H-NMR (600 MHz, CDCl3) δ 8.33 (s, 1H), 7.77 (app d, J = 7.8 Hz, 2H), 7.57 (app td, J 
= 7.2, 0.6 Hz, 1H), 7.44 (t, J = 7.8 Hz, 2H), 3.99 (dt, J = 9.6, 3.6 Hz, 1H), 3.87 – 3.78 (m, 
1H), 2.92 – 2.84 (m, 1H), 1.83 – 1.76 (m, 2H), 1.254 (s, 6H), 1.246 (s, 6H), 0.90 (s, 9H), 
0.11 (s, 3H), 0.07 (s, 3H). 
13C-NMR (151 MHz, CDCl3) δ 173.26, 136.01, 131.35, 130.51, 129.92, 82.86, 69.13, 
49.73, 35.37, 28.66, 27.99, 27.72, 20.98, -2.64, -2.72. 
FTIR (neat): 3192, 3072, 2955, 2928, 2856, 1609, 1576, 1527, 1489, 1362, 1250, 1154, 
1092, 1074, 1026, 833, 772, 706, 634, 579 cm-1. 
HSMS (DART+) calcd for C22H39BNO4Si ([M+H]+): 420.2741, found: 420.2742. 
Melting point: 104-106 ºC. [α]D20 = +30.9 (c = 0.46, THF) for 94:6 er. 
HPLC (Chiralpak® AZ-H column, hexanes: isopropanol = 99:1, 0.5 mL/min, 220 nm) tR 
(Major)= 23.41min, tR (minor) = 17.63 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.75 
Datafile Name:LX-07-p129-TBSOethyl-racemic1.lcd
Sample Name:LX-07-p129-TBSOethyl-racemic
Sample ID:lx-07-p129
12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 min
0
25
50
75
100
125
150
175
200
225
mV
Detector A Ch1 220nm 
 
Peak# Ret. Time (min) Area (%) 
1 17.78 49.62 
2 23.91 50.38 
 
Enantioenriched product (S)-2.75  
Datafile Name:LX-07-p130-TBSOethyl-chiral1.lcd
Sample Name:LX-07-p130-TBSOethyl-chiral
Sample ID:lx-07-p130
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Peak# Ret. Time (min) Area (%) 
1 17.63 6.38 
2 23.41 93.62 
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N-[(1S)-2-(phenylmethoxy)-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)ethyl]benzamide (S)-2.76  
(0.4 mmol reaction scale) 
The title compound was synthesized analogous to compound 2.68. N-(1-phenoxy-
2-(phenylmethoxy)ethyl]benzamide 2.67 (0.139 g, 0.4 mmol) was used in the reaction. 
The crude product was purified by florisil column chromatography (dichloromethane: 
hexanes: ethyl acetate = 2.5:1:0.5 to 2.5:1:0.8) to afford the title compound as a white 
solid (0.0487 g, 32% yield, 79:21 er). 
1H-NMR (600 MHz, CDCl3) δ 7.81 – 7.77 (m, 2H), 7.62 – 7.56 (overlapped peaks, m, 
2H), 7.48 – 7.44 (m, 2H), 7.37 – 7.26 (m, 5H), 4.57 (d, J = 11.4 Hz, 1H), 4.49 (d, J = 
11.4 Hz, 1H), 3.77 (dd, J = 10.2, 3.6 Hz, 1H), 3.63 – 3.60 (m, 1H), 3.17 – 3.11 (m, 1H), 
1.24 (s, 12H). 
13C-NMR (151 MHz, CDCl3) δ 171.82, 138.37, 133.76, 128.83, 128.46, 128.04, 127.85, 
127.72, 126.74, 80.32, 73.06, 72.38, 46.07, 25.26, 24.93. 
FTIR (neat): 3387, 3057, 2962, 2923, 1600, 1573, 1523, 1488, 1361, 1191, 1156, 1108, 
1066, 1017, 755, 710, 688, 628, 582, 460 cm-1.  
HSMS (DART+) calcd for C22H29BNO4 ([M+H]+): 382.2190, found: 382.2171. 
Melting point: >180 ºC (start decomposing). [α]D20 = +26.7 (c = 0.33, THF) for 79:21 er. 
HPLC (Chiralpak® AD-H column, hexanes: isopropanol = 96:4, 0.5 mL/min, 220 nm) tR 
(Major)= 24.75 min, tR (minor) = 18.65 min. The authentic racemic sample was prepared 
with CuCl as the catalyst and tricyclohexylphosphine as the ligand. 
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Authentic racemic product 2.76 
 
Peak# Ret. Time (min) Area (%) 
1 18.54 50.01 
2 24.64 49.99 
 
Enantioenriched product (S)-2.76 
 
Peak# Ret. Time (min) Area (%) 
1 18.65 20.58 
2 24.75 79.42 
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Single crystal x-ray data of enantioenriched (S)-2.54
 
 
Table 1.  Crystal data and structure refinement for C17H26BNO3•CH2Cl2. 
Identification code  C17H26BNO3•CH2Cl2 
Empirical formula  C18H28BCl2NO3 
Formula weight  388.12 
Temperature  100(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 9.3865(7) ≈ a= 90∞. 
 b = 10.8411(8) ≈ b= 90∞. 
 c = 20.0415(14) ≈ g = 90∞. 
Volume 2039.4(3) ≈3 
 113 
Z 4 
Density (calculated) 1.264 Mg/m3 
Absorption coefficient 2.990 mm-1 
F(000) 824 
Crystal size 0.600 x 0.400 x 0.250 mm3 
Theta range for data collection 6.461 to 66.755∞. 
Index ranges -10<=h<=11, -12<=k<=12, -23<=l<=23 
Reflections collected 16822 
Independent reflections 3549 [R(int) = 0.0307] 
Completeness to theta = 66.750∞ 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.4816 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3549 / 3 / 243 
Goodness-of-fit on F2 1.071 
Final R indices [I>2sigma(I)] R1 = 0.0245, wR2 = 0.0629 
R indices (all data) R1 = 0.0246, wR2 = 0.0630 
Absolute structure parameter 0.045(3) 
Extinction coefficient na 
Largest diff. peak and hole 0.230 and -0.183 e.≈-3 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(≈2x 103) for C17H26BNO3•CH2Cl2.  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
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________________________________________________________________ 
 x y z U(eq) 
_____________________________________________________________________ 
O(1) 4562(1) 4639(1) 5008(1) 14(1) 
O(2) 2657(1) 3846(1) 4251(1) 14(1) 
O(3) 4702(1) 4694(1) 3792(1) 15(1) 
N(1) 5715(2) 2879(1) 5130(1) 13(1) 
B(1) 4186(2) 3932(2) 4325(1) 14(1) 
C(1) 4990(2) 2618(2) 4489(1) 14(1) 
C(2) 5388(2) 3974(2) 5367(1) 13(1) 
C(3) 5899(2) 4476(2) 6010(1) 14(1) 
C(4) 6952(2) 3889(2) 6375(1) 18(1) 
C(5) 7435(2) 4422(2) 6965(1) 24(1) 
C(6) 6862(2) 5526(2) 7187(1) 23(1) 
C(7) 5801(2) 6099(2) 6825(1) 22(1) 
C(8) 5319(2) 5580(2) 6234(1) 18(1) 
C(9) 2218(2) 4869(2) 3832(1) 16(1) 
C(10) 3532(2) 5019(2) 3363(1) 17(1) 
C(11) 1983(2) 5998(2) 4273(1) 19(1) 
C(12) 835(2) 4527(2) 3484(1) 23(1) 
C(13) 3748(2) 6325(2) 3101(1) 23(1) 
C(14) 3514(2) 4111(2) 2780(1) 23(1) 
C(15) 6002(2) 2113(2) 3951(1) 17(1) 
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C(16) 7378(2) 2854(2) 3901(1) 22(1) 
C(17) 6325(2) 736(2) 4046(1) 23(1) 
C(1S) 6856(3) 6711(2) 4378(1) 28(1) 
Cl(1S) 8143(1) 6042(1) 4908(1) 32(1) 
Cl(2S) 7638(1) 7018(2) 3584(1) 45(1) 
Cl(2Y) 7204(7) 7513(6) 3709(3) 34(2) 
_____________________________________________________________________  
Table 3.   Bond lengths [≈] and angles [∞] for  C17H26BNO3•CH2Cl2. 
_____________________________________________________  
O(1)-C(2)  1.281(2) 
O(1)-B(1)  1.607(2) 
O(2)-B(1)  1.446(2) 
O(2)-C(9)  1.451(2) 
O(3)-B(1)  1.435(2) 
O(3)-C(10)  1.440(2) 
N(1)-C(2)  1.315(3) 
N(1)-C(1)  1.483(2) 
N(1)-H(1N)  0.826(19) 
B(1)-C(1)  1.645(3) 
C(1)-C(15)  1.537(2) 
C(1)-H(1)  0.976(19) 
C(2)-C(3)  1.478(2) 
C(3)-C(4)  1.386(3) 
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C(3)-C(8)  1.389(3) 
C(4)-C(5)  1.391(3) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.385(3) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.380(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.388(3) 
C(7)-H(7)  0.9500 
C(8)-H(8)  0.9500 
C(9)-C(12)  1.520(3) 
C(9)-C(11)  1.525(3) 
C(9)-C(10)  1.559(3) 
C(10)-C(13)  1.524(3) 
C(10)-C(14)  1.528(3) 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
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C(13)-H(13C)  0.9800 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-C(16)  1.524(3) 
C(15)-C(17)  1.536(3) 
C(15)-H(15)  1.0000 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(1S)-Cl(2Y)  1.631(5) 
C(1S)-Cl(1S)  1.765(2) 
C(1S)-Cl(2S)  1.785(2) 
C(1S)-H(1S1)  0.9900 
C(1S)-H(1S2)  0.9900 
 
C(2)-O(1)-B(1) 110.06(14) 
B(1)-O(2)-C(9) 106.96(14) 
B(1)-O(3)-C(10) 109.14(14) 
C(2)-N(1)-C(1) 112.22(15) 
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C(2)-N(1)-H(1N) 123.7(16) 
C(1)-N(1)-H(1N) 124.0(16) 
O(3)-B(1)-O(2) 107.21(15) 
O(3)-B(1)-O(1) 106.52(14) 
O(2)-B(1)-O(1) 109.66(14) 
O(3)-B(1)-C(1) 119.45(15) 
O(2)-B(1)-C(1) 114.82(16) 
O(1)-B(1)-C(1) 98.25(13) 
N(1)-C(1)-C(15) 113.08(14) 
N(1)-C(1)-B(1) 102.59(14) 
C(15)-C(1)-B(1) 116.92(14) 
N(1)-C(1)-H(1) 108.2(13) 
C(15)-C(1)-H(1) 107.1(13) 
B(1)-C(1)-H(1) 108.6(13) 
O(1)-C(2)-N(1) 116.51(15) 
O(1)-C(2)-C(3) 118.64(17) 
N(1)-C(2)-C(3) 124.84(16) 
C(4)-C(3)-C(8) 120.30(17) 
C(4)-C(3)-C(2) 121.52(17) 
C(8)-C(3)-C(2) 118.16(17) 
C(3)-C(4)-C(5) 119.36(18) 
C(3)-C(4)-H(4) 120.3 
C(5)-C(4)-H(4) 120.3 
 119 
C(6)-C(5)-C(4) 120.37(19) 
C(6)-C(5)-H(5) 119.8 
C(4)-C(5)-H(5) 119.8 
C(7)-C(6)-C(5) 120.04(18) 
C(7)-C(6)-H(6) 120.0 
C(5)-C(6)-H(6) 120.0 
C(6)-C(7)-C(8) 120.05(18) 
C(6)-C(7)-H(7) 120.0 
C(8)-C(7)-H(7) 120.0 
C(7)-C(8)-C(3) 119.87(18) 
C(7)-C(8)-H(8) 120.1 
C(3)-C(8)-H(8) 120.1 
O(2)-C(9)-C(12) 108.75(15) 
O(2)-C(9)-C(11) 108.61(14) 
C(12)-C(9)-C(11) 109.75(16) 
O(2)-C(9)-C(10) 101.77(14) 
C(12)-C(9)-C(10) 115.08(15) 
C(11)-C(9)-C(10) 112.38(16) 
O(3)-C(10)-C(13) 109.33(16) 
O(3)-C(10)-C(14) 107.94(15) 
C(13)-C(10)-C(14) 109.68(15) 
O(3)-C(10)-C(9) 102.59(14) 
C(13)-C(10)-C(9) 114.18(16) 
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C(14)-C(10)-C(9) 112.70(16) 
C(9)-C(11)-H(11A) 109.5 
C(9)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
C(9)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
C(9)-C(12)-H(12A) 109.5 
C(9)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
C(9)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
C(10)-C(13)-H(13A) 109.5 
C(10)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
C(10)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
C(10)-C(14)-H(14A) 109.5 
C(10)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
C(10)-C(14)-H(14C) 109.5 
 121 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
C(16)-C(15)-C(17) 110.70(16) 
C(16)-C(15)-C(1) 112.45(15) 
C(17)-C(15)-C(1) 112.39(16) 
C(16)-C(15)-H(15) 107.0 
C(17)-C(15)-H(15) 107.0 
C(1)-C(15)-H(15) 107.0 
C(15)-C(16)-H(16A) 109.5 
C(15)-C(16)-H(16B) 109.5 
H(16A)-C(16)-H(16B) 109.5 
C(15)-C(16)-H(16C) 109.5 
H(16A)-C(16)-H(16C) 109.5 
H(16B)-C(16)-H(16C) 109.5 
C(15)-C(17)-H(17A) 109.5 
C(15)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B) 109.5 
C(15)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
Cl(2Y)-C(1S)-Cl(1S) 125.2(3) 
Cl(1S)-C(1S)-Cl(2S) 109.37(14) 
Cl(1S)-C(1S)-H(1S1) 109.8 
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Cl(2S)-C(1S)-H(1S1) 109.8 
Cl(1S)-C(1S)-H(1S2) 109.8 
Cl(2S)-C(1S)-H(1S2) 109.8 
H(1S1)-C(1S)-H(1S2) 108.2 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (≈2x 103) for C17H26BNO3•CH2Cl2. The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* 
b* U12 ] 
_____________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
____________________________________________________________________ 
O(1) 16(1)  15(1) 12(1)  0(1) -2(1)  0(1) 
O(2) 14(1)  16(1) 12(1)  2(1) 0(1)  -1(1) 
O(3) 13(1)  21(1) 13(1)  4(1) -1(1)  0(1) 
N(1) 15(1)  16(1) 9(1)  1(1) -1(1)  2(1) 
B(1) 15(1)  15(1) 11(1)  -2(1) -1(1)  -1(1) 
C(1) 15(1)  17(1) 10(1)  0(1) -2(1)  -1(1) 
C(2) 11(1)  17(1) 11(1)  2(1) 2(1)  -1(1) 
C(3) 15(1)  16(1) 11(1)  0(1) 2(1)  -4(1) 
C(4) 19(1)  21(1) 14(1)  -3(1) -1(1)  3(1) 
C(5) 26(1)  29(1) 16(1)  -2(1) -8(1)  5(1) 
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C(6) 28(1)  27(1) 14(1)  -5(1) -1(1)  -5(1) 
C(7) 29(1)  19(1) 17(1)  -4(1) 2(1)  -1(1) 
C(8) 20(1)  19(1) 15(1)  1(1) 0(1)  1(1) 
C(9) 17(1)  18(1) 14(1)  5(1) -2(1)  1(1) 
C(10) 17(1)  22(1) 12(1)  3(1) -1(1)  2(1) 
C(11) 18(1)  20(1) 19(1)  2(1) 1(1)  4(1) 
C(12) 17(1)  30(1) 23(1)  3(1) -5(1)  1(1) 
C(13) 22(1)  26(1) 21(1)  10(1) 2(1)  2(1) 
C(14) 27(1)  30(1) 12(1)  2(1) -1(1)  1(1) 
C(15) 20(1)  22(1) 10(1)  -1(1) -3(1)  5(1) 
C(16) 20(1)  31(1) 14(1)  3(1) 4(1)  6(1) 
C(17) 28(1)  23(1) 19(1)  -5(1) -2(1)  8(1) 
C(1S) 31(1)  28(1) 26(1)  -4(1) 0(1)  -4(1) 
Cl(1S) 26(1)  39(1) 31(1)  3(1) 3(1)  1(1) 
Cl(2S) 43(1)  66(1) 26(1)  12(1) -1(1)  -28(1) 
 
Table 5.  Hydrogen coordinates ( x 104) and isotropic displacement parameters (≈2x 10 3) 
for C17H26BNO3•CH2Cl2. 
_____________________________________________________________________ 
 x  y  z  U(eq) 
_____________________________________________________________________ 
H(1N) 6230(20) 2379(19) 5328(10) 16 
H(1) 4270(20) 1988(19) 4568(11) 17 
 124 
H(4) 7341 3129 6225 22 
H(5) 8162 4027 7216 28 
H(6) 7199 5887 7589 27 
H(7) 5399 6850 6981 26 
H(8) 4595 5979 5982 22 
H(11A) 1275 5804 4617 28 
H(11B) 1638 6685 4000 28 
H(11C) 2883 6230 4486 28 
H(12A) 950 3733 3257 35 
H(12B) 594 5165 3156 35 
H(12C) 69 4464 3814 35 
H(13A) 3867 6893 3478 34 
H(13B) 2916 6573 2838 34 
H(13C) 4601 6351 2819 34 
H(14A) 4441 4123 2555 34 
H(14B) 2768 4349 2463 34 
H(14C) 3322 3278 2947 34 
H(15) 5502 2198 3513 20 
H(16A) 7151 3722 3816 32 
H(16B) 7961 2531 3535 32 
H(16C) 7908 2785 4321 32 
H(17A) 6913 441 3675 35 
H(17B) 5429 271 4057 35 
 125 
H(17C) 6838 615 4467 35 
H(1S1) 6500 7489 4577 34 
H(1S2) 6039 6142 4325 34 
___________________________________________________________________  
 
Table 6.  Torsion angles [∞] for C17H26BNO3•CH2Cl2. 
________________________________________________________________  
C(10)-O(3)-B(1)-O(2) -3.65(19) 
C(10)-O(3)-B(1)-O(1) -120.99(15) 
C(10)-O(3)-B(1)-C(1) 129.16(16) 
C(9)-O(2)-B(1)-O(3) -19.44(18) 
C(9)-O(2)-B(1)-O(1) 95.82(15) 
C(9)-O(2)-B(1)-C(1) -154.71(14) 
C(2)-O(1)-B(1)-O(3) -119.32(16) 
C(2)-O(1)-B(1)-O(2) 124.98(16) 
C(2)-O(1)-B(1)-C(1) 4.83(17) 
C(2)-N(1)-C(1)-C(15) 132.08(16) 
C(2)-N(1)-C(1)-B(1) 5.25(18) 
O(3)-B(1)-C(1)-N(1) 108.78(17) 
O(2)-B(1)-C(1)-N(1) -121.75(15) 
O(1)-B(1)-C(1)-N(1) -5.55(15) 
O(3)-B(1)-C(1)-C(15) -15.5(2) 
O(2)-B(1)-C(1)-C(15) 113.92(17) 
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O(1)-B(1)-C(1)-C(15) -129.87(15) 
B(1)-O(1)-C(2)-N(1) -2.0(2) 
B(1)-O(1)-C(2)-C(3) 178.10(15) 
C(1)-N(1)-C(2)-O(1) -2.3(2) 
C(1)-N(1)-C(2)-C(3) 177.54(16) 
O(1)-C(2)-C(3)-C(4) -170.41(16) 
N(1)-C(2)-C(3)-C(4) 9.8(3) 
O(1)-C(2)-C(3)-C(8) 7.9(2) 
N(1)-C(2)-C(3)-C(8) -171.90(17) 
C(8)-C(3)-C(4)-C(5) -0.7(3) 
C(2)-C(3)-C(4)-C(5) 177.59(18) 
C(3)-C(4)-C(5)-C(6) 0.5(3) 
C(4)-C(5)-C(6)-C(7) 0.3(3) 
C(5)-C(6)-C(7)-C(8) -0.9(3) 
C(6)-C(7)-C(8)-C(3) 0.6(3) 
C(4)-C(3)-C(8)-C(7) 0.2(3) 
C(2)-C(3)-C(8)-C(7) -178.18(17) 
B(1)-O(2)-C(9)-C(12) 154.45(15) 
B(1)-O(2)-C(9)-C(11) -86.14(17) 
B(1)-O(2)-C(9)-C(10) 32.58(17) 
B(1)-O(3)-C(10)-C(13) 144.75(16) 
B(1)-O(3)-C(10)-C(14) -95.99(17) 
B(1)-O(3)-C(10)-C(9) 23.21(18) 
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O(2)-C(9)-C(10)-O(3) -33.82(17) 
C(12)-C(9)-C(10)-O(3) -151.22(16) 
C(11)-C(9)-C(10)-O(3) 82.18(17) 
O(2)-C(9)-C(10)-C(13) -151.99(16) 
C(12)-C(9)-C(10)-C(13) 90.6(2) 
C(11)-C(9)-C(10)-C(13) -36.0(2) 
O(2)-C(9)-C(10)-C(14) 82.00(18) 
C(12)-C(9)-C(10)-C(14) -35.4(2) 
C(11)-C(9)-C(10)-C(14) -162.00(16) 
N(1)-C(1)-C(15)-C(16) -46.7(2) 
B(1)-C(1)-C(15)-C(16) 72.1(2) 
N(1)-C(1)-C(15)-C(17) 79.0(2) 
B(1)-C(1)-C(15)-C(17) -162.19(16) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 7.  Hydrogen bonds for C17H26BNO3•CH2Cl2  [≈ and ∞]. 
_____________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
_____________________________________________________________________ 
 N(1)-H(1N)...O(2)#1 0.826(19) 2.07(2) 2.890(2) 174(2) 
_____________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms: #1 x+1/2,-y+1/2,-z+1       
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Chapter 3 
Ruthenium-Catalyzed Tandem Reactions for Constructing N-
Protected 2,3-Dihydroxypyrrolidines and 2,3-
Dihydroxypiperidines	  
3.1 General Introduction 
The application of degenerate pathways of Grubbs’ catalysts in non-metathesis 
reactions1 has become an active branch in the field of tandem catalysis.2 Many examples 
have demonstrated that tandem metathesis reactions are useful synthetic tools to perform 
sequential transformations of alkenyl groups in a more economic and efficient fashion, 
such as tandem olefin metathesis-hydrogenation, 3  oxidation, 4  cyclopropanation 5  and 
hydroarylation.6  
 
                                                
1 For a review, see: Alcaide, B.; Almendros, P.; Luna A. Chem. Rev. 2009, 109, 3817-3858. 
2 For general reviews, see: (a) Fogg, D. E.; dos santos, E. N. Coord. Chem. Rev. 2004, 248, 2365-2379. (b) 
Ajamian, A.; Gleason, J. L. Angew. Chem. Int. Ed. 2004, 43, 3754-3760. (c) Wasilke, J.-C.; Obrey, S.; 
Baker, R. T.; Bazan, G. C. Chem. Rev. 2005, 105, 1001-1020. (d) Shindoh, N.; Takemoto, Y.; Takasu, K. 
Chem.-Eur. J. 2009, 15, 12168-12179. For a review of tandem catalysis in enantioselective reactions, see: 
(d) Chapman, C.; Frost, C. Synthesis 2007, 1-21.  
3 (a) Louie, J.; Bielawski, C. W.; Grubbs, R. H. J. Am.Chem. Soc. 2001, 123, 11312–11313. (b) Camm, K. 
D., Castro, N. M.; Liu, Y.; Czechura, P.; Snelgrove, J. L.; Fogg, D. E., J. Am. Chem. Soc. 2007, 129, 4168. 
4 (a) Beligny, S.; Eibauer, S.; Maechling, S.; Blechert, S. Angew. Chem. Int. Ed. 2006, 45, 1900-1903. (b) 
Scholte A. A.; An, M. H.; Snapper, M. L. Org. Lett. 2006, 8, 4759-4762. (c) Schmidt B.; Krehl S.; Hauk, S. 
J. Org. Chem. 2013, 78, 5427-5435. 
5 Kim, B. G.; Snapper, M. L. J. Am. Chem. Soc. 2006, 128, 52-53.  
6 Chen, J.-R.; Li, C.-F.; An, X.-L.; Zhang, J.-J.; Zhu, X.-Y.; Xiao, W.-J. Angew. Chem. Int. Ed. 2008, 47, 
2489-2492.  
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Figure 3.1 Commercially available Grubbs’ catalysts 
 
Herein we aim to develop a three-step tandem sequence, which includes ring-
closing metathesis (RCM), olefin isomerization and olefin dihydroxylation, to make N-
protected 2,3-dihydroxypyrrolidines and 2,3-dihydroxypiperidines from readily available 
nitrogen-tethered dienes 3.1 (Scheme 3.1). The Grubbs’ catalyst added in the first step 
will serve as the metal source in the subsequent two transformations. Olefin 
isomerization would normally be catalyzed by ruthenium hydride while olefin 
dihydroxylation would be catalyzed by ruthenium oxide. A suitable additive will function 
as the promoter to modify the different catalyst precursor between steps. 
 
 
Scheme 3.1 Proposed tandem RCM/olefin isomerization/dihydroxylation sequence 
 
The anticipated challenges are (1) minimizing side effects of additives on the 
following reaction and (2) the limited number of electron-rich oelfins shown to 
participate in Ru-catalyzed dihydroxylations. Ruthenium tetroxide is known to be a 
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robust catalyst for olefin dihydroxylation under specific conditions.7 However, in a 
recently reported study of tandem Z-selective cross metathesis/olefin dihydroxylation by 
Robert Grubbs, it was noted that unfunctionalized electron-rich olefins inhibited the Ru-
catalyzed dihydroxylation.8 In addition, the variation of oxidation states of ruthenium 
through the proposed tandem sequence is ambiguous to us, which makes the 
dihydroxylation step more challenging.  
N-Protected 2,3-dihydroxypyrrolidines and 2,3-dihydroxypiperidines are versatile 
building blocks in synthesis. The hemiaminal motif can be treated as a masked 
aminoaldehyde and used as a reactant in Wittig reactions;9 the acid-labile hydroxyl group 
or the derived acetate at 2-position makes these compounds good precursors for the 
corresponding iminium ions.10 The iminium intermediates can react with a nucleophile to 
introduce a new substituent onto the heterocyclic rings.  
In 2005 Takeuchi and Harayama reported a racemic synthesis of Febrifugine, a 
potent antimalarial alkaloid.9a 2,3-Dihydroxy-N-(benzyloxycarbonyl)piperidine 3.4 was 
used in a Wittig reaction to access the key intermediate (E)-ω-amidoenone 3.5, which 
                                                
7 For reviews of RuO4 in oxidations, see: (a) Plietker, B.; Niggemann, M. Org. Biomol. Chem. 2004, 2, 
2403-2407. (b) Plietker, B. Synthesis 2005, 15, 2453-2472. 
8 Dornan, P. K.; Wickens, Z. K.; Grubbs, R. H. Angew. Chem. Int. Ed. 2015, 54, 7134-7138. 
9 (a) Takeuchi, Y.; Oshige, M.; Azuma, K.; Abe, H.; Harayama, T. Chem. Pharm. Bull. 2005, 53(7), 868-
869. (b) Sukemoto, S.; Oshige, M.; Sato, M.; Mimura, k.-i.; Nishioka, H.; Abe, H.; Harayama, T.; 
Takeuchi, Y. Synthesis 2008, 3081-3087. (c) Mclaughlin, N. P.; Evans, P. J. Org. Chem. 2010, 75, 518-
521.   
10 For reviews of chemistry of acyliminium ion, see: (a) Speckamp, W. N.; Moolenaar, M. J. Tetrahedron 
2000, 56, 3817-3856. (b) Maryanoff, B. E.; Zhang, H.-C.; Cohen, J. H.; Turchi, I. J.; Maryanoff, C. A. 
Chem. Rev. 2004, 104, 1431-1628. (c) Yazici, A.; Pyne, S. G. Synthesis 2009, 3, 339-368. (d) Yazici, A.; 
Pyne, S. G. Synthesis 2009, 4, 513-541. For representative examples of N-protected 2,3-
dihydroxypyrrolidines and 2,3-dihydroxypiperidine as precursors to iminium ions, see: (e) Macdonald, S. J. 
F.; Spooner, J. E.; Dowle, M. D. Synlett 1998, 1375-1377. (f) Batey, R. A.; Mackay, D. B. Tetrahedron 
Lett. 2000, 41, 9935-9938. (g) Okitsu, O.; Suzuki, R.; Kobayashi, S. J. Org. Chem. 2001, 66, 809-823. (h) 
Martin, C. L.; Overman, L. E.; Rohde, J. M. J. Am. Chem. Soc. 2010, 132, 4894-4906. (i) Miller, K. E.; 
Wright, A. J.; Olesen, M. K.; Hovey, M. T.; Scheerer, J. R. J. Org. Chem. 2015, 80, 1569-1576.    
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underwent a Lewis-acid catalyzed diastereoselective Michael addition to construct the 
2,3-disubstituted piperidine fragment in the target molecule (Scheme 3.2). 
 
Scheme 3.2 Racemic 2,3-dihyroxypiperidine in Wittig reaction 
 
Overman’s group developed a synthetic route to access enantioenriched (3R)-2,3-
diacetoxy-N-(tert-butoxycarbonyl)piperidine 3.10, and used this compound in the total 
synthesis of (-)-actinophyllic acid (Scheme 3.4).9h In presence of catalytic amount of 
Sc(OTf)3, 3.10 reacts with the substituted indole in a highly diastereoselective way. 
 
 
Scheme 3.3 Enantioselective synthesis of 2,3-dihydroxypiperidine diacetate 
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Scheme 3.4 2,3-Dihydroxypiperidine diacetate as an acyliminium ion precursor 
 
Scheerer and coworkers applied Petasis borono-Mannich addition developed by 
Batey 11  in their recent synthesis of (+)-loline alkaloid skeleton (Scheme 3.5).9i 
Enantioenriched (3S)-2,3-dihydroxy-N-(benzyloxycarbonyl)pyrrolidine 3.16 was 
prepared from commercially available (S)-4-amino-2-hydroxybutanoic acid 3.13, and 
used as a N-acyliminium ion precursor directly. The hydroxyl group at 3-position may 
coordinate with the vinyl boronate reagent and hence function as a directing group in the 
highly diastereoselective nucleophilic addition.   
                                                
11 Batey, R. A.; Mackay, D. B.; Santhakumar, V. J. Am. Chem. Soc. 1999, 121, 5075-5076. 
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Scheme 3.5 2,3-Dihydroxypyrrolidine in Petasis borono-Mannich addition 
 
Our proposed tandem sequence can provide an alternative method of synthesizing 
2,3-dihydroxypyrrolidines and 2,3-dihydroxy piperidines, and demonstrate the synthetic 
utility of a carefully designed tandem reaction in building up molecular complexicity in a 
rapid fashion.   
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3.2 Background 
3.2.1 Tandem RCM/olefin isomerization process 
Ruthenium hydride complexes were well-known catalysts for olefin isomerization 
of allyl alcohols, allyl ethers and allyl amides in 1970s and 1980s.12 The driving force for 
this type of transformation is that the carbon-carbon double bond migrates to a 
thermodynamically more favorable position after undergoing a series of reversible 
hydrometallation/β-hydride elimination.13 If the ruthenium alkylidene species in the post-
metathesis phase could be efficiently converted to a ruthenium hydride complex, an 
olefin isomerization reaction can be coupled to olefin metathesis reactions. Based on 
employing different hydride sources, several tandem RCM/olefin isomerization strategies 
have been developed. 
     
 
Figure 3.2 A general mechanism of transition metal hydride-catalyzed olefin isomerization 
 
                                                
12 (a) Sasson, Y.; Rempel, G. L.; Tetrahedron Lett. 1974, 47, 4133-4136. (b) Suzuki, H.; Koyama, Y.; 
Moro-oka, Y.; Ikawa, T. Tetrahedron Lett. 1979, 16, 1415-1418. (c) Suzuki, H.; Yashima, H.; Hirose, T.; 
Takahashi, M.; Moro-oka, Y.; Ikawa, T. Tetrahedron Lett. 1980, 21, 4927-4930. (d) Stille, J. K.; Becker, Y. 
J. Org. Chem. 1980, 45, 2139-2145. 
13 For discussion of the general mechanisms, see: McGrath, D. V.; Grubbs, R. H. Organometallics 1994, 
13, 224-235. 
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Grubbs’ group successfully isolated a new ruthenium hydride complex 3.18 from 
thermal decomposition of GII,14 and proved that it is an active olefin isomerization 
catalyst.13a,b This finding not only rationalizes observed isomerization of some terminal 
olefins in a slow olefin metathesis reaction,15 but also sheds some light on developing a 
tandem RCM/olefin isomerization method. Fustero and coworkers reported an additive-
free protocol16 for this type of tandem sequence (Figure 3.3). The ruthenium hydride 
species in situ generated through thermal decomposition of GII was believed to be the 
catalyst in olefin isomerization step.    
 
Figure 3.3 An additive-free strategy for tandem RCM/olefin isomerization 
                                                
14 (a) Hong, S. H.; Day, M. W.; Grubbs, R. H. J. Am. Chem. Soc. 2004, 126, 7414-7415. (b) Hong, S. H.; 
Sanders, D. P.; Lee, C. W.; Grubbs, R. H., J. Am Chem. Soc. 2005, 127, 17160-17161. (c) Hong, S. H.; 
Wenzel, A. G.; Salguero, T. T.; Day, M. W.; Grubbs, R. H. J. Am. Chem. Soc. 2007, 129, 7961-7968. 
15 Some representative examples, see: (a) Formentín, P.; Gimeno, N.; Steinke, J. H.; Vilar, R. J. Org. 
Chem. 2005, 70, 8235-8238. (b) Michalak, M.; Wicha, J. Synlett 2005, 15, 2277-2280. (c) Hekking, K. F. 
W.; Waalboer, D. C. J.; Moelands, M. A. H.; van Delf F. L.; Rutjes, F. P. J. T. Adv. Synth. Catal. 2008, 
350, 95-106.  
16 Fustero, S.; Sánchez-Roselló, M.; Jiménez, D.; Sanz-Cervera, J. F.; del Pozo, C.; Aceña, J. L. J. Org. 
Chem. 2006, 71, 2706-2714. 
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Schmidt used substoichiometric amount of NaBH4 or NaH (ca. 50 mol%) to 
generate ruthenium hydrides from GI (Figure 3.4).17 The nucleophilic replacement 
between sodium or boron hydride bond and ruthenium chloride bond might account for 
generation of ruthenium hydrides.17c Nonetheless, functional groups tolerance is the 
limitation to this method, in which free hydroxy groups can be deprotonated and ester 
groups can be slowly reduced under the reaction conditions.  
 
 
 
 
 
 
 
Figure 3.4 Use of NaH or NaBH4 as the hydride source in tandem RCM/olefin isomerization 
 
                                                
17 (a) Schmidt, B. Eur. J. Org. Chem. 2003, 816-819. (b) Schmidt, B. J. Org. Chem. 2004, 69, 7672-7687. 
(c) Schmidt, B. J. Mol. Catal. A. 2006, 254, 53-57. 
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Schmidt also found that triethylsilane can function as a hydride source for 
modification of GI, despite longer reaction time was usually needed for good conversions 
in olefin isomerization step (Figure 3.5).17b,c While it was not disclosed by Schmidt 
whether substoichiometric amount of triethylsilane would be insufficient, Cossy and 
coworkers observed that with excess of triethylsilane a tandem RCM/hydrogenation 
reaction could occur.18 It should be mentioned that for the substrates containing primary 
alcohols a faster dehydrogenative silylation could take place prior to the olefin migration 
(Figure 3.5).19   
 
 
 
 
 
Figure 3.5 Use of triethylsilane as the hydride source in tandem RCM/olefin isomerization 
 
                                                
18 Menozzi, C.; Dalko, P. I.; Cossy, J. Synlett 2005, 16, 2449-2452. 
19 Maifeld, S. V.; Miller, R. L.; Lee, D. Tetrahedron Lett. 2002, 43, 6363-6366. 
O
1) GI (5 mol%)
2) Et3SiH (1.0 equiv)
O
+
OO O
3.34
O
3.35 3.3683% yield
3.35 : 3.36 >19 : 1
PhMe, rt
110 °C
O
1) GI (5 mol%)
2) Et3SiH (1.0 equiv)
O
OH
O
OSiEt3
OSiEt3
84% yield3.37 3.38
PhMe, rt
110 °C, 10 -16 h
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Inspired by Mol’s study of GI reacting with primary alcohols in presence of 
inorganic or organic bases,20 Schmidt discovered that iPrOH/NaOH is a more effective 
additive (Figure 3.6).17b Presumably, the higher nucleophilicity of in situ generated 
isopropoxide benefits formation of ruthenium alkoxide species, which undergo β-hydride 
elimination to produce ruthenium hydrides. This protocol did not give satisfactory results 
for making five-membered rings, because isomerized products were further hydrogenated 
under the reaction conditions. However, this side reaction is relatively slow to the six-
membered rings in the same reaction time scale.  
 
 
Figure 3.6 Use of iPrOH/NaOH as the additives in tandem RCM/olefin isomerization 
 
More recently, Schmidt discovered that NaOH alone could be an effective 
additive in a tandem RCM/olefin isomerization reaction to make N-protected cyclic 
enamines (Equation 3.1).21 With 2.5 mol% GII as the ruthenium source a variety of 
substituted N-Boc-1,2,3,4-tetrahydropyridines were successfully prepared. It was not 
disclosed what role NaOH played in promoting the olefin isomerization step. It might 
                                                
20 Dinger, M. B.; Mol, J. C. Organometallics 2003, 22, 1089-1095. 
21 Schmidt, B.; Hauke, S.; Mühlenberg, N. Synthesis 2014, 46, 1648-1658.  
O O
+
O
1) GI (5 mol%)
2) iPrOH (25%, v/v)
    PhMe, rt
NaOH (50 mol%)
110 °C, 2 h
Ph
72% yield
Ph Ph
3.40
3.41 3.42
3.41 : 3.42 > 19 : 1
O
1) GI (5 mol%)
2) iPrOH (25%, v/v)
O + O
OCH3 OCH3 OCH3
+ O
OCH3
3.26 : 3.39 : 3.27 = 3 : 2 : 1
3.25
    PhMe, rt
NaOH (50 mol%)
110 °C, 2 h 3.26 3.39 3.27
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facilitate formation of ruthenium hydride 3.18, according to a mechanism proposed by 
Grubbs in his study of thermal decomposition of GII.14c  
 
Equation 3.1 Use of NaOH as an additive in tandem RCM/olefin isomerization 
 
Hydrogen gas is a more straightforward, cleaner and cheaper hydride source. 
Based on Fogg’s studies of hydrogenolysis of Grubbs’ catalysts under hydrogen 
atmosphere,22 The Snapper group found a mild condition to conduct tandem RCM/olefin 
isomerization (Equation 3.2 and Table 3.1).23 After the metathesis step a gas mixture of 
N2/H2 (95:5), which is commercially available, was bubbled into the reaction solution for 
minutes, and then the reaction vessel was sealed and heated at 70 °C. With the highly 
diluted hydrogen source, olefin hydrogenation products were suppressed to less than 10%. 
In addition to cyclic enol ethers, they also reported the first example of making a N-
protected cyclic enamine via a tandem RCM/olefin isomerization strategy. Immediate 
NMR studies of the reaction solutions sparged with N2/H2 mixture did not detect 
formation of a ruthenium hydride or other new ruthenium complexes.23 To clarify 
whether this short gas-introducing process is necessary, they conducted a control 
                                                
22 (a) Smanantha, D. D.; Yap, G. P. A.; Fogg, D. E. Inorg. Chem. 2000, 39, 5412-5414. (b) Drouin, S. D.; 
Zamanian, F.; Fogg, D. E. Organometallics 2001, 20, 5495-5497. (c) Beach, N. J.; Camm, K. D.; Fogg, D. 
E. Organometallics 2010, 29, 5450-5455.   
23 Sutton, A. E.; Seigel, B. A.; Finnegan, D. F.; Snapper, M. L. J. Am. Chem. Soc. 2002, 124, 13390-13391. 
NPh NPh
1) GII (2.5 mol%)
2) NaOH (1.5 equiv)
Boc Boc
 PhMe, 80 °C
110 °C
84% yield3.43
3.44
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experiment and proved that the thermal decomposition of GII did not lead to an 
appreciable olefin isomerization under the same conditions. 
 
Equation 3.2 Use of N2/H2 as the hydride source in tandem RCM/olefin isomerization 
 
 
Entry Substrate Product Yield (%) 
1 
  
46 
2 
  
58 
3 
  
54 
 
Table 3.1 Use of N2/H2 mixture as the hydride source in tandem RCM/olefin isomerization 
 
 
NPh NPh
1) GII (15 mol%)
2) N2/H2 (95:5), rt, 3 min,
Ts Ts
74% yield3.45
3.46
    CH2Cl2, rt
then 65-70 °C, 13 h
OR 1) GII (10 mol%)
2) N2/H2 (95:5), rt, 3 min,n
(n=0, 1, 2)
OR
n
CH2Cl2, rt
then 65-70 °C
O
3.47
O
3.48
O
Cl
3.49
O
Cl
3.50
O
3.51
O
3.52
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3.2.2 Ruthenium tetroxide-catalyzed dihydroxylation of olefins 
As an analog of OsO4, RuO4 can catalyze olefin dihydroxylation as well. 
However, carbonyl compounds, such as two molecules of aldehydes, are frequently 
observed as the major over-oxidation products from RuO4-catalyzed olefin 
dihydroxylation reactions. A general explanation for this oxidative cleavage of olefins is 
that RuO4, more electron-deficient than OsO4, tends to gain more electrons from double 
bonds and be reduced to low-valent ruthenium oxide species.24 Frenking et al. established 
a computational model to explain different oxidative behaviors of RuO4 and OsO4 with 
olefins (Figure 3.7).24 Due to the lower energy barrier (2.5 kcal/mol), the key Ru (VIII) 
intermediate in dihydroxylation can readily adopt the double-bond scission pathway. It is 
worth mentioning that this undesired reaction pathway is also synthetically useful, 
because it can serve as an alternative method to olefin ozonolysis.25  
 
Figure 3.7 Energy diagram of oxidative olefin cleavage via RuO4 and OsO4 
                                                
24 Frunzke, J.; Loschen, C.; Frenking, G. J. Am. Chem. Soc. 2004, 126, 3642-3652. 
25 Yang, D.; Zhang, C. J. Org. Chem. 2001, 66, 4814-4818.  
O
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The breakthrough in RuO4-catalyzed olefin dihydroxylation was achieved in the 
1990’s. A solvent mixture, EtOAc/MeCN/H2O (3:3:1), provided a good solution to tune 
the reactivity of RuO4 to the desired pathway (Table 3.2).26  
 
Entry Substrate Time (min) Product Yield (%) 
1 
 
0.5 
 
58 
2 
 
3 
 
72 
3 
 
0.5 
 
36 
4 
 
3 
 
81 
5 
 
3 
 
77 
 
Table 3.2 RuO4-catalyzed olefin dihydroxylation in a solvent mixture 
 
                                                
26 (a) Shing, J. K. M.; Tai, V. W.-F.; Tam, E. K. W. Angew. Chemie. Int. Ed. 1994, 33, 2312-2313. (b) 
Shing, J. K. M.; Tam, E. K. W.; Tai, V. W.-F.; Chung, I. H. F.; Jiang Q. Eur. Chem. J. 1996, 2, 50-57. (c) 
Shing, T. K. M.; Tam, E. K. W. Tetrahedron Lett. 1999, 40, 2179-2180. 
 
RuCl3 (7 mol%)
NaIO4 (1.5 equiv.)
EA/MeCN/H2O (3:3:1)
c = 0.07 M, 0 °CR2
R2 OH
OH
R1
R2
time
3.53
OH
OH
3.54
OAc
3.55
OH
OH
OAc
3.56
O
3.57
O
OH
OH
3.58
O
3.59
O
OH
OH
3.60
Ph CO2Et
3.61
Ph CO2Et
OH
OH
3.62
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Due to the short reaction time, from half minute up to three minutes, this 
oxidation method was also called as “flash dihydroxylation”.26a Electron-deficient or 
sterically hindered olefins, which are conventionally difficult substrates in OsO4-
catalyzed olefin dihydroxylations, gave more satisfying yields in this method. 
Considering diols and aldehydes are generated from the same ruthenate 
intermediate through two competing routes, Plietker and Niggemann proposed that 
addition of a proton source would benefit generation of diols by facilitating the 
hydrolysis process (Table 3.3).27 Through screening, sulfuric acid (2M aqueous solution) 
turned to be most effective, and the accelerated turnover of RuO4 allowed a much lower 
catalyst loading (0.5 mol%) to be used. In order to improve tolerance of functional groups, 
the same group subsequently investigated the influence of Lewis acids on 
dihydroxylation, and discovered that CeCl3 gave the best chemoselectivity along with 
good conversions among the screened metal chlorides (Table 3.3).28,29 
 
Entry Additive (x mol%) c (M) 3.62:3.63a Yield (%) 
1 ⎯ 0.07 2.8:1 47 
2 aq. H2SO4 (5) 0.07 3.8:1 71 
3 ⎯ 0.28 2:1  61b 
4 CeCl3•7H2O (10) 0.28 21:1 82 
                       aDetermined by GC. bConverison, determined by GC.   
 
Table 3.3 Influence of different additives on selectivity and yields of olefin dihydroxylation 
                                                
27 Plietker, B.; Niggemann, M. Org. Lett. 2003, 5, 3353-3356.  
28 Plietker, B.; Niggemann, M. J. Org. Chem. 2005, 70, 2402-2405. 
29 Metal bromides and iodides will be oxidized under the same reaction conditions. 
 
Ph CO2Me
RuCl3 (0.5 mol%)
NaIO4 (1.5 equiv)
EA/MeCN/H2O (3:3:1), c, 0 °C
additive (x mol%)
Ph CO2Me
OH
OH
+
O
HPh
3.61
3.62 3.63
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Figure 3.8 Proposed catalytic cycle of RuO4-catalyzed olefin dihydroxylation 
 
Although the specific mechanism of CeCl3 in Plietker’s dihydroxylation strategy 
is still unclear, Plietker assessed the possible role of this reagent: (1) decreasing pH value 
of the reaction solutions, similar to the effect of sulfuric acid; (2) in situ reacting with 
NaIO4 to form a Ce(IV)-periodato complex, which possesses higher redox potential.  
Reoxidant pH value Redox potential (V) 3.62:3.63 
NaIO4 2.8 1.020 1:1 
CeCl3/NaIO4 1.94 1.075 10.2:1 
H[Ce(IO6)]/NaIO4 2.61 1.071 4.6:1 
          
Table 3.4 Influence of CeCl3 as an additive on pH and redox potential 
 
An argument about generation of aldehydes or ketones in the above mentioned 
catalytic system is that they may come from a rapid glycol cleavage of cis-diol products 
by NaIO4, instead of oxidative cleavage of corresponding olefins by RuO4. To gain some 
insight on the relative rate of these two possible pathways, Plietker treated hydrobenzoin 
(1,2-diphenyl-1,2-ethanediol) with NaIO4 and set up a dihydroxylation reaction of trans-
O
Ru
O
O
O
R1
R2
O
Ru
O
O
O R1
R2
Ru
O
O R1
R2
O
O
O
H2O
OxidantO
R1 H
+
O
R2 H
competition
R1
OH
R2
OH
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stilbene at the same time.27 When the dihydroxylation reaction reached almost full 
conversion, the glycol cleavage of hydrobenzoin was still in initiation phase. This implies 
that if the RuO4-catalyzed dihydroxylation was quenched in timely fashion, one should 
not observe any glycol cleavage of generated 1,2-diols by NaIO4.     
 
3.2.3 Low-valent Ruthenium oxide-catalyzed dihydroxylation of olefins 
  Low-valent ruthenium oxide species can also be used in dihydroxylation of 
olefins, but only few examples have been published. Che’s group first studied the 
stoichiometric cis-dihydroxylation of unfunctionalized olefins with a Ru(VI) complex,30 
and then developed a ruthenium (III)-based catalytic system for synthesizing cis-diols 
from olefins with hydrogen peroxide as the oxidant.31 In the latter case, basic alumina and 
NaCl were employed as additives to improve the selectivity toward cis-products, but the 
mechanism of them in the reaction was unclear. With the Ru(III)/H2O2 system most 
simple olefins gave good yields and high selectivities, but electron-deficient olefins 
reacted tardily in the same condition. When 3.61 was used as the substrate no reaction 
occurred. Che and co-workers also investigated a Ru(IV)/porphyrin complex-catalyzed 
dihydroxylation of styrenes.32 Diols products were generated through in situ ring-opening 
hydrolysis of corresponding epoxide intermediates.  
                                                
30 Yip, W.-P.; Yu, W.-Y.; Zhu, N.; Che, C.-M. J. Am. Chem. Soc. 2005, 127, 14239-14249.  
31 Yip, W.-P.; Ho, C.-M.; Zhu, N.; Lau, T.-C.; Che, C.-M. Chem. Asian J. 2008, 3, 70-77. 
32 Hu, W.-X.; Li, P.-R.; Jiang, G.; Che, C.-M.; Chen, J. Adv. Synth. Catal. 2010, 352, 3190-3194. 
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Equation 3.3 Low-valent Ru-catalyzed olefin dihydroxylation 
 
3.2.4 Tandem RCM/olefin dihydroxylation reactions33	  
Blechert’s group reported the first tandem RCM/olefin dihydroxylation sequence 
(Table 3.5).34 Through control experiments with different Grubbs’ catalysts, they found 
NHC-ligated ruthenium catalysts exhibited a relatively lower activity in oxidation. The 
strong affinity between NHC and ruthenium presumably restrained generation of the 
active ruthenium oxide smoothly.34 Electron-deficient alkenes produced in the RCM step 
gave higher yields of the diol products. To achieve better yields in dihydroxylation step, 
dichloromethane, the solvent used in metathesis step, needs to be fully removed. Small 
amount of this solvent residing in metathesis products caused low yields in oxidation. In 
addition, they used YbCl3, instead of CeCl3, as an additive in the dihydroxylation step.  
 
 
 
                                                
33 For tandem cross metathesis/olefin dihydroxylation, see reference 8, 34 and 35. 
34 Beligny, S.; Eibauer, S.; Maechling, S.; Blechert, S. Angew. Chemie. Int. Ed. 2006, 45, 1900-1903. 
  
Ru
N NNMeMe Me
Cl
Cl
Cl
(10 mlo%)
Basic Al2O3 (1.0 equiv)
NaCl (0.2 equiv)
+ H2O2
(2.2 equiv)
OH
OH
3.53 3.54
+
OH
OH
3.64
78% yield 20% yieldt-BuOH/H2O (2:1), 60 °C
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Entry NaIO4 (equiv) Substrate Product Yield (%) 
1 1.6 
 
 
33 
2 1.6 
  
63 
3 1.4 
 
 
88 
(0.8:1 dr) 
4 1.4 
 
 
49 
(24:1 dr) 
 
Table 3.5 Representative examples of Blechert’s tandem RCM/olefin dihydroxylation 
 
Shortly after Blechert’s publication, the Snapper group also reported a tandem 
RCM/olefin dihydroxylation protocol (Table 3.6),35 in which ethyl acetate was used as 
the solvent in the metathesis step to avoid an extra solvent-swapping operation in 
                                                
35 Scholte, A. A.; An, M. Y.; Snapper, M. L. Org. Lett. 2006, 8, 4759-4762.  
EtOAc/MeCN/H2O (3: 3:1)
R R
1) GI (1 mol%)
  CH2Cl2, reflux
2) YbCl3 (10 mol%)
OH
OH NaIO4 (x equiv)
0 °C, 20-30 min
O
3.65 O
OH
OH
3.66
O
Cl
Cl 3.67
O
OH
OHCl
Cl 3.68
N
Ts
CO2Me
3.69
N
Ts
OH
OH
MeO2C
3.70
OAc
3.71
OAc
OH
OH
3.72
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Blechert’s method. The typically used solvent composition, EtOAc/MeCN/H2O = 3:3:1, 
in RuO4-catalyzed olefin dihydroxylation was modified to EtOAc/MeCN/H2O = 6:6:1.  
 
Entry Substrate Product Yield (%) 
1 
 
 
60 
(22:1 dr) 
2 
  
69 
(1.5:1 dr) 
3 
  
77 
(7:1 dr) 
 
Table 3.6 Representative examples of Snapper’s tandem RCM/olefin dihydroxylation 
 
We envisioned that the tandem RCM/olefin isomerization strategy developed by 
the Snapper group is more compatible with our proposed three-step tandem sequence. 
The N2/H2 (95:5) mixture used as the addtive in the olefin isomerization step will leave 
the least “contamination” to the following dihydroxylation reaction. On the other hand, 
the ene-carbamates and ene-sulfonamides generated from the olefin isomerization step 
are electron-rich olefins, which may not be applicable in RuO4-catalyzed olefin 
dihdyroxylation. Hence, we started to explore specific reaction conditions for each step in 
our proposed three-step tandem sequence.           
EtOAc/MeCN/H2O (6:6:1), 0 °C
R R
1) GII (5 mol%)
EtOAc, rt
2) CeCl3•7H2O (10 mol%)
OH
OHNaIO4 (1.5 equiv)
OAc
3.71
OAc
OH
OH
3.72
O
3.73
O OH
OH
3.74
TsN
3.75MeO
TsN
3.76MeO
OH
OH
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3.3 Modification of previously established RCM/olefin isomerization condition 
In order to simplify the procedure for the olefin dihydroxylation step, we decided 
to modify the established RCM/olefin isomerization condition developed by our group. 
RuO4-catalyzed olefin dihydroxylation requires a specific solvent mixture 
(EtOAc/MeCN/H2O, 3:3:1) to achieve good yields, but our tandem RCM/olefin 
isomerization strategy employs CH2Cl2 in the sequential two steps. To avoid a solvent 
swapping operation (from CH2Cl2 to EtOAc/MeCN/H2O), it would be more practical to 
use EtOAc as the initial solvent. More importantly, Blechert’s study revealed that small 
amount of CH2Cl2 was detrimental to Ru-catalyzed olefin dihydroxylation.34 
Control experiments were first conducted to test the solvent effect (Table 3.7). 
Diene 3.77 was chosen as the model substrate, because an analog of this compound 
(3.45) was successfully applied in a tandem RCM/olefin isomerization reaction.23 
 
Entry GII (mol%) Solvent Yield (%) 
1 15  CH2Cl2 98 
2 10  CH2Cl2 98 
3 10  EtOAc 24a 
                                                    a73% RCM product was isolated. 
 
Table 3.7 Solvent effect on tandem RCM/olefin isomerization reaction 
 
At the same catalyst loading ene-sulfonamide 3.78 was generated in a high yield 
in CH2Cl2 but in a much lower yield in EtOAc (entry 2 and 3). 73% RCM product was 
recovered from the reaction of entry 3 in Table 3.7, which indicated that the low yield of 
N
Ts 1) GII (x mol%)
2) N2/H2 (95:5), rt, 5 min,
N
Ts
3.77
3.78
Solvent (0.05 M), rt
then 70 °C, 12 h
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the tandem reaction was not due to an unsuccessful RCM reaction but to an unsuccessful 
olefin isomerization. Presumably, EtOAc competed with the ring-closing metathesis 
product to coordinate with the active ruthenium complex, and hence made olefin 
isomerization sluggish.  
In case that diene 3.77 is not a good substrate in the new condition, a N-Cbz diene 
3.79 was examined for optimization of the olefin isomerization condition (Table 3.8).  
 
Entry Solvent Hydride Source Temp. (°C) Time (h) Yield (%) 
1 CH2Cl2 N2/H2 (95:5), rt, 5 min 70 12 76 
2 EtOAc N2/H2 (95:5), rt, 5 min 70 12 19 
3 EtOAc   N2/H2 (95:5), rt, 10 min 70 12 14 
4 EtOAc N2/H2 (95:5), rt, 5 min 100 12 96 
5 EtOAc N2/H2 (95:5), rt, 5 min 100 4 90 
6 EtOAc ⎯ 100 4 11 
 
Table 3.8 Optimization of the olefin isomerization step 
  
Switching the solvent from CH2Cl2 to EtOAc also led to a low yield (entry 1 and 
2, Table 3.8). Prolonging the time of bubbling the gas mixture (N2/H2, 95:5) into the 
reaction solution did not solve this problem (entry 3), although it was expected that more 
ruthenium hydride could be generated through exposing GII to H2 atmosphere. Finally, 
we found that increasing temperature of the isomerization step was an effective and direct 
way to regain the reactivity (96% yield, entry 4), and the reaction time could be reduced 
to 4 h with slight drop in yield  (entry 5). Since there is a precedent that showed the Ru-H 
complex generated from thermal decomposition of GII were effective enough for olefin 
N
Cbz 1) GII (5 mol%)
2) olefin isomerization
N
Cbz
3.79 3.80
Solvent (0.1 M), rt
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isomerization,16 someone would argue that our method might rely on a similar 
mechanism and the aid of an external hydride source is unnecessary. To resolve this 
confusion, we did a blank experiment (entry 6) to demonstrate that introduction of highly 
diluted H2 is imperative for a good yield.  
Next, we evaluated other diene substrates in the new tandem RCM/olefin 
isomerization conditions (Table 3.9 and Table 3.10).  
 
Entry Substrate Product GII (mol%) Temp. (°C) Yield (%) 
1 
  
5 100 71 
2 
 
 
  
5 
10 
10 
100 
100 
120 
14 
34 
89 
3 
 
  
5 
10 
100 
100 
51 
68 
 
Table 3.9 Optimization of the olefin isomerization step 
 
 
N
PG 1) GII (x mol%)
    EtOAc (0.1 M), rt
2) N2/H2 (95:5), rt, 5 min,
   Temperature, 4 h
N
PG
n n
(n = 1, 2)
N
Boc
3.81
N
Boc
3.82
N
Ts
3.77
N
Ts
3.78
N
Cbz
3.83
N
Cbz
3.84
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N-Boc diene 3.81 reacted smoothly under the optimal condition used for 3.79, but 
diene 3.77 still showed a much lower reactivity (entry 1 and 2, Table 3.9). While 
increasing catalyst loading did improve the yield of ene-sulfonamide 3.78, higher 
temperature was found to be more effective. At 120 ºC after 4 h ene-sulfonamide 3.78 
was obtained in 89% isolated yield (entry 2). For preparation of the seven-membered ring 
product 3.84, the reaction also went sluggishly, and we observed another olefin regiomer 
from 1H-NMR of the unpurified product. By increasing catalyst loading to 10 mol%, we 
improved the yield of cyclic ene-carbamate 3.84 to 68% (entry 3), which is synthetically 
useful for the dihydroxylation step.    
 
Entry Substrate Product Time (h) Yield (%) 
1 
 
  
4 
2 
81 
84 
2 
  
2 67 
3 
  
2 86 
 
Table 3.10 Optimization of olefin isomerization step 
 
N
PG 1) GII (5 mol%)
    EtOAc (0.1 M), rt
2) N2/H2 (95:5), rt, 5 min,
   then 100 °C, time
N
PG
N
Cbz
3.85
N
Cbz
3.86
N
Boc
3.87
N
Boc
3.88
N
Ts
3.89
N
Ts
3.90
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The reaction time for making five-membered rings can be further reduced to 2 h 
while achieving a comparable yield (entry 1 and 2, Table 3.10). A possible explanation 
for this observation is that in the course of β-hydride elimination the heterocyclic rings 
needs to adopt a suitable conformation to reach good orbital alignment of the C-Ru bond 
and the adjacent C-H bond, and the energy barrier between the envelope conformation 
and the half-chair conformation of a five-membered ring is relatively lower (for 
cyclopentane, it is less than 3 kcal/mol). For the six-membered rings, the energy barrier 
between a chair and a half-chair conformation is relatively higher (for cyclohexane, it is 
about 10 kcal/mol). Thus, olefin isomerization of five-membered heterocyclic rings is 
faster than that of the six-membered rings. 
 
Figure 3.9 Proposed transition states of β-hydride elimination 
 
3.4 Development of tandem RCM/olefin isomerization/olefin dihydroxylation 
sequence 
 As the new condition for tandem RCM/olefin isomerization was established, we 
started to investigate the olefin dihydroxylation step. The basis of this exploration is the 
previously reported RuCl3/NaIO4/CeCl3•7H2O catalytic system for olefin 
dihydroxylation.  
N
H
[Ru]
H
PG
N PG
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 Diene 3.79 was selected as the model substrate in the three-step tandem reaction, 
as the OsO4-catalyzed dihydroxylation of ene-carbamate 3.80 to make diol 3.91 had been 
reported before.9b,10g Through adjusting additive loading and specific solvent 
composition, we assessed the effect of these two factors on the reaction yield and the 
ratio of cis/trans diastereomers.  
 
Entry CeCl3•7H2O (mol%) EtOAc/MeCN/H2O Time (min) 
Yielda 
(%) 
drb 
(cis:trans) 
1 10 3:3:1 35 41(33)c 1.2:1 
2 25 3:3:1 45 53 1.4:1 
3 25 6:6:1 60 60(46)c 1.5:1 
4 25 4:6:1 60 52 1.6:1 
5 25 4:6:3 50 35 2.3:1 
6 — 3:3:1 15 38(<24)c 2.0:1 
             aDetermined by 1H-NMR of the unpurified product with 1,3,5-trimethoxybenzene as the  
         internal standard. bDetermined by integrations of 1H-NMR of the unpurified products. cThe 
         isolated yield is shown in the parenthesis.   
 
Table 3.11 Exploration of key factors in the olefin dihydroxylation step 
 
With the same dihydroxylation condition reported by Plietker, only 33% diol 3.91 
was obtained (entry 1). The major byproduct was also isolated, but we could not identify 
its specific structure. Through comparison of the 1H-NMR and high-resolution mass 
spectra of the desired product and the byproduct, we tentatively assigned the byproduct to 
be a dimer of diol 3.91 (two molecules 3.91 condensed with each other by loosing one 
molecule H2O). In absence of CeCl3•7H2O the ene-carbamate 3.80 was completely 
N
Cbz 1) GII (5 mol%)
2) N2 : H2 (95 : 5), rt, 5 min,
N
Cbz
3) NaIO4 (1.5 equiv)
OH
OH
CeCl3•7H2O (x mol%)
EtOAc/MeCN/H2O, 0°C
3.79
3.91
EtOAc (0.1 M), rt
then 100 °C, 4 h
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consumed in the oxidation step in 15 min, and the byproduct was the major product (> 
39% isolated yield, entry 6). It should be noted that separation of the desired product and 
the byproduct is quite difficult, due to their close Rf values (with a hexanes/ethyl acetate 
mixture as the developing solvent, they show as the same spot in TLC; with a mixture of 
dichloromethane, hexanes and ethanol, the Rf difference of them is 0.08 after being 
developed twice on the TLC plate). The result of entry 6 suggested that addition of a 
Lewis acid suppressed formation of the byproduct, and it ruled out the theory that CeCl3 
caused formation of the byproduct. We also tried other oxidants, for instance, N-
Methylmorpholin N-oxide (NMO), (NH4)2S2O8 or KBrO3, to replace NaIO4, but they 
either gave no reaction or produced very low conversion in the dihydroxylation step.  
We assumed that lowering the concentration of IO4 anion in the solution could be 
an effective way to improve the yield. The inspiration for this assumption is that CeCl3 
can in situ react with NaIO4 to generate a water-insoluble Ce(IV)-periodato complex,36 
which might serve as the actual oxidant in the Ru-catalyzed dihydroxylation, and addition 
of 10 mol% CeCl3•7H2O indeed prolonged the reaction time needed for full conversion 
of ene-carbamate 3.80 in the dihydroxylation step and resulted in a higher yield (entry 1 
and entry 6, Table 3.11). When the additive loading was increased to 25 mol% we 
observed a further improved yield (entry 2, Table 3.11). Another way to “manipulate” the 
concentration of IO4 anion is changing the composition of reaction solvent. NaIO4 is 
soluble in MeCN and H2O but insoluble in EtOAc. When less H2O is added, less NaIO4 
will be dissolved in the organic phase, whereas decreasing EtOAc added in the solvent 
                                                
36 Levason, W.; Oldroyd, R. D. Polyhedron 1998, 15(3), 409-13. 
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will lead to more NaIO4 being dissolved. Results of entry 2, 3, 4 and 5 in Table 3.11 
indicated that reducing the content of H2O in the solvent benefitted the yield. 
 The diastereoselectivity in the above dihdyroxylation reaction is more 
complicated than we thought. Although, according to the mechanism of OsO4-catalyzed 
olefin dihydroxylation, someone would expect the cis-isomer as the absolute product, it is 
known that dihydroxylation of ene-carbamate 3.80 can also produce a trans-diol.9b,10g 
Shu̅ Kobayashi found that the diastereomeric ratio was sensitive to specific 
dihydroxylation conditions (Table 3.12). 
 
Entry Dihydroxylation condition Yield dr
a 
(cis:trans) 
1 
MCb OsO4 (5 mol%) 
NMO (1.5 equiv) 
Acetone/MeCN/H2O (1:1:1) 
79 100:0 
2 
K2OsO4•2H2O (1.7 mol%) 
K3Fe(CN)6 (3.0 equiv) 
CH3SO2NH2 (0.08 equiv) 
K2CO3 (3.0 equiv) 
t-BuOH/H2O (1:1) 
73 4:1 
aDetermined by 1H-NMR. bMC: Microencapsulated. 
Table 3.12 Kobayashi’s study of dihydroxylation of ene-carbamate 3.80 
 
If the cis- and trans-isomers were not thermally interconvertible under the 
dihdyroxylation condition, an iminium intermediate 3.93 could be used to explain 
observed epimerization at C-2 position. Ru(VIII) is more Lewis acid than Os(VIII). If 
RuO4 were the catalyst in the dihydroxylation step, it would be highly possible that the 
N
Cbz
[O] N
Cbz
OH
OH
3.80 3.91
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cyclic ruthenate fragment acted as a leaving group to generate 3.93, which could be 
further trapped by H2O in a less stereoselective fashion. In addition, Ce(IV) or the active 
proton generated from CeCl3 and NaIO4 in the aqueous phase can coordinate with one 
Ru-O double bond, making the ruthenium more Lewis acidic and a better leaving group. 
On the other hand, if cis and trans-isomers were interconverting to each other under the 
reaction condition, the diastereomeric ratio would be eventually under thermodynamic 
control after the cis and trans-diols reached equilibrium. For the condition of entry 1 in 
Table 3.11, if the reaction was quenched at 15 min before it proceeded to completion, we 
observed 1.1:1 ratio of the cis-diol to trans-diol. Based on the results in Table 3.11, it is 
more likely that the diastereomeric ratio of product 3.91 is eventually thermodynamically 
controlled under the reaction conditions. 
 
 
 
Scheme 3.6 The proposed pathway of epimerization of the hydroxyl group at C-2 position 
 
After some insight was gained of how additive loading and solvent composition 
can affect the yield, we continued to optimize the dihydroxylation step (Table 3.13). 
 
 
N
Cbz
O
Ru
O O
O
N
Cbz
O
Ru
O O
O
N OH
OH
Cbz
H2O N
Cbz
O
OH
RuO
O
OH
hydrolysis
3.933.92 3.94 3.91
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Entry Additive  (mol%) EtOAc/MeCN/H2O 
Time 
(min) 
Yielda  
(%) 
drb 
(cis:trans) 
1 CeCl3•7H2O (25) 8:8:1 90 49 1.4:1 
2 CeCl3•7H2O (25) 10:10:1 120 43 1.4:1 
3 CeCl3•7H2O (10) 10:10:1 165 52 1.5:1 
4 LaCl3•7H2O (25) 10:10:1 180 56 1.5:1 
5 LaCl3•7H2O (25) 8:8:1 135 50 1.3:1 
6c LaCl3•7H2O (25) 10:10:1 210 50 1.5:1 
     aIsolated yields after column chromatography. bDetermined by integrations of 1H-NMR of the 
      unpurified products. c1.25 equiv NaIO4 was used.  
 
Table 3.13 Further optimization of the olefin dihydroxylation step 
 
A concern we had was that the hydroxyl group at C-2 position in the product is 
acid-labile. A high Lewis acidic environment can cause decomposition of diol 3.91. On 
the other hand, NaIO3, the main reduced product of NaIO4, is a weak Lewis base (pKa of 
HIO3 is 0.75) and may buffer the acidity introduced by addition of CeCl3•7H2O. 
Furthermore, as the reaction time was prolonged the oxidative cleavage of diol 3.91 by 
NaIO4 might become more appreciable. Hence, a carefully balanced condition is 
important to the dihydroxylation step. 
 At 25 mol% loading of CeCl3•7H2O further reduction of H2O content in the 
reaction solvent decreased the yield (entry 1 and 2, Table 3.13). Lowering CeCl3•7H2O to 
10 mol% while maintaining the solvent composition enhanced the yield (entry 2 and 3). 
We think this variation reflected the acidity of the reaction environment where the 
stability of diol 3.91 also should be taken into account. Considering CeCl3•7H2O or 
N
Cbz 1) GII (5 mol%)
2) N2/H2 (95:5), rt, 5 min,
N
Cbz
3) NaIO4 (1.5 equiv)
OH
OH
Additive (x mol%)
EtOAc/MeCN/H2O, 0°C
3.79 3.91
then 100 °C, 4 h
EtOAc (0.1 M), rt
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YbCl3•6H2O is effective in promoting RuO4-catalyzed olefin dihydroxylation, it is 
reasonable to select a less Lewis acidic lanthanide trichloride as the additive to relieve the 
potential stability issue with diol 3.91. Imamoto and coworkers already demonstrated that 
La3+ is less Lewis acidic than Ce3+ under their evaluating conditions.37 When 25 mol% 
LaCl3•7H2O was used to replace CeCl3•7H2O, a higher yield was achieved (entry 4). 1.25 
equiv of NaIO4 was also tried in the reaction, but the yield was slightly diminished (entry 
6). When 1.0 equiv NaIO4 was used the dihydroxylation could not proceed to completion 
even after 9 h at 0 °C. Thus, the condition of entry 6 in Table 3.13 was found to be the 
optimal condition for the last step. 
With all the optimal conditions for the designed tandem sequence established, we 
evaluated other diene substrates in our method. 
 
 
 
 
 
 
 
 
                                                
37 Tsuruta, H.; Yamaguchi, K.; Imamoto, T. Tetrahedron 2003, 59, 10419-10438. 
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Entry Substrate GII  (mol%) Product 
Yielda 
(%) dr
b 
1 
 
5 
 
16 2:1 
2 
 
5 
 
36 1.5:1 
3 
 
5 
 
40 2:1 (cis:trans) 
4 
 
5 
 
61 1.5:1 (cis:trans) 
5 
 
10 
 
74 6.1:1 
6 
 
10 
 
29 1.7:1 
               aIsolated yields. bDetermined by integrations of 1H-NMR of the purified products.  
 
Table 3.14 Substrate scope of tandem RCM/olefin isomerization/olefin dihydroxylation 
 
N
PG 1) GII (x mol%)
2) N2/H2 (95:5), rt, 5 min,
N
PG
3) LaCl3•7H2O (25 mol%)
OH
OH
n
(n= 0, 1, 2)
n
 EtOAc (0.1 M)
EtOAc/MeCN/H2O
NaIO4 (1.5 equiv)
then 100-120 °C
(10:10:1), 0 °C
N
Cbz
3.85
N
Cbz
OH
OH
3.95
N
Ts
3.89
N
Ts
OH
OH
3.96
N
Boc
3.81 N
Boc
OH
OH
3.97
N
Cbz
3.79 N
Cbz
OH
OH
3.91
N
Ts
3.77 N
Ts
OH
OH
3.98
N
Cbz
3.83 N
Cbz
3.99
OH
OH
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 The yields of obtained 1,2-diol products, which contain different protecting 
groups and ring sizes, manifested the influence of electronic effect and ring strain on the 
Ru-catalyzed olefin dihydroxylation. Substrates bearing a more electron-withdrawing 
protecting group produced higher yields. Compared with Boc and Cbz group, tosyl group 
is more electron-withdrawing and the protected nitrogen atom donates less electron 
density to the alkenyl moiety in the corresponding ene-sulfonamides. Previously reported 
studies concluded that electron-deficient olefins are more suitable in RuO4-catalyzed 
dihydroxylations. The results we obtained confirmed this conclusion. For instance, the 
yields of six-membered ring products increased from diol 3.97, 3.91 to 3.98 (entry 3, 4 
and 5), which matches the distinctive electron-withdrawing capabilities of Boc, Cbz and 
Ts groups. Notably, the isolated yields of ene-carbamate 3.80 (90%, entry 5, Table 3.8) 
and ene-sulfonamide 3.78 (89%, entry 2, Table 3.9) are very close to each other, hence 
the overall yields of the tandem reactions reflect their reactivity difference in the 
dihydroxylation step. This trend was also observed by comparing the yield of diol 3.96 
and 3.95 (entry 1 and 2). 
 Additionally, the significant difference of the yields obtained from different ring 
systems drove us to think that ring strain may pose impact on their reactivities. From the 
1H-NMR of the unpurified products we did observe aldehyde signals, which presumably 
come from the oxidative cleavage products of either cyclic enamine intermediates or the 
1,2-diols. Based on the integrations of 1H-NMR of the crude products, the ratio of diol 
3.98 to the corresponding aldehyde byproduct is 27.5:1, but for diol 3.96 this ratio is 
about 1:1. A possible explanation is that five and seven-membered heterocyclic rings 
contain higher ring strain, compared with that of six-membered rings, hence the ruthenate 
 218 
intermediates in the dihydroxylation step tend to undergo an electrocyclic ring opening to 
generate aldehydes to release the ring strain.7a  
It should be noted that purification of the final products, especially, for diol 3.95 
and 3.96, is quite challenging, due to generation of multiple products (from the crude 
product of 3.95 or 3.96, we observed over ten spots on the TLC plate), and we could not 
identify the isolated byproducts. Furthermore, in case that the complexity of TLC 
analysis of the crude products arose from different diastereomers and cabamate rotamers, 
we used two-dimensional TLC technique to examine the column-purified diol 3.95, 3.97, 
3.91 and 3.99, but we did not find any visible off-diagonal spots on the TLC plate.  
 
3.5 Conclusion 
 We have developed a three-step tandem reaction sequence to prepare N-protected 
2,3-dihydroxypyrrolidines and 2,3-dihydroxypiperidines from nitrogen-tethered dienes. 
By optimizing the Ru-catalyzed olefin dihydroxylation step, we discovered the conditions 
that could be applied to the electronically challenging olefins. The future aim of this 
research is submitting additional substituted substrates to our method. 
 
3.6 Experimental Procedures and Characterizations 
General information 
Unless otherwise noted, reactions were conducted in oven-dried glassware 
(160 °C) under dry N2 atmosphere. Work-up and purification processes were carried out 
with reagent grade chemicals in air. Pressure tubes (#15 Ace-Thred) and PTFE plugs 
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equipped with PTFE® O-rings used for tandem reactions were purchased from Ace Glass 
Incoroported.  
Dichloromethane, tetrahydrofuran (THF), and acetonitrile (MeCN) used for 
reactions are analytical grade products purchased from Aldrich, and purified with a 
solvent dispensing system (Pure Process Technology) by passing the solvent through two 
activated neutral alumina columns after being purged with nitrogen. N,N-
dimethylformamide used for reactions was purchased from Aldrich (anhydrous form, 
sure sealed bottle) and used without further purification. Ethyl acetate used for reactions 
was purchased from Fisher Scientific International Inc. (ACS grade), distilled over 
anhydrous CaSO4 and stored over activated 3Å molecular sieves. Deuterated solvents for 
NMR studies were purchased from Cambridge Isotope Laboratories, Inc. The mixture of 
N2/H2 (N2:H2 = 95:5) was purchased from Airgas.   
Flash column chromatography was conducted on silica gel (SiliaFlash® F60, 230-
400 mesh) purchased from Silicycle. High performance flash chromatography (HPFC) 
for preparative purpose was carried out with pre-packed silica gel columns (Biotage Si) 
on a Biotage Horizon HPFC system. Thin-layer chromatography (TLC) was conducted 
on 250 µm glass-backed silica gel plates. TLC spots were visualized by using ultraviolet 
light (254 nm), iodine chamber, or phosphomolybdic acid (PMA). 
Fourier transform infrared (FTIR) spectra were measured with a Bruker alpha-P 
spectrophotometer, and transmission peaks are reported in wavenumber (cm-1). 1H NMR 
spectra were measured with a Varian INOVA-500 (500 MHz) or INOVA-600 (600 MHz) 
spectrometer. Chemical shifts are in ppm with the residual solvent resonance as the 
internal standard (CDCl3: δ 7.26 ppm; acetone-d6: δ 2.05 ppm). Peak data are reported as 
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follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = 
pentet, br = broad, m = multiplet, app = approximate), coupling constants (J, Hz) and 
integration. 13C NMR spectra were measured on a Varian INOVA-500 (126 MHz) or 
INOVA-600 (151 MHz) spectrometer with complete proton decoupling. Chemical shifts 
are reported in ppm with the residual solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm; acetone-d6: δ 206.68 ppm and 29.92 ppm). High-resolution mass 
spectrometry was performed on a JEOL AccuTOF-DART (positive mode) at the Mass 
Spectrometry Facility, Boston College.  
  
Allylamine was purchased from Acros and used as received. 
3-Butenylamine Hydrochloride was purchased from Aldrich and used as received. 
Di-tert-butyl Dicarbonate was purchased from Advanced ChemTech and used as 
received. 
Benzyl Chloroformate was purchased from Acros and used as received. 
p-Toluenesulfonyl Chloride was purchased from Aldrich and used as received. 
Triethylamine was purchased from Aldrich and distilled under N2 before use. 
Allylbromide was purchased from Aldrich and distilled under N2 before use. 
5-Bromo-1-pentene was purchased from TCI and used as received. 
Sodium Hydride (NaH, 95%, dry) was purchased from Aldrich and stored in a N2-filled 
glovbox. 
Sodium Periodate (NaIO4) was purchased from Aldrich and used as received. 
Cerium(III) Chloride Heptahydrate (CeCl3•7H2O) was purchased from Aldrich and 
stored in a desiccator filled with anhydrous calcium sulfate. 
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Lanthanum(III) Chloride Heptahydrate (LaCl3•7H2O) was purchased from Alfa 
Aesar and stored in a desiccator filled with anhydrous calcium sulfate. 
[1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)- 
-(tricyclohexylphosphine)ruthenium (Grubbs’ second generation catalyst, GII) was 
donated by Materia and purified on a short silica gel column (hexane: diethyl ether = 2:1) 
before use. 
 
Preparation of substrates 
 tert-Butyl N-allylcarbamate 3.100 
 To a 50 mL round bottom flask containing a stir bar were added allylamine 
(0.571 g, 748 µL, 10.0 mmol) and CH2Cl2 (20 mL). The flask was cooled with an ice 
bath followed by addition of di-tert-butyl dicarbonate (2.62 g, 12 mmol, 1.2 equiv) in one 
portion. After 10 min the ice bath was removed. The reaction mixture was allowed to stir 
vigorously at 22 ºC for 4 h before H2O (20 mL) was added. The resulting biphasic 
mixture was transferred to a separatory funnel. The organic layer was isolated, and the 
aqueous layer was extracted with CH2Cl2 (2×10 mL). The combined organic layers were 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The obtained pale 
yellow oil residue was purified by silica gel column chromatography (hexanes: ethyl 
acetate = 20:1) to afford the title compound as a colorless microcrystalline solid (1.243 g, 
79%). 
1H-NMR (600 MHz, CDCl3) δ 5.84 (ddt, J = 17.1, 10.8, 5.4 Hz, 1H), 5.18 (dq, J = 17.1, 
1.8 Hz, 1H), 5.11 (dq, J = 10.2, 1.2 Hz, 1H), 4.60 (br s, 1H), 3.75 (br s, 2H), 1.45 (s, 9H). 
13C-NMR (151 MHz, CDCl3) δ 155.73, 134.89, 115.63, 79.29, 43.04, 28.36. 
NH
Boc
3.100
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FTIR (neat): 3338, 2979, 1676, 1523, 1363, 1269, 1250, 1159, 1134, 1019, 951, 926, 862, 
665, 641 cm-1. 
HSMS (DART+) calcd for C8H16NO2 ([M+H]+): 158.1181, found: 158.1189. 
    
Benzyl N-allylcarbamate 3.101 
Under N2 atmosphere allylamine (0.571 g, 748 µL, 10.0 mmol), 
triethylamine (1.67 mL, 12.0 mmol, 1.2 equiv) and CH2Cl2 (20 mL) were added to a 2-
neck round bottom flask containing a stir bar via syringe. The flask was cooled to 0 ºC 
with an ice bath. Benzyl chloroformate (2.05 g, 1.71 mL, 12.0 mmol, 1.2 equiv) was then 
added dropwise via syringe. Upon complete addition (ca. 3 min) the ice bath was 
removed. The milky white cloudy solution was stirred vigorously at 22 ºC for 6 h before 
H2O (15 mL) was added. The resulting biphasic mixture was transferred to a separatory 
funnel. The organic layer was isolated, and the aqueous phase was extracted with CH2Cl2 
(2×15 mL). The combined organic layers were washed with brine (25 mL), dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo. The obtained yellow oil residue 
was purified by silica gel column chromatography (hexanes: ethyl acetate = 8:1) to afford 
the title compound as colorless oil (1.82 g, 95%).  
1H-NMR (600 MHz, CDCl3) δ 7.38 – 7.29 (m, 5H), 5.85 (ddt, J = 16.8, 10.2, 5.4 Hz, 1H), 
5.19 (dq, J = 17.4, 1.2 Hz, 1H), 5.15 – 5.10 (overlapped peaks, m, 3H), 4.86 (br s, 1H), 
3.90 – 3.73 (br t, J = 4.8 Hz, 2H) 
13C-NMR (151 MHz, CDCl3) δ 156.23, 136.51, 134.43, 128.51, 128.12, 116.06, 66.76, 
43.49. 
NH
Cbz
3.101
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FTIR (neat): 3330, 3065, 3033, 2949, 1695, 1645, 1516, 1453, 1420, 1340, 1239, 1132, 
1062, 1026, 987, 916, 775, 735, 695 cm-1. 
HSMS (DART+) calcd for C11H14NO2 ([M+H]+): 192.1025, found: 192.1026.  
 
N-allyl-4-methylbenzenesulfonamide 3.102 
Allyl amine (0.571 g, 748 µL, 10.0 mmol), triethylamine (1.67 mL, 12 
mmol, 1.2 equiv) and CH2Cl2 (30 mL) were added in a 50 mL round bottom flask 
containing a stir bar. The vessel was cooled to 0 ºC with an ice bath followed by addition 
of 4-methylbenzenesufonyl chloride (2.29 g, 12 mmol, 1.2 equiv) in one portion. The 
reaction mixture was stirred at 0 ºC for 10 min then at 22 ºC for 5 h before H2O (30 mL) 
was added. The resulting biphasic mixture was transferred to a separatory funnel. The 
organic layer was isolated, and the aqueous layer was extracted with CH2Cl2 (2×10 mL). 
The combined organic layers were washed with brine (40 mL), dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. The obtained pale yellow oil residue was 
purified by silica gel column chromatography (hexanes: ethyl acetate = 4:1) to afford the 
title compound as a white solid (2.10 g, 99%).  
1H-NMR (600 MHz, CDCl3) δ 7.75 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2 H), 5.72 
(ddt, J = 17.4, 10.2, 5.4, 1 H), 5.16 (dq, J = 17.4 Hz, 1.2 Hz, 1H), 5.09 (dq, J = 10.2, 1.2 
Hz, 1H), 4.48 (br t, J = 4.8 Hz, 1H), 3.58 (tt, J = 6.0, 1.2 Hz, 2H), 2.43 (s, 3H). 
13C-NMR (151 MHz, CDCl3) δ 143.49, 136.89, 132.96, 129.76, 127.13, 117.67, 45.75, 
21.58. 
FTIR (neat): 3245, 2926, 2858, 1594, 1421, 1316, 1287, 1155, 1092, 1061, 934, 873, 
809, 663, 568, 546, 483 cm-1. 
NH
Ts
3.102
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HSMS (DART+) calcd for C10H14NO2S ([M+H]+): 212.0745, found: 212.0742. 
 
tert-Butyl N-3-butenylcarbamate 3.103 
To a 50 mL round bottom flask containing a stir bar were added 3-
butenylamine hydrochloride (0.538 g, 5.0 mmol), CH2Cl2 (20 mL) and triethylamine 
(0.84 mL, 6.0 mmol, 1.2 equiv) in sequence. After a clear solution was obtained di-tert-
butyl dicarbonate (1.31 g, 6 mmol, 1.2 equiv) was added in one portion. The reaction 
mixture was stirred at 22 ºC for 4.5 h before saturated NaHCO3 aqueous solution (20 mL) 
was added. The resulting biphasic mixture was transferred to a separatory funnel. The 
organic layer was isolated, and the aqueous layer was extracted with CH2Cl2 (20 mL). 
The combined organic layers were washed with brine (20 mL), dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. The obtained yellow oil residue was purified 
by silica gel column chromatography (hexanes: ethyl acetate = 20:1) to afford the title 
compound as colorless oil (0.811 g, 95%). 
1H-NMR (600 MHz, CDCl3) δ 5.75 (ddt, J = 17.4, 10.2, 7.2 Hz, 1H), 5.11 – 5.05 (m, 2 
H), 4.55 (s, 1H), 3.19 (br q, J = 6.6 Hz, 2H), 2.23 (q, J = 6.6 Hz, 2H), 1.43 (s, 9H). 
13C-NMR (151 MHz, CDCl3) δ 155.86, 135.32, 117.01, 79.09, 39.61, 34.18, 28.39. 
FTIR (neat): 3347, 2977, 2931, 1688, 1641, 1512, 1452, 1391, 1365, 1274, 1248, 1166, 
1039, 1015,913, 865, 780, 632 cm-1. 
HSMS (DART+) calcd for C9H18NO2 ([M+H]+): 172.1338, found: 172.1341. 
  
 
 
N
H
Boc
3.103
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Benzyl N-3-butenylcarbamate 3.104 
To a 50 mL 2-neck round bottom flask containing a stir bar was 
added 3-butenylamine hydrochloride (0.538 g, 5.0 mmol). The flask 
was then sealed with a rubber septum and placed under N2 atmosphere. CH2Cl2 (20 mL) 
and triethylamine (1.74 mL, 12.5 mmol, 2.5 equiv) were added in sequence via syringe. 
After a clear solution was obtained the vessel was cooled to 0 ºC with an ice bath. Benzyl 
chloroformate (0.86 mL, 6.0 mmol, 1.2 equiv) was added dropwise via syringe. Upon 
complete addition (ca. 3 min), the resulting milky white cloudy solution was stirred at 0 
ºC for 15 min then at 22 ºC for 5 h before H2O (15 mL) was added. The resulting 
biphasic mixture was transferred to a separatory funnel. The orgnaic layer was isolated, 
and the aqueous layer was extracted with CH2Cl2 (2×15 mL). The combined organic 
layers were washed with brine (25 mL), dried over Na2SO4, filtered and concentrated in 
vacuo. The obtained yellow oil residue was purified by silica gel column chromatography 
(hexanes: ethyl acetate = 10:1) to afford the title compound as colorless oil (0.921 g, 
90%). 
1H-NMR (600 MHz, CDCl3) δ 7.38 – 7.28 (m, 5H), 5.75 (ddt, J = 17.4, 10.2, 7.2 Hz, 1H), 
5.13 – 5.05 (m, 4H), 4.79 (br s, 1H), 3.28 (q, J = 6.6 Hz, 2H), 2.26 (q, J = 6.6 Hz, 2H) 
13C-NMR (151 MHz, CDCl3) δ 156.28, 136.58, 135.04, 128.49, 128.10, 128.08, 117.32, 
66.62, 40.06, 34.10. 
FTIR (neat): 3331, 3066, 2938, 1694, 1520, 1453, 1245, 1216, 1131, 1023, 914, 735, 695, 
640. 603 cm-1. 
HSMS (DART+) calcd for C12H16NO2 ([M+H]+): 206.1181, found: 206.1192. 
 
N
H
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3.104
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N-3-butenyl-4-methylbenzenesulfonamide 3.105 
To a 50 mL round bottom flask containing a stir bar were added 3-
butenylamine hydrochloride (0.538 g, 5.0 mmol), triethylamine (1.74 mL, 12.5 mmol, 2.5 
equiv) and CH2Cl2 (20 mL). After a clear solution was obtained the vessel was cooled to 
0 ºC with an ice bath followed by addition of 4-methylbenzenesulfonyl chloride (1.14 g, 
6.0 mmol, 1.2 equiv) in one portion. The reaction mixture was stirred vigorously at 0 ºC 
for 20 min then at 22 ºC for 6 h before H2O (20 mL) was added. The resulting biphasic 
mixture was transferred to a separatory funnel. The organic layer was isolated, and the 
aqueous layer was extracted with CH2Cl2 (2×15 mL). The combined organic layers were 
washed with brine (25 mL), dried over anhydrous Na2SO4, filtered and concentrated in 
vacuo. The obtained pale yellow oil residue was purified by silica gel column 
chromatography (hexanes: ethyl acetate = 4:1) to afford the title compound as colorless 
oil (1.103 g, 98%). 
1H-NMR (600 MHz, CDCl3) δ 7.74 (d, J = 8.4 Hz, 2 H), 7.30 (d, J = 8.4 Hz, 2 H), 5.62 
(ddt, J = 16.8, 10.2, 7.2 Hz, 1H), 5.06 (partially overlapped dq, J = 10.2, 1.2 Hz 2H), 5.03 
(partially overlapped, dq, J = 17.4 Hz, 1.8 Hz), 4.59 (br s, 1 H)), 3.01 (q, J = 6.6 Hz, 2H), 
2.42 (s, 3H), 2.19 (tq, J = 6.6, 1.2 Hz, 2H). 
13C-NMR (151 MHz, CDCl3) δ 143.54, 137.08, 134.29, 129.83, 127.24, 118.23, 42.21, 
33.73, 21.64. 
FTIR (neat): 3275, 2927, 1641, 1597, 1424, 1320, 1154, 1091, 1073, 915, 813, 660, 566, 
548 cm-1. 
HSMS (DART+) calcd for C11H16NO2S ([M+H]+): 226.0902, found: 226.0913. 
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The representative procedure of alkylation of monosubstituted amines 
 
 
tert-Butyl N,N-diallylcarbamate 3.87 
In a N2-filled glovebox NaH (0.288 g, 12.0 mmol, 3.0 equiv) was added in 
a 25 mL round bottom flask containing a stir bar. The flask was sealed with 
a rubber septum before removed from the glovebox, and placed under N2 atmosphere. 
DMF (3.0 mL) was added in the flask via syringe, and then the vessel was cooled to 0 ºC 
with an ice bath. In a separate 5 mL pear-shaped flask tert-Butyl N-allylcarbamate 3.100 
(0.628 g, 4.0 mmol) was dissolved in DMF (1.0 mL, plus 2×0.5 mL for rinse), and the 
obtained solution was added in the cooled flask dropwise via syringe. Upon complete 
addition (ca. 3 min) the ice bath was removed. The milky white cloudy solution was 
stirred vigorously at 22 ºC for 20 min. The flask was cooled to 0 ºC with an ice bath 
before allyl bromide (1.04 mL, 12.0 mmol, 3.0 equiv) was added in one portion via 
syringe. The ice bath was removed, and the reaction mixture was allowed to stir 
vigorously at 22 ºC for 3 h until TLC analysis indicated complete consumption of the 
monosubstituted amine. Saturated NH4Cl aqueous solution (5.0 mL) was added to quench 
the reaction. The resulting mixture was diluted with H2O (30 mL) and CH2Cl2 (15 mL), 
and transferred to a separatory funnel. The organic phase was isolated, and the aqueous 
phase was extracted with CH2Cl2 (15 mL). The combined organic layers were washed 
with H2O (2×15 mL) and brine (30 mL), dried over anhydrous Na2SO4, filtered and 
NH
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concentrated in vacuo. The obtained yellow oil residue was purified by silica gel column 
chromatography (hexanes: ethyl acetate = 30:1) to afford the title compound as colorless 
oil (0.532 g, 67% yield).  
1H-NMR (600 MHz, CDCl3) of two cabamate rotamers (peaks become broad, due to 
slow rotation of N-C(sp2) bond): δ 5.81 – 5.69 (m, 2H), 5.168 – 5.04 (m, 4H), 3.95 – 3.63 
(overlapped broad peaks, m, 4H), 1.44 (s, 9H). 
13C-NMR (151 MHz, CDCl3) of two cabamate rotamers: δ 155.38, 133.98, 116.54, 
116.12, 79.55, 48.69, 28.36. 
FTIR (neat): 2977, 2929, 1691, 1643, 1454, 1402, 1365, 1291, 1245, 1171, 1149, 993, 
917, 870, 770 cm-1.  
HSMS (DART+) calcd for C11H20NO2 ([M+H]+): 198.1494, found: 198.1499. 
 
 Benzyl N,N-diallylcarbamate 3.85 
Following the representative alkylation procedure, Benzyl N-allylcarbamate 
3.101  (0.764 g, 4.0 mmol), NaH (0.228 g, 12.0 mmol, 3.0 equiv) and allyl- 
bromide (1.04 mL, 12.0 mmol, 3.0 equiv) were used in the reaction. The crude product 
was purified by silica gel column chromatography (hexanes: ethyl acetate = 25:1) to 
afford the title compound as slightly yellow oil (0.818 g, 88%). 
1H-NMR (600 MHz, CDCl3) of two carbamate rotamers (peaks become broad, due to 
slow rotation of N-C(sp2) bond): δ 7.38 – 7.27 (m, 5H), 5.77 (br s, 2H), 5.26 – 5.05 
(overlapped peaks, m, 6H), 3.97 – 3.81 (overlapped broad peaks, m, 4H). 
13C-NMR (151 MHz, CDCl3) two carbamate rotamers: δ 155.99, 136.79, 133.48, 128.41, 
127.88, 127.74, 117.15, 116.68, 67.14, 49.12, 48.49. 
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FTIR (neat): 3067, 3033, 2981, 1696, 1497, 1455, 1235, 1150, 1091, 1054, 991, 920, 
767, 734, 696 cm-1.     
HSMS (DART+) calcd for C14H18NO2 ([M+H]+): 232.1338, found: 232.1344. 
 
 N,N-diallyl-4-methylbenzenesulfonamide 3.89 
Following the representative alkylation procedure, N-allyl-4-
methylbenzenesulfonamide 3.102 (0.844 g, 4.0 mmol), NaH (0.228 g, 12.0 
mmol, 3.0 equiv) and allyl bromide (1.04 mL, 12.0 mmol, 3.0 equiv) were used in the 
reaction. The crude product was purified by silica gel column chromatography (hexanes: 
ethyl acetate = 13:1) to afford the title compound as slightly yellow oil (0.977 g, 97%). 
1H-NMR (600 MHz, CDCl3) δ 7.69 (d, J = 7.8 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 5.60 
(ddt, J = 16.8, 10.2, 6.6 Hz, 2H), 5.16 – 5.13 (m, 2H), 5.13 – 5.10 (m, 2H), 3.79 (d, J = 
6.0 Hz, 4H), 2.42 (s, 3H). 
13C-NMR (151 MHz, CDCl3) δ 143.19, 137.41, 132.65, 129.65, 127.15, 118.92, 49.31, 
21.49. 
FTIR (neat): 3079, 2982, 2922, 1643, 1597, 1341, 1304, 1153, 1090, 1041, 1017, 991, 
925, 903, 887, 814, 801, 761, 706, 659, 592, 545 cm-1. 
HSMS (DART+) calcd for C13H18NO2S ([M+H]+): 252.1058, found: 252.1067. 
  
 tert-Butyl N-3-butenyl-N-2-propenylcarbamate 3.81 
Following the representative alkylation procedure, tert-butyl N-3-
butenylcarbamate 3.103 (0.361 g, 2.11 mmol), NaH (0.152 g, 6.33 mmol, 3.0 
N
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equiv), allyl bromide (0.55 mL, 6.33 mmol, 3.0 equiv) and DMF (1.0 mL for NaH, 2.0 
mL for monoalkylamine) were used in the reaction. The crude product was purified by 
silica gel column chromatography (hexanes: ethyl acetate = 30:1) to afford the title 
compound as colorless oil (0.319 g, 72%). 
1H-NMR (600 MHz, CDCl3), carbamate rotamers (peaks become broad, due to slow 
rotation of N-C(sp2) bond): δ 5.82 – 5.71 (m, 2H), 5.11 (br d, J = 10.2 Hz, 2H), 5.05 (d, J 
= 16.8 Hz, 1H), 5.01 (dd, J = 10.2, 0.6 Hz, 1H), 3.89 – 3.73 (overlapped broad peaks, m, 
2H), 3.28 (br d, J = 16.8 Hz, 2H), 2.26 (br d, J = 6.0 Hz, 2H), 1.45 (s, 9H). 
13C-NMR (151 MHz, CDCl3), carbamate rotamers: δ 155.40, 135.51, 134.31, 116.38, 
115.82, 79.37, 49.90, 49.41, 46.17, 33.09, 32.69, 28.38. 
FTIR (neat): 3078, 2976, 2928, 1691, 1642, 1460, 1406, 1364, 1245, 1227, 1150, 993, 
912, 876, 771 cm-1. 
HSMS (DART+) calcd for C12H22NO2 ([M+H]+): 212.1651, found: 212.1657. 
 
 Benzyl N-3-butenyl-N-2-propenylcarbamate 3.79 
Following the representative alkylation procedure, Benzyl N-3-
butenylcarbamate (0.477 g, 2.32 mmol), NaH (0.167 g, 6.96 mmol, 3.0 
equiv), allyl bromide (0.60 mL, 6.96 mmol, 3.0 equiv) and DMF (1.0 mL for 
NaH, 2.0 mL for monoalkyl amine) were used in the reaction. The crude product was 
purified by silica gel column chromatography (hexanes: ethyl acetate = 20:1) to afford 
the title compound as colorless oil (0.539 g, 95%). 
1H-NMR (600 MHz, CDCl3), carbamate rotamers (peaks become broad, due to slow 
rotation of N-C(sp2) bond): δ 7.44 – 7.27 (m, 5H), 5.75 (br s, 2H), 5.24 – 4.94 
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(overlapped, m, 6 H), 3.98 – 3.83 (overlapped broad peaks, m, 2H), 3.40 – 3.25 
(overlapped broad peaks, m, 2H), 2.41 – 2.19 (m, 2H). 
13C-NMR (151 MHz, CDCl3), carbamate rotamers: δ 156.05, 136.87, 135.29, 135.15, 
133.87, 133.78, 128.41, 127.87, 127.76, 127.73, 67.01, 50.00, 49.61, 46.65, 45.88, 33.02, 
32.51. 
FTIR (neat): 3076, 2979, 2943, 1695, 1641, 1497, 1465, 1365, 1235, 1218, 1152, 1089, 
992, 913, 767, 733, 696 cm-1. 
HSMS (DART+) calcd for C15H20NO2 ([M+H]+): 246.1494, found: 246.1502. 
 
 N-3-butenyl-4-methyl-N-2-propenylbenzenesulfonamide 3.77 
Following the representative alkylation procedure, N-3-butenyl-4-
methylbenzenesulfonamide (0.31 g, 1.38 mmol), NaH (0.099 g, 4.14 mmol, 
3.0 equiv), allyl bromide (0.36 mL, 4.14 mmol, 3.0 equiv) and DMF (1.0 mL 
for NaH, 2.0 mL for monoalkyl amine) were used in the reaction. The crude product was 
purified by silica gel column chromatography (hexanes: ethyl acetate = 15:1) to afford 
the desired product as pale yellow oil (0.352 g, 96%). 
1H-NMR (600 MHz, CDCl3) δ 7.68 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 5.68 
(ddt, J =17.1, 10.2, 6.6 Hz, 1H), 5.63 (ddt, J =17.1, 10.2, 6.6 Hz, 1H), 5.17 (dq, J = 17.1, 
1.2 Hz, 1H), 5.13 (q, J = 10.2, 1.2 Hz, 1H), 5.04 – 4.98 (m, 2H), 5.01 (q, J = 1.8 Hz, 1H), 
3.80 (dt, J = 6.0, 1.2 Hz, 2H), 3.20 – 3.14 (m, 2H), 2.41 (s, 3H), 2.29 – 2.23 (m, 2H). 
13C-NMR (151 MHz, CDCl3) δ 143.16, 137.12, 134.69, 133.18, 129.64, 127.11, 118.73, 
116.92, 50.67, 46.67, 32.84, 21.47. 
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FTIR (neat): 3078, 2979, 2922, 2863, 1641, 1597, 1451, 1339, 1304, 1286, 1153, 1089, 
992, 913, 814, 746, 659 cm-1. 
HSMS (DART+) calcd for C14H20NO2S ([M+H]+): 266.1215, found: 266.1226. 
 
Benzyl N-4-pentenyl-N-2-propenylcarbamate 3.83 
 
Following the representative alkylation procedure, benzyl N-allycarbamate (0.382 
g, 2.0 mmol), NaH (0.144 g, 6.0 mmol, 3.0 equiv), 5-bromo-1-pentene (0.47 mL, 4.0 
mmol, 2.0 equiv) and DMF (2.0 mL for NaH, 3.0 mL for monoalkyl amine) were used in 
the reaction. The crude product was purified by silica gel column chromatography 
(hexanes: ethyl acetate = 25:1) to afford the title compound as pale yellow oil (0.472 g, 
91%).  
1H-NMR (600 MHz, CDCl3), carbamate rotamers (peaks become broad, due to slow 
rotation of N-C(sp2) bond): δ 7.42 – 7.27 (m, 5H), 5.78 (br s, 2H), 5.14 (overlapped 
peaks, s, 4H), 5.07 – 4.91 (m, 2H), 3.96 – 3.81 (overlapped broad peaks, m, 2H), 3.26 (br 
dd, J = 13.5, 6.0 Hz, 2H), 2.04 (broad peaks, m, 2H), 1.70 – 1.57 (m, 2H). 
13C-NMR (151 MHz, CDCl3), carbamate rotamers: δ 156.12, 156.02, 137.90, 137.78, 
136.89, 133.92, 133.82, 128.41, 127.85, 127.74, 116.87, 116.40, 114.90, 66.99, 49.90, 
49.49, 46.75, 45.90, 30.90, 27.54, 27.13. 
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FTIR (neat): 3067, 2932, 1696, 1641, 1467, 1455, 1413, 1365, 1233, 1212, 1152, 1092, 
991, 911, 767,734, 696 cm-1. 
HSMS (DART+) calcd for C16H22NO2 ([M+H]+): 260.1651, found: 260.1653. 
 
The representative procedure of tandem RCM/olefin isomerization reactions  
 
3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester 3.80 
 
Benzyl N-3-butenyl-N-2-propenylcarbamate 3.79 (0.0245 g, 0.1 mmol) was 
dissolved in ethyl acetate (1.0 mL) in a pressure tube (approximate capacity, 15 mL) 
containing a stir bar. After GII (0.0042 g, 0.005 mmol, 0.05 equiv) was added in one 
portion, the tube was sealed with a rubber septum and placed under N2 atmosphere. The 
reaction mixture was stirred at 22 ºC for 1.5 h until TLC analysis indicated complete 
consumption of the starting material. A gas mixture of N2/H2 (N2:H2 = 95:5, balloon) was 
then bubbled vigorously into the solution via a cannula at 22 ºC for 5 min. Upon finishing 
the rubber septum was replaced with a PTFE plug, and the sealed tube was placed in a 
100 ºC oil bath. The reaction mixture was stirred at 100 ºC for 4 h before it was allowed 
to cool down to 22 ºC naturally. The reaction mixture was transferred to a round bottom 
flask (3×2 mL CH2Cl2 was used to rinse the pressure tube), and concentrated in vacuo. 
The obtained dark brown oil residue was purified by silica gel column chromatography 
N
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(hexanes: ethyl acetate = 20:1) to afford the title compound 3.80 as colorless oil (0.0195 
g, 90%).  
1H-NMR (600 MHz, CDCl3), two carbamate rotamers in 1:1.5 ratio: δ 7.38 – 7.31 (m, 
5H), 6.89 (d, J = 8.4 Hz, 0.4H), 6.80 (d, J = 8.4 Hz, 0.6H), 5.18 (s, 2H), 4.97 (dt, J = 8.4, 
3.6 Hz, 0.4H), 4.86 (dt, J = 8.4, 4.2 Hz 0.6H), 3.65 – 3.61 (m, 2H), 2.07 – 2.01 (m, 2H), 
1.87 – 1.78 (m, 2H). 
13C-NMR (151 MHz, CDCl3), two carbamate rotamers: δ 153.53, 153.11, 136.38, 128.50, 
128.10, 127.99, 125.34, 124.88, 106.73, 106.39, 67.41, 67.31, 42.39, 42.19, 21.62, 21.43, 
21.24. 
FTIR (neat): 2937, 2883, 1699, 1650, 1446, 1407, 1343, 1298, 1226, 1181, 1103, 1051, 
967, 948, 8190, 761, 741, 716, 696, 447 cm-1. 
HSMS (DART+) calcd for C13H16NO2 ([M+H]+): 218.1181, found: 218.1186. 
 
 3,4-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 3.82 
Following the representative procedure, tert-butyl N-3-butenyl-N-2-
propenylcarbamate 3.81 (0.0211 g, 0.1 mmol) was used in the reaction. The 
crude product was purified by silica gel column chromatography (hexanes: ethyl acetate 
= 35:1) to afford the title compound as colorless oil (0.013 g, 71%). 
1H-NMR (600 MHz, CDCl3), two carbamate rotamers in 1:1.5 ratio: δ 6.83 (d, J = 7.2 
Hz, 0.4H), 6.70 (d, J = 7.8 Hz, 0.6H), 4.88 (br s, 0.4H), 4.81 – 4.73 (m, 0.6H), 3.58 – 
3.47 (m, 2H), 2.00 (qd, J = 6.0, 1.8 Hz, 2H), 1.79 (app d, J = 4.8 Hz, 2H), 1.47 (s, 9H). 
13C-NMR (151 MHz, CDCl3), two carbamate rotamers, δ 152.71, 152.29, 125.60, 125.25, 
105.56, 105.11, 80.39, 80.25, 42.54, 41.44, 28.31, 21.72, 21.47, 21.31. 
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FTIR (neat): 2975, 2930, 1697, 1650, 1475, 1452, 1404, 1354, 1300, 1251, 1163, 1111, 
1051, 992, 876, 742, 713, 442 cm-1. 
HSMS (DART+) calcd for C10H18NO2 ([M+H]+): 184.1338, found: 184.1333. 
 
 2,3-dihyro-1H-pyrrole-1-carboxylic acid benzyl ester 3.86 
The title compound was synthesized according to the representative procedure 
with slight modification. Benzyl N,N-diallylcarbamate 3.85 (0.0231 g, 0.1 mmol) 
was used in the reaction. After the sealed tube was placed in a 100 ºC oil bath, the 
reaction mixture was stirred at 100 ºC for 2 h. Then, it was allowed to cool down to 22 ºC 
naturally. The crude product was purified by silica gel column chromatography (hexanes: 
ethyl acetate = 12:1) to afford the title compound as colorless oil (0.017 g, 84%).  
1H-NMR (600 MHz, CDCl3), two cabamate rotamers in 1:1.2 ratio: δ 7.40 – 7.28 (m, 5H), 
6.63 (br s, 0.45H), 6.55 (br t, J = 1.8 Hz, 0.55H), 5.17 (s, 2H), 5.09 (br s, 0.45H), 5.04 (br 
t, J = 1.8 Hz, 0.55H), 3.79 (m, 2H), 2.71 – 2.60 (m, 2H). 
13C-NMR (151 MHz, CDCl3), two carbamate rotamers: δ 152.80, 152.10, 136.60, 136.55, 
129.73, 129.03, 128.75, 128.47, 128.05, 128.00, 127.91, 126.10, 108.76, 108.61, 67.02, 
66.85, 45.24, 45.05, 29.70, 28.63. 
FTIR (neat): 2954, 2892, 1696, 1451, 1404, 1335, 1284, 1210, 1175, 1086, 1043, 969, 
914, 849, 770, 736, 696, 603, 559, 458 cm-1. 
HSMS (DART+) calcd for C12H14NO2 ([M+H]+): 204.1025, found: 204.1026. 
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 2,3-dihyro-1H-pyrrole-1-carboxylic acid tert-butyl ester 3.88 
The title compound was synthesized according to the representative procedure 
with slight modification. tert-Butyl N,N-diallylcarbamate 3.87 (0.0197 g, 0.1 
mmol)  was used in the reaction. After the sealed tube was placed in a 100 ºC oil bath, the 
reaction mixture was stirred at 100 ºC for 2 h. Then, it was allowed to cool down to 22 ºC 
naturally. The crude product was purified by silica gel column chromatography (hexanes: 
ethyl acetate = 25:1) to afford the title compound as pale yellow oil (0.0114 g, 67%). 
Caution! The title compound is volatile under high vacuum. 
1H-NMR (600 MHz, CDCl3), two carbamate rotamers in 1:1.3 ratio: δ 6.58 (s, 0.43H), 
6.45 (s, 0.57H), 5.01 (partially overlapped s, 0.43H), 4.96 (partially overlapped s, 0.57H), 
3.77 – 3.62 (m, 2H), 2.69 – 2.56 (m, 2H), 1.47 (s, 9H). 
13C-NMR (151 MHz, CDCl3), two carbamate rotamers, δ 152.31, 151.61, 129.81, 107.48, 
79.99, 79.85, 45.26, 44.75, 29.69, 28.67, 28.40. 
FTIR (neat): 2974, 2929, 1695, 1617, 1477, 1389, 1364, 1350, 1284, 1165, 1130, 1088, 
1039, 999, 969, 879, 762, 702, 453 cm-1. 
HSMS (DART+) calcd for C9H16NO2 ([M+H]+): 170.1181, found: 170.1181. 
 
2,3-dihydro-1-[(4-methylphenyl)sulfonyl]-1H-pyrrole 3.90 
The title compound was synthesized according to the representative procedure 
with slight modification. N,N-Diallyl-4-methylbenzenesulfonamide 3.89 (0.0251 
g, 0.1 mmol) was used in the reaction. After the sealed tube was placed in a 100 ºC oil 
bath, the reaction mixture was stirred at 100 ºC for 2 h. Then, it was allowed to cool 
down to 22 ºC naturally. The crude product was purified by silica gel column 
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chromatography (hexanes: ethyl acetate = 8:1) to afford the title compound as a white 
solid (0.0193 g, 86%).  
1H-NMR (600 MHz, CDCl3) δ 7.66 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 6.36 (dt, 
J = 4.2, 2.4 Hz, 1H), 5.11 (dt, J = 4.2, 2.4 Hz, 1H), 3.47 (t, J = 9.0 Hz, 2H), 2.47 (tt, J = 
9.0, 2.4 Hz, 2H), 2.43 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ 143.75, 132.87, 130.69, 129.63, 127.71, 111.21, 47.18, 
29.59, 21.55. 
FTIR (neat): 3101, 2989, 2919, 2878, 1616, 1593, 1335, 1305, 1288, 1156, 1110, 1085, 
1062, 970, 811, 743, 708, 659, 588, 545, 504, 490, 456 cm-1. 
HSMS (DART+) calcd for C11H14NO2S ([M+H]+): 224.0745, found: 224.0741. 
 
1,2,3,4-tetrahydro-1-[(4-methylphenyl)sulfonyl]-pyridine 3.78 
 
N-3-Butenyl-4-methyl-N-2-propenylbenzenesulfonamide 3.77 (0.0133 g, 0.05 
mmol) was dissolved in ethyl acetate (0.5 mL) in a pressure tube (approximate capacity, 
15 mL) containing a stir bar. GII (0.0042 g, 0.005 mmol, 0.1 equiv) was then added in 
the tube in one portion. The tube was sealed with a rubber septum and and placed under 
N2 atmosphere. The reaction mixture was stirred at 22 ºC for 1.5 h until TLC analysis 
indicated complete consumption of the starting material. A gas mixture of N2 and H2 
(N2/H2 = 95:5, balloon) was bubbled vigorously into the solution via a cannula at 22 ºC 
N
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for 5 min. Upon finishing the rubber septum was replaced with a PTFE plug, and the 
sealed tube was placed in a 120 ºC oil bath. The reaction mixture was stirred at 120 ºC for 
4 h before it was allowed to cool down to 22 ºC naturally. The reaction mixture was 
transferred to a round bottom flask (3×2 mL CH2Cl2 was used to rinse the pressure tube), 
and concentrated in vacuo. The obtained dark brown oil residue was purified by silica gel 
column chromatography (hexanes: ethyl acetate = 10:1) to afford the title compound as a 
white solid (0.0106 g, 89%). 
1H-NMR (600 MHz, CDCl3) δ 7.66 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 6.63 (dt, 
J = 8.4, 2.4 Hz, 1H), 4.96 (dt, J = 8.4, 4.2 Hz, 1H), 3.37 – 3.34 (m, 2H), 2.42 (s, 3H), 
1.90 (tdd, J = 6.6, 3.6, 1.8 Hz, 2H), 1.67 – 1.62 (m, 2H). 
13C-NMR (151 MHz, CDCl3) δ 143.49, 135.11, 129.67, 127.04, 125.05, 108.26, 43.82, 
21.53, 20.92, 20.88. 
FTIR (neat): 2932, 2854, 1646, 1444, 1395, 1336, 1263, 1160, 1101, 1043, 968, 928, 812, 
708, 680, 637, 541 cm-1. 
HSMS (DART+) calcd for C12H16NO2S ([M+H]+): 238.0902, found: 238.0892. 
 
2,3,4,5-tetrahydro-1H-azepine-1-carboxylic acid benzyl ester 3.84 
 
Benzyl N-4-pentenyl-N-2-propenylcarbamate 3.83 (0.026 g, 0.1 mmol) was 
dissolved in ethyl acetate (1.0 mL) in a pressure tube (approximate capacity, 15 mL) 
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containing a stir bar. GII (0.0085 g, 0.01 mmol, 0.1 equiv) was then added in the tube in 
one portion. The tube was sealed with a rubber septum, protected under N2 atmosphere 
and then placed in a 35 ºC oil bath. The reaction mixture was stirred at 35 ºC for 1 h until 
TLC analysis indicated complete consumption of the starting material. The reaction 
mixture was allowed to cool down to 22 ºC. A mixture of N2 and H2 (N2/H2 = 95:5, 
balloon) was bubbled vigorously into the solution via a cannula at 22 ºC for 5 min. Upon 
finishing the rubber septum was replaced with a PTFE plug, and the sealed tube was 
placed in a 100 ºC oil bath. The reaction mixture was stirred at 100 ºC for 4 h before it 
was allowed to cool down to 22 ºC naturally. The reaction mixture was transferred to a 
round bottom flask (3×2 mL CH2Cl2 was used to rinse the pressure tube), and 
concentrated in vacuo. The obtained dark brown oil residue was purified by silica gel 
column chromatography (hexanes: ethyl acetate = 25:1) to afford the title compound as 
colorless oil (0.0157 g, 68%). 
1H-NMR (600 MHz, CDCl3), two carbamate rotamers in 1:1.8 ratio: δ 7.39 – 7.29 (m, 
5H), 6.60 (br d, J = 6.6 Hz 0.36H), 6.52 (d, J = 8.4 Hz, 0.64H), 5.18 (s, 2H), 5.08 
(partially overlapped br s, 0.36H), 5.04 (partially overlapped br s, 0.64H), 3.75 – 3.68 (m, 
2H), 2.19 (dd, J = 10.2, 5.4 Hz, 2H), 1.87 – 1.64 (m, 4H). 
13C-NMR (151 MHz, CDCl3), two carbamate rotamers: δ 154.37, 136.53, 130.63, 129.86, 
128.48, 128.01, 127.86, 115.87, 115.71, 67.41, 67.29, 47.68, 28.06, 26.29, 25.97, 25.09. 
FTIR (neat): 3033, 2936, 2861, 1699, 1649, 1452, 1407, 1340, 1272, 1251, 1208, 1166, 
1109, 1014, 856, 764, 723, 695 cm-1. 
HSMS (DART+) calcd for C14H18NO2 ([M+H]+): 232.1338, found: 232.1327. 
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The representative procedure of tandem RCM/olefin isomerization/olefin 
dihydroxylation reaction 
 
2,3-Dihydroxy-1-piperidinecarboxylic acid phenymethyl ester 3.91 
 
 
 
Tandem RCM/olefin isomerization step 
Benzyl N-3-butenyl-N-2-propenylcarbamate 3.79 (0.098 g, 0.4 mmol) was 
dissolved in ethyl acetate (4.0 mL) in a pressure tube (approximate capacity, 15 mL) 
containing a stir bar. GII (0.017 g, 0.02 mmol, 5 mol%) was then added in the tube in 
one portion. The tube was sealed with a rubber septum and placed under N2 atmosphere. 
The reaction mixture was stirred at 22 ºC for 1.5 h until TLC analysis indicated the 
complete consumption of the starting material. A gas mixture of N2/H2 (N2/H2 = 95:5, 
balloon) was bubbled vigorously into the solution via a cannula at 22 ºC for 5 min. Upon 
finishing the rubber septum was replaced with a PTFE plug, and the sealed tube was 
placed in a 100 ºC oil bath. The reaction mixture was stirred at 100 ºC for 4 h before it 
was allowed to cool down to 22 ºC naturally.  
Olefin dihydroxylation step 
N
Cbz 1) GII (5 mol%)
    EtOAc (0.1 M), rt
2) N2/H2 (95:5), rt, 5 min,
   then 100 °C, 4 h
N
Cbz
OH
OH
3.79 3.913) LaCl3•7H2O (25 mol%)
EtOAc/MeCN/H2O    (10:10:1), 0 °C
NaIO4 (1.5 equiv)
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In a 50 mL round bottom flask containing a stir bar LaCl3•7H2O (0.0371 g, 0.1 
mmol), 25 mol%) was dissovled in H2O (0.4 mL). NaIO4 (0.128 g, 0.6 mmol, 1.5 equiv) 
was then added in the flask, and the resulting mixture was stirred vigorously at 22 ºC for 
5 min until a white slurry was obtained. The flask was cooled to 0 ºC with an ice bath. 
Acetonitrile (0.8 mL) was added in the pressure tube, and the obtained brown solution 
was added in the cooled flask in one portion via a Pasteur pipette. Acetonitrile (0.2 mL) 
was used to rinse the pressure tube and then added in the flask as well. The reaction 
mixture was stirred vigorously at 0 ºC for ca. 3 h until TLC analysis indicated complete 
consumption of ene-carbamate 3.80. The reaction was quenched with saturated Na2S2O3 
aqueous solution (5.0 mL) at 0 ºC. Then, the ice bath was removed and the mixture was 
further stirred at 22 ºC for 10 min.  
Work-up 
CH2Cl2 (15 mL) was added in the quenched reaction mixture, and the resulting 
biphasic mixture was transferred into a separatory funnel. The organic layer was isolated, 
and the rest aqueous layer was extracted with CH2Cl2 (3×10 mL). The combined organic 
layers were washed with saturated Na2SO3 aqueous solution (15 mL), saturated NaHCO3 
aqueous solution (15 mL) and brine (10 mL) in sequence. The organic phase was dried 
over anhydrous Na2SO4, filtered and concentrated in vacuo. A brown gum was obtained 
as the crude product. 
Purification 
The crude product was first purified by silica gel chromatography (hexanes: ethyl 
acetate = 1:1). Rf = 0.17, developing solvent: hexanes: ethyl acetate = 1:1. The collected 
compound was loaded on a Biotage Si 12+M pre-packed silica gel column (dimensions: 
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12 mm × 15.0 cm, 8.0 g silica gel), and further purified with a Biotage HPFC system 
(eluent: dichloromethane: hexanes: ethanol = 2:2.2:0.1). Rf = 0.19, developing solvent: 
dichloromethane: hexanes: ethanol = 2:2:0.1 (developed three times). The cis and trans 
isomers are partially separable under the second purification conditions. The purified title 
compound was obtained as opaque pale brown gum (0.0609 g, 61% yield) 
Cis-3.91 is a known compound.9b,10g  Our 1H-NMR and 13C-NMR data matches 
the reported literature values.  
 
1H-NMR (500 MHz, CDCl3), carbamate rotamers: δ 7.39 – 7.28 (m, 5H), 
5.73 (d, J = 3.0 Hz, 1H), 5.12 (s, 2H), 4.19 (br s, 1H), 3.82 (br d, J = 10.5 
Hz, 1H), 3.57 (br d, J = 10.0 Hz, 1H), 3.04 (app dt, J = 13.0, 2.5 Hz, 1H), 
2.80 (br s, 1H), 1.83 – 1.74 (m, 1H), 1.74 – 1.60 (m, 2H), 1.55 – 1.39 (m, 1H). 
13C-NMR (126 MHz, CDCl3), carbamate rotamers: δ 156.02 (carbonyl carbon, weak 
signal due to slow relaxation and existence of carbamate rotamers), 136.16, 128.53, 
128.16, 127.94, 76.56, 69.02, 67.53, 38.15, 26.74, 23.46. 
 
1H NMR (500 MHz, CDCl3), two diastereomers and carbamate rotamers, 
δ 7.42 – 7.27 (m, 5H), 5.72 (s, 0.6H), 5.59 (s, 0.4H), 5.11 (s, 2H), 4.43 
(br s, 1H), 3.97 – 3.73 (m, 1.4H), 3.55 (br d, J = 10.0 Hz, 0.6H), 3.17 
(overlapped with a broad peak, app t, J = 11.5 Hz, 1H), 3.03 (overlapped with a broad 
peak, t, J = 12.5 Hz, 1H), 1.97 – 1.56 (m, 3H), 1.54 – 1.35 (m, 1H). 
13C NMR (126 MHz, CDCl3), two diastereomers and carbamate rotamers, δ 156.92 and 
155.94 (carbonyl carbon, weak signals due to slow relaxation and existence of carbamate 
N
Cbz
OH
OH
cis-3.91
N
Cbz
OH
OH
cis/trans-3.91
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rotamers), 136.17, 128.52, 128.51, 128.14, 128.10, 127.92, 127.84, 78.19, 76.54, 69.05, 
67.52, 67.00, 38.85, 38.13, 26.64, 24.88, 23.50, 18.62. 
FTIR (neat): 3384, 2930, 1675, 1423, 1344, 1304, 1255, 1153, 1128, 1070, 1037, 989, 
892, 873, 736, 686 cm-1.  
HSMS (DART+) calcd for C13H16NO3 ([M+H-H2O]+): 234.1130, found: 234.1125. 
 
2,3-Dihydroxy-1-pyrrolidinecarboxylic acid phenymethyl ester 3.95 
 
The title compound was synthesized according to the representative 
procedure, except that the tandem RCM/olefin isomerization step followed 
the procedure of preparation of ene-carbamate 3.86. Benzyl N,N-
diallylcarbamate 3.85 (0.0925 g, 0.4 mmol) was used in the reaction. The crude product 
was first purified by silica gel chromatography (hexanes: ethyl acetate = 1:1.2). Rf = 
0.13, developing solvent: hexanes: ethyl acetate = 1:1.2. The collected compound was 
loaded on a Biotage Si 12+M pre-packed silica gel column (dimensions: 12 mm × 15.0 
cm, 8.0 g silica gel), and further purified with a Biotage HPFC system (eluent: 
dichloromethane: hexanes: ethanol = 2:1.2:0.1). Rf = 0.12, developing solvent: 
dichloromethane: hexanes: ethanol = 2:1:0.1 (developed twice). The cis and trans 
isomers are inseparable under the two purification conditions. The purified title 
compound was obtained as opaque pale brown gum (0.0154 g, 16% yield) 
Diol 3.95 (a cis and trans mixture) is a known compound,11 but the reported NMR 
data does not disclose any defined signal information about the ratio of two diastereomers 
(the reported NMR data was recorded on a 200 MHz NMR instrument). 
N
Cbz
OH
OH
3.95
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1H-NMR (600 MHz, CDCl3), two diastereomers and carbamate rotamers: δ 7.52 – 7.28 
(m, 5H), 5.32 (s, 0.67H), 5.27 (s, 0.33H), 5.21 – 5.06 (m, 2H), 4.30 – 4.09 (m, 1.7H), 
3.67 – 3.53 (m, 2H), 3.16 (s, 0.3H), 2.80 (s, 0.67H), 2.55 (s, 0.32H), 2.28 – 2.16 (m, 1H), 
1.91 – 1.80 (m, 1H). 
13C-NMR (151 MHz, CDCl3), two diastereomers and carbamate rotamers: δ 158.64, 
157.33, 138.87, 131.29, 131.17, 130.94, 130.78, 130.55, 130.50, 89.94, 89.30, 78.81, 
77.99, 69.97, 69.84, 46.94, 46.64, 45.54, 33.10, 32.66, 32.34. 
FTIR (neat): 3391, 2953, 2924, 1679, 1553, 1413, 1351, 1177, 1119, 1096, 1032, 987, 
735, 696, 607 cm-1. 
HSMS (DART+) calcd for C12H14NO3 ([M+H-H2O]+): 220.0974, found: 220.0963. 
 
2,3-Dihydroxy-1-[(4-Methylphenyl)sulfonyl]pyrrolidine 3.96 
 
 The title compound was synthesized according to the representative 
procedure, except that the tandem RCM/olefin isomerization step followed 
the procedure of preparation of ene-sulfonamide 3.90. N,N-diallyl-4-
methylbenzenesulfonamide 3.89 (0.101 g, 0.4 mmol) was used in the reaction. The crude 
product was first purified by silica gel chromatography (hexanes: ethyl acetate = 1:1.2). 
Rf = 0.13, developing solvent: hexanes: ethyl acetate = 1:1.2. The collected compound 
was loaded on a Biotage Si 12+M pre-packed silica gel column (dimensions: 12 mm × 
15.0 cm, 8.0 g silica gel), and further purified with a Biotage HPFC system (eluent: 
dichloromethane: hexanes: methanol = 2:1:0.1). Rf = 0.07, developing solvent: 
dichloromethane: hexanes: methanol = 2:1:0.1. The cis- and trans-isomers are 
N
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inseparable under the two purification conditions. The purified title compound was 
obtained as opaque pale brown gum (0.0369 g, 36% yield). 
Diol 3.96 is a known compound, 38  but we have not found any reported 
characterization data of this compound. 
1H-NMR (500 MHz, CDCl3), two diastereomers: δ 7.80 – 7.69 (m, 2H), 7.32 – 7.25 (m, 
2H), 5.29 (app s, 1H), 4.36 (br s, 0.4H), 4.17 (d, J = 3.0 Hz, 0.6H), 4.03 (br s, 0.6H), 3.96 
(br s, 0.4H), 3.50 (td, J = 9.0, 2.0 Hz, 0.6H), 3.45 (ddd, J = 9.0, 8.5, 4.0 Hz, 0.4H), 3.32 – 
3.24 (app ddd, J = 10.0, 9.0, 6.5 Hz, 0.6H), 3.16 (br d, J = 5.5 Hz, 0.4H), 3.07 (td, J = 
8.5, 7.5 Hz, 0.4H), 2.66 (br d, J = 2.0 Hz, 0.6H), 2.44 – 2.36 (partially overlapped two 
singlets, 3H), 2.27 – 2.18 (m, 0.6H), 2.05 – 1.97 (m, 0.4H), 1.96 – 1.86 (m, 0.4H), 1.81 
(dd, J = 13.5, 7.0 Hz, 0.6H). 
13C-NMR (126 MHz, CDCl3), two diastereomers: δ 143.88, 143.72, 135.36, 135.15, 
129.83, 129.68, 127.38, 127.26, 89.31, 81.79, 75.85, 71.39, 45.55, 43.90, 30.64, 30.34, 
21.52. 
FTIR (neat): 3427, 2954, 1597, 1400, 1326, 1185, 1155, 1090, 1071, 1025, 1012, 985, 
963, 837, 814, 706, 663, 586, 547, 504 cm-1. 
HSMS (DART+) calcd for C11H14NO3S ([M+H-H2O)]+): 240.0694, found: 240.0693. 
 
 
 
 
 
                                                
38 Sunose, M.; Anderson, K. M.; Guy Orpen, A.; Gallagher, T.; Macdonald, S. J. F. Tetrahedron Letters 
1998, 39, 8885-8888. 
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2,3-Dihydroxy-1-piperidinecarboxylic acid tert-butyl ester 3.97 
 
The title compound was synthesized according to the representative 
procedure. tert-Butyl N-3-butenyl-N-2-propenylcarbamate 3.81 (0.0845 g, 
0.4 mmol) was used in the reaction. The crude product was first purified by 
silica gel column chromatography (hexanes: ethyl acetate = 1.2:1). Rf = 0.21, developing 
solvent: hexanes: ethyl aceate = 1:1. The collected compound was loaded on a Biotage Si 
12+M pre-packed silica gel column (dimensions: 12 mm × 15.0 cm, 8.0 g silica gel), and 
further purified with a Biotage HPFC system (eluent: dichloromethane: hexanes: ethanol 
= 2:3:0.15). Rf = 0.23, developing solvent: dichloromethane: hexanes: ethanol = 2:3:0.15 
(developed three times). The cis and trans isomers are partially separable under the 
second purification conditions. The purified title compound was obtained as an off-white 
solid (0.0351 g, 40% yield). 
Cis-3.91 is a known compound.9b Our 1H-NMR and 13C-NMR data matches the 
reported literature values.  
 
1H-NMR (600 MHz, CDCl3), carbamate rotamers: δ 5.66 (s, 1H), 3.73 (s, 
1H), 3.63 – 3.51 (m, 1H), 2.95 (app t, J = 10.5 Hz, 1H), 2.59 (s, 1H), 1.94 
(s, 1H), 1.86 – 1.75 (m, 1H), 1.74 – 1.53 (m, 3H), 1.53 – 1.36 (a singlet 
overlapped with other peaks, m, 10H). 
13C-NMR (151 MHz, CDCl3), carbamate rotamers: δ 157.92(carbonyl carbon, weak 
signal due to slow relaxation and existence of carbamate rotamers), 83.29, 79.05, 71.72, 
40.68, 30.99, 29.60, 26.13. 
N
Boc
OH
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1H-NMR (600 MHz, CDCl3), two diastereomers and carbamate 
rotamers: δ 5.65 (s, 0.67H), 5.48 (s, 0.33H), 4.11 – 3.39 (m, 2H), 3.10 
(dt, J = 12.6, 2.4 Hz, 0.33H), 2.95 (app t, J = 13.2 HZ, 0.67H), 2.70 (s, 
1H), 2.52 (br s, 0.5H), 2.03 (s, 0.5H), 1.95 – 1.58 (m, 3H), 1.53 – 1.36 (a singlet 
overlapped with other peaks, m, 10H). 
13C-NMR (151 MHz, CDCl3), two diastereomers and carbamate rotamers: δ 158.93 and 
157.97 (carbonyl carbon, weak signals due to slow relaxation and existence of carbamate 
rotamers), 83.35, 83.28, 80.87, 78.94, 71.73, 69.80, 41.53, 40.70, 31.02, 30.99, 29.57, 
27.73, 21.37. 
FTIR (neat): 3411, 2975, 2935, 1673, 1415, 1392, 1366, 1268, 1253, 1174, 1149, 1071, 
990, 877 cm-1.  
HSMS (DART+) calcd for C10H18NO3 ([M+H-H2O]+): 200.1287, found: 200.1280. 
 
2,3-Dihydroxy-1-[(4-Methylphenyl)sulfonyl]piperidine 3.98 
 
The title compound was synthesized according to the representative 
procedure, except that the tandem RCM/olefin isomerization step followed 
the procedure of preparation of ene-sulfonamide 3.78. N-3-Butenyl-4-
methyl-N-2-propenylbenzenesulfonamide 3.77 (0.106 g, 0.4 mmol) and GII (0.034 g, 
0.04 mmol) were used in the reaction. The crude product was first purified by silica gel 
column chromatography (hexanes: ethyl acetate = 1:1). Rf = 0.15, developing solvent: 
hexanes: ethyl acetate = 1:1. The collected compound was further purified with by silica 
gel column chromatography (dichloromethane: hexanes: ethanol = 2:1.5:0.05). Rf = 0.12, 
N
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developing solvent: dichloromethane: hexanes: ethanol = 2:1.2:0.05 (developed three 
times). The cis and trans isomers are inseparable under the above two purification 
conditions. The purified title compound was obtained as an off-white solid (0.0806 g, 
74% yield). 
Diol 3.96 is a known compound,39 but we have not found any reported 
characterization data of this compound. 
1H-NMR (500 MHz, acetone-d6), two diastereomers: δ 7.82 – 7.74 (overlapped peaks, m, 
2H), 7.40 – 7.32 (overlapped peaks, m, 2H), 5.49 (app t, J = 4.0 Hz, 0.86H), 5.41 (dd, J = 
5.0, 3.0 Hz, 0.14H), 4.82 (app dd, J = 5.5, 0.5 Hz, 0.14H), 4.54 – 4.45 (app dd, J = 4.5, 
0.5 Hz, 0.86H), 3.96 (d, J = 5.0 Hz, 0.14H), 3.91 (d, J = 6.5 Hz, 0.86H), 3.81 – 3.77 (m, 
0.14H), 3.61 – 3.54 (m, 0.86H), 3.41 – 3.34 (m, 1H), 2.77 (td, J = 12.0, 2.5 Hz, 1H), 2.45 
– 2.38 (two overlapped singlets, 3H), 1.74 – 1.48 (m, 4H). 
13C-NMR (126 MHz, acetone-d6), two diastereomers: δ 142.97, 137.50, 129.22, 129.11, 
127.77, 127.68, 79.46, 78.37, 69.60, 67.30, 39.77, 39.08, 26.12, 24.59, 23.67, 20.46, 
18.58. 
FTIR (neat): 3460, 2946, 1325, 1305, 1286, 1157, 1108, 1090, 1057, 1019, 991, 927, 889, 
814, 761, 660, 586, 563, 542, 511 cm-1. 
HSMS (DART+) calcd for C12H16NO3S ([M+H-H2O]+): 254.0851, found: 254.0858. 
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Hexahydro-2,3-dihydroxy-1H-azepine-1-carboxylic acid phenylmethyl ester 3.99 
 
  The title compound was synthesized according to the representative 
procedure, except that the tandem RCM/olefin isomerization step 
followed the procedure of preparation of ene-carbamate 3.84. Benzyl N-
4-pentenyl-N-2-propenylcarbamate 3.83 (0.052 g, 0.2 mmol) and GII (0.017, 0.02 mmol, 
10 mol%) were used in the reaction. The crude product was first purified by silica gel 
column chromatography (hexanes: ethyl acetate = 1:1). Rf = 0.15, developing solvent: 
hexnaes: ethyl acetat = 1:1. The collected compound was loaded on a Biotage Si 12+M 
pre-packed silica gel column (dimensions: 12 mm × 15.0 cm, 8.0 g silica gel), and further 
purified with a Biotage HPFC system (eluent: dichloromethane: hexanes: ethanol = 
2:2:0.1). Rf = 0.16, developing solvent: dichloromethane: hexanes: ethanol = 2:1.6:0.1 
(developed twice). The cis and trans isomers are inseparable under the two purification 
conditions. The purified title compound was obtained as opaque pale brown gum (0.0153 
g, 29% yield). 
1H-NMR (600 MHz, CDCl3), two diastereomers and carbamate rotamers: δ 7.42 – 7.29 
(m, 5H), 5.29 – 5.21 (m, 1H), 5.20 – 5.10 (m, 2H), 4.02 (br s, 0.63H), 3.91 (br d, J = 11.4 
Hz, 0.5H), 3.81 – 3.72 (m, 1.5H), 3.15 (br s, 0.37H), 2.97 (app dd, J = 15.0, 11.4 Hz, 
0.63H), 2.89 (app dd, J = 14.4, 10.8 Hz, 0.37H), 2.71 (br s, 0.63H), 2.63 (br s, 0.37H) 
1.90 – 1.75 (m, 2H), 1.75 – 1.66 (m, 1H), 1.62 (app q, J = 11.4 Hz, 1H), 1.53 – 1.37 (m, 
2H). 
13C-NMR (151 MHz, CDCl3), two diastereomers and carbamate roatmers: δ 159.38, 
158.13, 138.90, 138.79, 131.32, 131.20, 130.98, 130.79, 130.73, 130.42, 87.61, 87.59, 
N
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87.11, 77.96, 77.93, 77.63, 77.59, 70.34, 70.13, 45.08, 45.04, 34.84, 34.68, 31.66, 31.31, 
28.62, 28.20. 
FTIR (neat): 3390, 2931, 2855, 1676, 1453, 1418, 1336, 1278, 1174, 1040, 991, 969, 
843, 771, 735, 696 cm-1. 
HSMS (DART+) calcd for C14H18NO3 ([M+H-H2O]+): 248.1289, found: 248.1285. 
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